
<html lang="en"     class="pb-page"  data-request-id="4920d4ad-0246-4ab5-8856-083bd75778b4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm201649s;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-10;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy" /></meta><meta name="dc.Creator" content="Jonathan A.  Lee" /></meta><meta name="dc.Creator" content="Mark T.  Uhlik" /></meta><meta name="dc.Creator" content="Christopher M.  Moxham" /></meta><meta name="dc.Creator" content="Dirk  Tomandl" /></meta><meta name="dc.Creator" content="Daniel J.  Sall" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 23, 2012" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201649s" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201649s" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201649s" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201649s" /></link>
        
    
    

<title>Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201649s" /></meta><meta property="og:title" content="Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201649s"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201649s">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201649s&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201649s&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201649s&amp;href=/doi/10.1021/jm201649s" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4527-4538</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm300035p" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+A.++Lee">Jonathan A. Lee</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+T.++Uhlik">Mark T. Uhlik</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+M.++Moxham">Christopher M. Moxham</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dirk++Tomandl">Dirk Tomandl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+J.++Sall">Daniel J. Sall</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Departments of <sup>†</sup>Quantitative Biology, <sup>‡</sup>Cancer-Angiogenesis, <sup>§</sup>Discovery Informatics, and <sup>∥</sup>Discovery Chemistry Research and Technologies, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">⊥</span> <span class="aff-text">ImClone Systems, a Wholly Owned Subsidiary of Eli Lilly and Company, New York, New York</span></div><div class="corresp-info"><strong>*</strong>Phone: 317-277-8123. Fax: 317-276-6009. E-mail: <a href="/cdn-cgi/l/email-protection#ddb7b2b3bca9b5bcb382bc82b1b8b89db1b4b1b1a4f3beb2b0"><span class="__cf_email__" data-cfemail="8ce6e3e2edf8e4ede2d3edd3e0e9e9cce0e5e0e0f5a2efe3e1">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201649s&amp;href=/doi/10.1021%2Fjm201649s" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4527–4538</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 12, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 December 2011</li><li><span class="item_label"><b>Published</b> online</span>23 March 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 May 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201649s" title="DOI URL">https://doi.org/10.1021/jm201649s</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4527%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJonathan%2BA.%2BLee%252C%2BMark%2BT.%2BUhlik%252C%2BChristopher%2BM.%2BMoxham%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D10%26contentID%3Djm201649s%26title%3DModern%2BPhenotypic%2BDrug%2BDiscovery%2BIs%2Ba%2BViable%252C%2BNeoclassic%2BPharma%2BStrategy%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4538%26publicationDate%3DMay%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201649s"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6295</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">137</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201649s" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;A. Lee&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;T. Uhlik&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;M. Moxham&quot;},{&quot;first_name&quot;:&quot;Dirk&quot;,&quot;last_name&quot;:&quot;Tomandl&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;J. Sall&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;4527-4538&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201649s&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201649s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201649s" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201649s&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201649s" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201649s&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201649s" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201649s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201649s&amp;href=/doi/10.1021/jm201649s" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201649s" /></input><a href="/doi/pdf/10.1021/jm201649s" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201649s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201649s%26sid%3Dliteratum%253Aachs%26pmid%3D22409666%26genre%3Darticle%26aulast%3DLee%26date%3D2012%26atitle%3DModern%2BPhenotypic%2BDrug%2BDiscovery%2BIs%2Ba%2BViable%252C%2BNeoclassic%2BPharma%2BStrategy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D10%26spage%3D4527%26epage%3D4538%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292183" title="Angiogenesis">Angiogenesis</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291583" title="Mathematical methods">Mathematical methods</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jmcmar.2012.55.issue-10/production/jmcmar.2012.55.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The pharmaceutical industry (Pharma) is currently facing unprecedented challenges. In addition to strategic patent expirations, the rate of drug launches has been essentially constant for 60 years<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> with overall productivity falling since the 1970s.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Similarly, the appearance of novel targets to FDA approved drugs, a measure of industry innovation, has not dramatically improved since the 1980s.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Although Pharma productivity is a multifaceted problem, detailed analyses of comprehensive, industry-wide data indicate that late stage clinical failures are a major contributor that has been attributed to poor target validation (TV) and the lack of predictive biomarkers that translate to the clinic.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In the spirit of “reinventing innovation”<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Pharma needs to introspectively identify areas for improvement. This communication considers how choices in drug screening strategies may relate to target validation issues and influence the probability of identifying novel medicines.</div><div class="NLM_p">Target-directed drug discovery (TDD) and phenotypic drug discovery (PDD) are Pharma strategies that have roots in distinct but complementary philosophies. Advantages of gene-specific, reductionist approaches include the formulation and testing of specific molecular hypotheses. TDD approaches utilize advances in automation, biochemistry, structural biology, and chemistry related technologies to provide efficient and high capacity testing of unprecedented numbers of compounds and molecular targets.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In addition, deep mining of cDNA expressed sequence tags (ESTs)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and subsequently entire genomes<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> led to the discovery of thousands of unknown genes and the potential for deep insight into novel drug target biology. Taken together, these advances in science and technology, in conjunction with the innate human desire to seek new challenges, contributed to the rapid adoption of molecular-reductionist views of biology. In contrast, PDD tests compounds in complex biological systems and monitors physiological responses with minimal assumptions concerning the participation of specific molecular targets and/or signaling pathways.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Analyses of new molecular entities (NMEs) approved by the FDA between 1999 and 2008 indicate that for first in class molecules, 37% resulted from projects that used phenotypic screening whereas target based screening identified 23%; moreover, the discovery rate of PDD NMEs was greater than TDD NMEs and was invariant over the 9-year study period.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Since significantly more TDD efforts were conducted during this period,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> the overall launch rate for first in class drugs underestimates the intrinsic probability of technical success (pTS) of classic PDD.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">A hybrid of classic phenotypic and target-directed strategies, which blends the use of physiologically relevant biological systems with the high throughput and statistical robustness of modern assay technologies, may have a higher pTS for launching first in class drugs than either classic PDD or TDD. Academia has utilized modern phenotypic approaches to study cell cycle, stem cell renewal, cell migration, metastasis, and induction of pluripotent stem cells.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15">(11-15)</a> However, such “neoclassic” PDD approaches are not widely used in Pharma because of concerns about assay performance, statistical robustness, perceived difficulties in establishing compound structure–activity relationships (SARs), anticipated limited applicability of chemoinformatics tools, and the difficulty/requirement for elucidating a molecular drug target.</div><div class="NLM_p last">The results outlined in this presentation address commonly perceived issues related to the use of complex biological systems for modern lead generation. Our data, using an angiogenesis assay incorporating a coculture of primary human endothelial and stromal progenitor cells, indicate that phenotypic assays can be statistically robust, can be used to identify novel compound scaffolds by chemoinformatics enabled hit expansion, and can provide evidence of compound structure–activity relationships. Identification of novel molecular targets important to angiogenesis, acetyl Co-A carboxylase (ACC) and a protein related to cellular β-secretase (β-sec) activity, demonstrates that PDD provides a means to test multiple biologically relevant pathways in a target agnostic fashion. These attributes of PDD enabled the discovery of chemical scaffolds that were readily differentiated, structurally and mechanistically, from antiangiogenic agents that constitute the current standard of care (SOC) and demonstrated in vivo activity. We conclude that PDD complements gene-specific target-directed strategies, may mitigate TV risks, and has the potential to enhance innovation in drug discovery.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41077" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41077" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Phenotypic Assay Systems</h3><div class="NLM_p last">Modern phenotypic assays should capture key aspects of the physiological process such as relevant cell types, cell–cell interactions, growth factors, signal transduction pathways, and molecular targets while utilizing in vitro systems amenable to rigorous statistical validation and high throughput operations. Angiogenesis is a complex biological process that requires the migration, differentiation, physical interaction, and coordinated cellular signaling of precursor and mature forms of endothelial cells with stromal cells. Although VEGF is recognized as the dominant proangiogenic stimulus, other protein factors modulate angiogenesis.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> Previously we described and statistically validated an in vitro model of neovascularization utilizing a coculture of endothelial (ECFC) and stromal (ADSC) cell precursors.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> ADSCs have pericyte-like qualities,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and collagen-fibrin matrix cocultures of ECFCs/ADSCs form functional blood vessels in vivo.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Therefore, the in vitro ECFC/ADSC assay captures multiple aspects of the biological complexity related to neovascularization with minimal assumptions on the relevance of various signaling pathways and molecular targets. In contrast, use of cellular assays systems that overexpress or monitor specific signaling components relies on the accuracy of previous TV studies and provides focused readouts that may not fully capture the biological complexity of the system.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Phenotypic Screening and Hit Expansion</h3><div class="NLM_p">Marketed drugs that inhibit VEGFR and related receptor tyrosine kinases (RTKs) currently constitute antiangiogenic (AA) SOC.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In order to differentiate from AA SOC, we sought to identify compounds that inhibit endothelial cord formation (ECF) in vitro via non-kinase mechanisms and do not exhibit undesirable cellular mechanisms such as overt cytotoxicity or cell cycle inhibition.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Approximately 32 000 internal compounds originating from target biased screening libraries and unrelated chemical diversity were tested in the ECFC/ADSC coculture system. The distribution of single point (SP) activity (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A) from the medium throughput screen (MTS) is enriched in compounds with high ECF inhibitory activity with 4% of tested compounds showing activity of >2 STD above the mean, corresponding to >60% inhibition (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A, shaded). Compounds active in SP screening were retested in dose response; approximately 65% of single point actives were confirmed. Elimination of actives that were overtly cytotoxic, inhibited cell cycle,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> associated with kinase activity, or had unpromising structures resulted in 194 compounds that inhibited ECF activity with IC<sub>50</sub> < 6 uM. These compounds were subsequently used to search for additional compounds within the Lilly collection using structure based chemoinformatics approaches and traditional medicinal chemistry principles. This hit expansion (HE) process and subsequent compound clustering identified 19 000 compounds that were tested in SP mode. The SP activity distribution (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B) from the first two rounds of HE exhibits a significant enrichment in active compounds relative to the primary screen (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) with nearly 11% and 5% of compounds exhibiting >60% and >90% ECF inhibition, respectively.</div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/medium/jm-2011-01649s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Screening results of medium throughput in vitro angiogenesis assay. (A) Phenotypic primary screening: activity distribution of single point testing data of 32 000 compounds. Compounds were tested at 2 μM as described.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The mean percent inhibition was −8.2%. 3.7% and 1.9% of tested compounds were ≥2STD and >3STD above the mean (shaded) corresponding to >60% and >90% endothelial cord inhibition, respectively. (B) Phenotypic hit expansions. Compounds with confirmed endothelial cord inhibition activity, no overt cytotoxicity, and no predicted/known kinase activity were used as seeds for virtual screening of the Lilly compound collection as described in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. 19 000 compounds relating to similar structures and novel scaffolds were identified and tested as described for the primary screen. The observed mean of the single point data distribution is significantly shifted toward higher cord area inhibitory activity (10%) with 10.6% and 4.8% of tested compounds exhibiting >60% and >90% inhibition, respectively (shaded).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> summarizes the discovery of unique chemical clusters of compounds showing >60% SP ECF inhibition. The MTS identified a total of 654 active compound clusters, 178 of which were represented in subsequent HE testing. Significantly, HE identified 1017 additional active chemical clusters that were distinct from compounds within the original screening libraries. Analysis of the compounds that had confirmed ECF activity without overt cytotoxicity indicates that virtual screening and chemoinformatics methods such as similarity searching, 2D scaffold hopping, 3D-ROCS, and machine learning methods identified active, noncytotoxic compounds. These observations indicate that structure–activity relationships can be successfully modeled with phenotypic end points to identify active novel chemical diversity even when MOA and exact molecular target(s) are unknown.</div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/medium/jm-2011-01649s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Phenotypic actives are structurally diverse. Unique compound clusters observed during the medium throughput screen and hit expansion phases are indicated. Screening actives were confirmed and triaged as described in the text; 194 compounds were used as “seeds” for similarity searching and scaffold hopping by chemoinformatics interrogation of the Lilly compound collection for the first round of hit expansion. The number of unique clusters corresponding to active compounds (single point activity >60%) from the 32 000 compound primary screen and the collective 19 000 compounds from two hit expansions are indicated. Of the 1195 active compound clusters identified after hit expansion, 178 clusters (∼4700 compounds) were observed in the medium throughput screen and 1017 clusters (∼8800 compounds) were novel active chemical scaffolds. 476 chemical scaffolds (∼4300 compounds) active in the screen were either deprioritized using criteria given in the text or were inactive upon retest.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Biological Diversity of Phenotypic Actives</h3><div class="NLM_p">Mining of biological activity databases in conjunction with results visualization using heat maps composed of target class phylogenetic trees provides a means to visualize known and predicted biochemical activity and selectivity of compounds.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A summarizes the activity profiles of four confirmed actives from the ECF screen; three compounds show predominant kinase, GPCR, or NHR activity with multiple activities observed within and across target families (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). Follow-up on SP actives from hit expansion 1 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B) identified 451 compounds that inhibited angiogenesis in a dose dependent manner with IC<sub>50</sub> ≤ 3.5 uM and exhibited desired cell cycle and cytotoxicity phenotypes.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B summarizes the ECF potency and predominant molecular target class known to be modulated by these compounds. Potent ECF inhibition is observed for compounds with known kinase activity (31.9%), an expected result given the known importance of VEGF and RTKs to angiogenesis.<a onclick="showRef(event, 'ref17 ref23'); return false;" href="javascript:void(0);" class="ref ref17 ref23">(17, 23)</a> Interestingly, potent ECF inhibition is observed with compounds with known activities on GPCRs (21.5%), NHRs (4.9%), and PDEs (2.4%), target families not commonly associated with angiogenesis (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). Significantly, 39.2% of ECF inhibitors and their structural analogues did not have activity in any biochemical assay in which they were tested (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Although this analysis suffers from the caveat that compounds are not systematically tested in all available biochemical assays, an issue that is somewhat mitigated by interrogation of databases with compounds that are structurally similar to query molecules, the approach provides an overall view of the biochemical activities associated with ECF inhibitors derived from phenotypic screening. These results are consistent with the notion that phenotypic lead generation broadly interrogates multiple signaling pathways and molecular targets in an unbiased fashion. Although speculative, the high percentage of confirmed inhibitors with unknown biochemical activity (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B) suggests that PDD readily identifies compounds that utilize novel mechanisms and/or molecular targets.</div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/medium/jm-2011-01649s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Phenotypic actives utilize diverse molecular mechanisms. 451 confirmed inhibitors of endothelial cord formation (IC<sub>50</sub> < 3.5 μM) which did not display overt cytotoxicity or cell cycle activity<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> were identified following hit expansion 1. (A) Visualization of known and predicted biochemical activities of four endothelial cord formation inhibitors using a heat map display based on the phylogenetic diagrams of the kinase, GPCR, NHR, and PDE target families.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Phenotypic actives with predominant biochemical activities in kinase, GPCR, or NHR target families are indicated; a compound without identified activity is designated “unknown”. Color coding is as follows. Red indicates potent activity (EC<sub>50</sub> or IC<sub>50</sub> of ≤10 nM). Green indicates poor activity EC<sub>50</sub> or IC<sub>50</sub> of >10 uM). (B) Distribution of endothelial cord inhibition potencies for confirmed phenotypic actives. Results of database mining were visualized using the phylogenetic-activity display, and compounds were classified on the basis of their predominant biochemical activities or designated “unknown” if no tested or predicted activity was associated with the compound. The predominant target class of phenotypic actives is indicated with the total number of molecules and percentage of molecules found in each target class (inset).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Differentiation of Phenotypic Actives from Standard of Care</h3><div class="NLM_p">Pharma seeks to identify novel therapeutics that are clearly differentiated from and are therapeutically superior to competitor’s compounds. The first approved SOC small molecule inhibitors of angiogenesis were Sutent and Nexavar, which are multitargeted RTK inhibitors that potently act on VEGFR2 and PDGFRβ<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and are approved for use in metastatic renal cell carcinoma. The broad biological and chemical diversity of the confirmed ECF inhibitors from the phenotypic screen (Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) increases the likelihood of identifying AA compounds with novel mechanisms of action (MOA). In order to maximize differentiation from SOC AA, only compounds that did not exhibit biochemical kinase activity were considered further. Similarly, compounds that exhibited overt cytotoxicity or cell cycle inhibition, undesirable cellular AA mechanisms,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> were eliminated. Finally only compound scaffolds that had promising structures, were amenable to synthetic chemistry, and possess favorable druglike/physical properties compounds were advanced. Use of multiple and rigorous exclusion criteria enhances the pTS of identifying safe and efficacious druglike molecules, an exercise more relevant to pharmaceutical research than academia where investigating basic biology and identifying novel molecular targets and MOAs are valued.</div><div class="NLM_p">Multiple compound scaffolds fulfilling many of these filter criteria were identified through the phenotypic screen (not shown). The structures of two exemplary ECF inhibitors are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B summarizes the in vitro activities of compounds <b>A</b> and <b>B</b>, their phenotypic profiles, and a comparison to SOC AA drugs Sutent and Nexavar. Compounds <b>A</b> and <b>B</b> inhibit endothelial cord formation with potencies ranging from 21 to 41 nM without overt cytotoxicity in the coculture system, results that are comparable to those of SOC (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). Significantly, the PDD approach readily identified compounds that inhibit ECF through non-kinase mechanisms (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B), an important point of differentiation from SOC and potentially useful for the development of therapeutics for clinical combination with marketed drugs. Significantly, compound <b>A</b> and Sutent both exhibited dramatic in vivo inhibition of angiogenesis in mice bearing U87MG xenograft tumors (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/medium/jm-2011-01649s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of phenotypic actives with antiangiogenesis standards of care. (A) Structures of two compounds identified by the phenotypic endothelial cord assay. (B) Functional comparison of phenotypic actives and antiangiogenesis standard of care, Sutent and Nexavar. The biochemical kinase activity for each molecule is summarized in the kinase phylogenetic-activity display. Color coding is as follows. Red indicates potent activity (EC<sub>50</sub> or IC<sub>50</sub> of ≤10 nM). Green indicates poor activity EC<sub>50</sub> or IC<sub>50</sub> of >10 uM). Phenotypic characterization and determination of EC<sub>50</sub> and IC<sub>50</sub> values used statistically validated assays as summarized in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/medium/jm-2011-01649s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of angiogenesis in vivo. Mice bearing U87MG xenograft tumors were treated with vehicles, compound <b>A</b> (30 mg/kg) or Sutent (10 mg/kg), administered twice a day for 3 days as described in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. Tumors were removed, fixed, sectioned, stained, and examined by fluorescence microscopy as described in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. Total cell number (Hoechst 33342) and the extent of blood vessel network formation, pericyte coverge, and tumor hypoxia were monitored with antibodies to CD31, smooth muscle actin, and Glut-1 respectively. Color coding is as follows: green = CD31 (endothelial tubes); blue = total nuclei; red = smooth muscle actin; yellow = Glut-1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Compound Structure–Activity Relationships and Phenotypic Assays</h3><div class="NLM_p">In order to optimize screening actives, medicinal chemists require in vitro assays that detect compound SAR. It is commonly believed that once active molecules have been identified by phenotypic screens, they are best optimized using gene-specific biochemical assays,<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a> suggesting that assays utilizing complex biological systems lack statistical robustness which limits their SAR utility. Although cell based assays are generally more difficult to enable and validate than biochemical assays, the collective Lilly experience with assays monitoring various cell cycle related end points,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> secretion of ApoE and insulin, endothelial cord formation, osteoblast-like differentiation,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and cell migration<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> indicates that complex cell based assays can support SAR if effort is taken in the design, statistical validation,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and operation of the assay.<a onclick="showRef(event, 'ref18 ref22 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref18 ref22 ref27 ref28">(18, 22, 27, 28)</a></div><div class="NLM_p">By use of statistically validated biochemical, cell based substrate phosphorylation and phenotypic end points to systematically compare the SAR of ∼1000 cell cycle kinase inhibitors, Low et al.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> demonstrated that phenotypic readouts respond to compound structural modifications in an equivalent manner as biochemical and cell based phosphorylation assays when linkage between molecular target and phenotype exists. Similarly, the differential ECF activity of the four diastereomers of compound <b>A</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) suggests that the angiogenesis coculture assay is able to detect specific interactions between the compounds and their respective molecular target(s). The similar potency shifts observed between two phenotypic assays, the ECFC/ADSC angiogenesis and the functional β-secretase assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), suggest that the diastereomers work through a specific, although unknown, ligand–protein interaction. Although investigators have expressed concerns about the ability of phenotypic assays to support SAR<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a> and the optimization of molecular properties,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> our experience (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>)<a onclick="showRef(event, 'ref18 ref22 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref18 ref22 ref27 ref28">(18, 22, 27, 28)</a> and the results of others<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> indicate that this is not a general issue.</div><figure id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/medium/jm-2011-01649s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Molecular targets of phenotypic actives identified by compound structure–activity correlations. (A) Cell based activity correlation between inhibition of acetyl-CoA carboxylase and endothelial cord formation activities for 29 analogues of compound <b>B</b>. Linear regression line is indicated, <i>R</i><sup>2</sup> = 0.81 with <i>p</i> < 0.001. (B) Cell based activity correlation between inhibition of cellular β-secretase and endothelial cord formation activities for 306 analogues of compound <b>A</b>. Linear regression line is indicated, <i>R</i><sup>2</sup> = 0.65 with <i>p</i> < 0.001(inset). A subset of 15 compound <b>A</b> analogues were further tested for activity in biochemical BACE and cellular γ-secretase assays as summarized in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. Linear regression line is indicated, <i>R</i><sup>2</sup> = 0.95 with <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure–Phenotypic Activity Relationships<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/medium/jm-2011-01649s_0006.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table a</sup><p class="last">The potencies of compound <b>A</b> diastereomers were determined in cellular assays measuring inhibition of endothelial cord formation (cord area), ECFC/ADSC cytotoxicity (nuclear count), functional β-secretase, and γ-secretase activities as summarized in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. The decrease in compound potency relative to the 1<i>S</i>,2<i>S</i> diastereomer is indicated in parentheses.</p></div></div><div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Phenotypic Actives and Mechanism of Action</h3><div class="NLM_p">Questions related to the identity of putative molecular drug targets inevitably arise during discussions of PDD. Mining of biochemical activity databases is one method to identify molecular targets associated with a phenotypic activity. Data mining of 1100 ECF inhibitors (IC<sub>50</sub> < 2.5 μM) that were <i>not</i> filtered for kinase or cell cycle inhibition identified clusters of biochemical activities associated with kinases involved with angiogenesis (Abl, CSF1R, EphBs, FGFRs, Flts, KDR, NTRKs, PDGFRs, and Src) and cell cycle (Aurora, CDKs, and CHEK) as expected (not shown). ECF inhibitors with known activities associated with adrenergic α-1B and α-2C and serotonin 2A and 2C receptors were observed; however, follow-up testing with additional compounds targeting these GPCRs did not result in activity correlations between GPCR and ECF activity (data not shown) even though these receptors have been implicated in angiogenesis in other experimental systems.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31-33)</a> These results highlight the importance of signaling and cellular context in the linkage of a molecular target to a biological phenotype.</div><div class="NLM_p">Mining of biochemical activity data also identified ACC and functional β-sec as potential molecular targets associated with AA activity (not shown). Cellular inhibition of ACC by various compound <b>B</b> analogues demonstrated good potency correlations with inhibition of ECF in the ECFC/ADSC coculture system (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A). In addition, inhibition of ECF was observed with a series of structurally distinct, nonspiro ACC inhibitors and soraphen A, a natural product that is a potent ACC inhibitor<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> (data not shown). Taken together, the activity correlations between inhibition of ECF and cellular ACC activity with three structurally distinct compound series suggest that ACC is a likely molecular target for ECF in the ECFC/ADSC coculture system. A role of ACC in angiogenesis has not been previously documented; moreover, existing studies predict that inhibition of ACC via phosphorylation of Ser 77 would lead to increased angiogenesis<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> rather than inhibition of angiogenesis as experimentally observed (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A).</div><div class="NLM_p">Functional correlation between inhibition of cellular β-sec and ECF activity was observed with over 300 analogues of compound <b>A</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B, inset). In order to better characterize the MOA of this series, a subset of these analogues was tested in a proteolysis assay using recombinant IgG construct of the BACE-1 ectodomain<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and a cellular assay that monitors the γ-secretase mediated cleavage of a recombinant Notch-1 construct<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B). Although γ-secretase has multiple roles in angiogenesis (reviewed in ref <a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">40</a>), each of the 15 compound <b>A</b> analogues had undetectable inhibition of Notch-1 cleavage up to 5 μM (not shown) whereas ECF inhibition and functional β-sec activity was potent and highly correlated over a 1000-fold concentration range (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B). These functional β-sec inhibitors also had no discernible effect on proteolysis catalyzed by purified BACE-1-IgG (not shown), suggesting that inhibition of the functional β-sec activity by these analogues may involve (1) additional cellular BACE-1 accessory proteins,<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> (2) BACE-1 dimer interactions that occur in a cellular context but not in BACE-1-IgG,<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> or (3) a protease, distinct from BACE-1, but that has somewhat overlapping cellular activity. In contrast to the well-known roles of γ-secretase in angiogenesis,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> the potential function of BACE-1 or cellular β-sec activity in angiogenesis has been described, to our knowledge, in one publication.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p last">Taken together, these results illustrate how PDD approaches agnostically and simultaneously interrogate multiple molecular targets and signaling pathways of direct biological relevance in a manner that is independent of the veracity of prior target validation studies.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Phenotypic Deconvolution and Molecular Targets of Approved Drugs</h3><div class="NLM_p">The identification of novel molecular targets related to angiogenesis suggests that thorough activity profiling may facilitate the deconvolution of phenotypic actives (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). This approach is limited by the lack of biochemical profiling data due to the operational costs and limited availability of assays needed for comprehensive compound characterization. As a result, 39% of the confirmed ECF inhibitors and their structural analogues did have known biochemical activity (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The difficulty and uncertainty related to the identification of molecular targets for phenotypic actives have been commonly considered a weakness of the PDD approach. In this regard it is important to better understand the scientific, drug discovery, and regulatory rationales that underlie this viewpoint.</div><div class="NLM_p">Life scientists currently enjoy ready access to information on the composition and expression patterns of genes at a genomic scale and possess an unprecedented ability to manipulate and measure biology at the molecular level. Such reaching capabilities have contributed to a molecular-centric view of contemporary biology that may contribute to misconceptions regarding the level of molecular target detail that is required for regulatory submission of an NME. Guidance from the Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research at the Food and Drug Administration indicates that identification of the molecular target for a drug is <i>not</i> required for initiation of clinical trials (<a href="http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071597.pdf" class="extLink">http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071597.pdf</a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Accordingly, 29% of the small molecule NMEs approved by the FDA from 2001 to 2004 (excluding natural products or imaging agents) did not have known molecular targets.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p last">The “one drug, one target paradigm”, a hallmark of gene-specific TDD strategies, sought to minimize off-target side effects.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> However, analysis of known drug–protein interactions has put this “magic bullet paradigm” into question; target specificity is rare for approved drugs with “known” molecular targets.<a onclick="showRef(event, 'ref3 ref50'); return false;" href="javascript:void(0);" class="ref ref3 ref50">(3, 50)</a> Analyses of 890 approved drugs indicate that 788 share molecular targets with at least one other drug.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Extensive mining of seven databases by Mestres et al.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> indicate that on average each drug interacts with six known molecular targets. Given the overall poor target selectivity of knowndrugs<a onclick="showRef(event, 'ref3 ref50'); return false;" href="javascript:void(0);" class="ref ref3 ref50">(3, 50)</a> and that identification of molecular targets is not required for FDA approval, we feel that in vivo efficacy and safety should be the principle criteria for advancing phenotypic therapeutics.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Pharma Reality, Target Validation, and Phenotypic Drug Discovery</h3><div class="NLM_p">Productivity issues in the pharmaceutical industry are multifaceted and have been the subject of many editorial and review articles.<a onclick="showRef(event, 'ref1 ref4 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref1 ref4 ref51 ref52">(1, 4, 51, 52)</a> Analysis indicates that late stage clinical failures remain the primary reason for poor Pharma productivity,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> which has been attributed to poor target validation and the lack of predictive biomarkers that translate to clinical studies.<a onclick="showRef(event, 'ref4 ref53'); return false;" href="javascript:void(0);" class="ref ref4 ref53">(4, 53)</a> Clinically relevant target validation goes beyond mRNA expression profiling and is a difficult, time-consuming process that requires successful integration of biology, chemistry, and pharmacology.<a onclick="showRef(event, 'ref24 ref46 ref54 ref55 ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref24 ref46 ref54 ref55 ref56 ref57 ref58">(24, 46, 54-58)</a> Notable failures in preclinical TV that were invalidated only after compounds advanced to clinical trials include farnesyl transferase,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> matrix metalloproteases,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> and neurokinin receptor.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a>Edwards et al. highlighted the difficulties and high risk associated with TV and suggested that these activities may be best suited for an open access Pharma consortium<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> where precompetitive TV data are shared.</div><div class="NLM_p">TV difficulties have also lessened the impact of the genomics revolution on drug discovery.<a onclick="showRef(event, 'ref51 ref57'); return false;" href="javascript:void(0);" class="ref ref51 ref57">(51, 57)</a> Analysis of the molecular targets for launched drugs from the mid-1980s to mid-2000s reveals that the appearance of new targets has been nearly constant (5 per year) for the past 20 years.<a onclick="showRef(event, 'ref3 ref62'); return false;" href="javascript:void(0);" class="ref ref3 ref62">(3, 62)</a> Moreover, the appearance rate of novel drug targets was not significantly increased by the availability of novel molecular targets identified by deep EST sequencing.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In addition, difficulties in TV<a onclick="showRef(event, 'ref46 ref58'); return false;" href="javascript:void(0);" class="ref ref46 ref58">(46, 58)</a> and the widespread use of gene-specific TDD approaches in Pharma may have focused drug discovery efforts onto a relatively small set of highly validated molecular targets, a scenario that is conceivably related to decreased Pharma innovation and increased numbers of “me too” drugs.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">In contrast to gene-specific TDD approaches, PDD strategies directly interrogate complex biological systems in a molecular agnostic manner. If care is taken to develop in vitro biological systems that capture key aspects of the relevant in vivo biology, PDD expands the molecular playing field from a single molecular target and function to multiple processes, signaling pathways, and molecular functions/targets. It follows that PDD approaches enable the direct chemical interrogation of physiologically relevant biology in a manner that is independent of the target validation status of specific molecular components. This notion that PDD strategies may mitigate TV risk is consistent with Swinney’s observation that PDD approaches led to a higher discovery rate of first in class NMEs approved by the FDA between 1999 and 2008.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">Given the views that late stage clinical failures may be due, in large part, to inadequate TV,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> it may be useful to reevaluate how the choice of a lead generation strategy, one of the earliest decision points in the drug development process, may impact overall pTS. It is noteworthy that the majority of phenotypic assays that identified the majority of first in class NMEs utilized low throughput, physiology based animal or tissue systems and/or tested selected compounds based on prior knowledge.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> These classic PDD approaches are more difficult and lower throughput than target-based approaches which readily incorporate advances in lab automation and high throughput chemical diversity testing. As a result, TDD approaches have become the predominant lead generation strategy used by Pharma.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> We have explored a “neoclassic” hybrid of traditional phenotypic and target directed drug discovery approaches that blend the use of physiologically relevant biological systems with the high throughput and statistical robustness offered by modern technologies. We find that common concerns related to PDD in regard to assay performance, statistical robustness, difficulties in establishing compound structure–activity relationships, and applicability of chemoinformatics tools are not necessarily realized (Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>–<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref18 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref18 ref27 ref28">(18, 27, 28)</a> Identification of phenotypic actives that inhibit ACC and cellular β-sec activity, novel biochemical targets involved in angiogenesis (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), demonstrates that PDD provides a means to agnostically interrogate multiple, biologically relevant pathways and molecular targets in a manner that is independent of their validation status in the scientific literature.<a onclick="showRef(event, 'ref46 ref58'); return false;" href="javascript:void(0);" class="ref ref46 ref58">(46, 58)</a></div><div class="NLM_p">Estimates of the “druggable genome” indicate that roughly 1100 molecular targets have significant primary sequence homology to known drug targets,<a onclick="showRef(event, 'ref3 ref62'); return false;" href="javascript:void(0);" class="ref ref3 ref62">(3, 62)</a> suggesting that greater than 95% of the predicted proteins encoded by the human genome<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> are not modulated by current therapeutics. Results from phenotypic testing of compounds accepted to the Lilly PD<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> initiative demonstrate that small molecules with chemical diversity significantly different from internal collections and known drugs and are therefore likely to have distinct molecular mechanisms<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> had high confirmed hit rates (2–10%) and excellent selectivity between five phenotypic assays.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This observation suggests that high throughput, modern PDD approaches in conjunction with novel chemical diversity provides a means to access novel molecular targets and cellular mechanisms<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and emphasizes the importance of academic–industrial collaborations like the Open Innovation Drug Discovery initiative (<a href="https://openinnovation.lilly.com/dd/" class="extLink">https://openinnovation.lilly.com/dd/</a>).</div><div class="NLM_p last">Chemical diversity is large, and biology is complex. New approaches are needed to enhance our ability to find novel and efficacious therapeutics. Our results indicate that novel chemical diversity in conjunction with a modern, neoclassic PDD strategy may provide a means to identify molecules that modulate physiologically relevant signaling pathways and novel molecular targets, decrease TV risk, and increase the pTS of translating preclinical to clinical results.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Assays</h3><div class="NLM_p last">All cell growth and cell based assay incubations were conducted at 37 °C in a humidified incubator at 5% CO<sub>2</sub> unless otherwise noted. The in vitro angiogenesis model was operated in a 384-well format utilizing a coculture of endothelial and stromal precursor cells, ECFC (Endgenitor)<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> and ADSC (Zen Bio),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> respectively, as described.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The CD31 positive cord area channel was used for single point screening at 2 μM compound; screen actives were confirmed using a 10-point dose response curve utilizing CD31 cord area and total nuclei count as a measure of ECF activity and overt cytotoxicity, respectively.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> ECFC migration was quantitatively measured using the Oris cell migration plates (Platypus Technologies, LLC, Madison, WI) as described.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Cell cycle arrest in G2 or M phase was measured in HeLa (ATCC CCL-2) cells as described.<a onclick="showRef(event, 'ref18 ref27'); return false;" href="javascript:void(0);" class="ref ref18 ref27">(18, 27)</a> Enzymatic activity of soluble human BACE was measured by hydrolysis of a labeled peptide substrate by a purified BACE-IgG construct.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Functional γ-secretase activity was measured in HEK293 cells (ATCC CRL-1573) expressing recombinant human APP by monitoring the production of soluble of APPsβ as described<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> but using an ELISA format and a Lilly propriety mouse monoclonal antibody to the β-secretase neoepitope of hAPP. Functional γ-secretase activity was measured in HEK293 cells expressing a human Notch-1 construct, analogous to the constitutively active mouse NotchΔE<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> lacking an extracellular ligand binding domain. Cellular γ-secretase activity was measured with a Lilly propriety mouse monoclonal antibody to the γ-secretase neoepitope of human Notch-1. Cellular acetyl CoA carboxlyase activity was measured by incorporation of [<sup>14</sup>C]acetate into triacylglycerol (TAG) using modifications of published procedures.<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65, 66)</a> In short, HEK293 cells were switched from growth medium, DMEM medium supplemented with 10% fetal bovine serum and 1% antibiotic–antimycotic (Gibco), to Opti-MEM medium containing the designated compound concentration in 0.2% DMSO. After 1 h, fatty acid labeling was initiated by addition of 30 μM [<sup>14</sup>C]acetate (Amersham, CFA13). After 4 h, the medium was removed and samples were washed with Hank’s balanced salt solution and aspirated dry. Cells were dissolved with Triton X-100 (0.175%) containing basic ethanol and isopropanol at room temperature. Labeled TAG was extracted into a heptane phase and measured by liquid scintillation counting. In vitro assays were statistically validated for run to run plate uniformity by determining the <i>Z</i>′ score<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> between plates of minimum and maximum assay signals. Compound potency reproducibility was validated for day to day variation by using the minimum significant ratio (MSR)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> determined for at least 20 compounds of varying potency. Assays passed Eli Lilly–NIH Chemical Genomics Center guidelines for assay enablement and statistical validation; <i>Z</i>′ > 0.4 and MSR ≤ 3 (<a href="http://spotlite.nih.gov/assay/index.php/Table_of_Contents" class="extLink">http://spotlite.nih.gov/assay/index.php/Table_of_Contents</a>).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Xenograft Studies</h3><div class="NLM_p last">U87MG glioblastoma tumor cells were mixed 1:1 with Matrigel (BD Biosciences) and implanted subcutaneously in the right rear flank of athymic nude female mice (Harlan) at 5.0 × 10<sup>6</sup> cells/injection. Xenografts were grown to an average tumor volume of 250 mm<sup>3</sup>, and the mice were randomized at baseline according to tumor volume and body weight (10/group). Compound <b>A</b> was formulated in 100% peanut oil as the vehicle and administered as subcutaneous injections twice daily for 3 days. Sutent was formulated in 10% acacia and admistered by oral gavage twice daily for 3 days. Three days after treatment, xenografts were excised and placed into zinc-Tris fixative (BD Pharmingen). Tumors were blocked in paraffin and sectioned as 4 μm slices. Slides were baked at 60 °F for 1 h and then deparaffinized in xylene (4 × 10 min); rehydrated with ethanol/water immersions with final washes in TBST; blocked with protein block (Dako) for 30 min; stained with a combination of Hoechst 33324, rat anti-mouse CD31 (Pharmingen)/anti-rat Alexa-488 (Invitrogen), rabbit anti-GLUT1 (Dako)/anti-rabbit Alexa 647 (Invitrogen), and mouse anti-smooth muscle actin/Cy3 (Sigma); imaged using a Marianas digital imaging workstation configured with a Zeiss Axiovert 200M inverted fluorescence microscope (Intelligent Imaging Innovations).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Hit Expansion</h3><div class="NLM_p last">Several rounds of HE were executed using a variety of virtual screening technologies. Substructure and similarity searches utilizing structural fingerprints, Tanimoto similarity, and internal measures were used to fill existing active clusters with structurally similar analogues to explore structure–activity relationships. In order to investigate chemical space not represented in the screening libraries, 2D scaffold-hopping (Lilly tools using 2D pharmacophore descriptors), 2D SVM models,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and 3D ROCS (<a href="http://www.eyesopen.com/rocs" class="extLink">http://www.eyesopen.com/rocs</a>) searches were used. Structural clusters were defined by an internal program that utilizes a variant of leader clustering and Taylor–Butina cluster algorithm<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and several internal chemoinformatics similarity measures.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Data Mining and Visualization</h3><div class="NLM_p last">Pharmacology and biochemical database mining was enabled by a Lilly program that takes a list of query compounds and comprehensively searches internal and external in vitro data associated with the compounds and their structural analogues. The resulting data are visualized either as a heat map of compound activity verses molecular target or as a phylogenetic diagram of GPCR, kinase, NHR, and PDE target families (human kinome provided courtesy of Cell Signaling Technology, Inc., <a href="http://www.cellsignal.com" class="extLink">www.cellsignal.com</a>) with color coded biochemical activity. In both visualization methods, red indicates high activity (EC<sub>50</sub> or IC<sub>50</sub> of ≤10 nM) and green indicates low activity (EC<sub>50</sub> or IC<sub>50</sub> of >10 uM).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm201649s" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71536" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71536" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan A. Lee</span> - <span class="hlFld-Affiliation affiliation">Departments of †Quantitative Biology, ‡Cancer-Angiogenesis, §Discovery Informatics, and ∥Discovery Chemistry
Research and Technologies, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana</span>; 
    <span class="hlFld-Affiliation affiliation">ImClone Systems, a Wholly Owned Subsidiary of Eli Lilly and Company, New York, New
York</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a7cdc8c9c6d3cfc6c9f8c6f8cbc2c2e7cbcecbcbde89c4c8ca"><span class="__cf_email__" data-cfemail="9af0f5f4fbeef2fbf4c5fbc5f6ffffdaf6f3f6f6e3b4f9f5f7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark T. Uhlik</span> - <span class="hlFld-Affiliation affiliation">Departments of †Quantitative Biology, ‡Cancer-Angiogenesis, §Discovery Informatics, and ∥Discovery Chemistry
Research and Technologies, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana</span>; 
    <span class="hlFld-Affiliation affiliation">ImClone Systems, a Wholly Owned Subsidiary of Eli Lilly and Company, New York, New
York</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher M. Moxham</span> - <span class="hlFld-Affiliation affiliation">ImClone Systems, a Wholly Owned Subsidiary of Eli Lilly and Company, New York, New
York</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dirk Tomandl</span> - <span class="hlFld-Affiliation affiliation">Departments of †Quantitative Biology, ‡Cancer-Angiogenesis, §Discovery Informatics, and ∥Discovery Chemistry
Research and Technologies, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana</span>; 
    <span class="hlFld-Affiliation affiliation">ImClone Systems, a Wholly Owned Subsidiary of Eli Lilly and Company, New York, New
York</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel J. Sall</span> - <span class="hlFld-Affiliation affiliation">Departments of †Quantitative Biology, ‡Cancer-Angiogenesis, §Discovery Informatics, and ∥Discovery Chemistry
Research and Technologies, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana</span>; 
    <span class="hlFld-Affiliation affiliation">ImClone Systems, a Wholly Owned Subsidiary of Eli Lilly and Company, New York, New
York</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All authors are employed by Eli Lilly and Company.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13834" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13834" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Jonathan A. Lee</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=bio1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jonathan A. Lee</b>is currently a Senior Research Advisor in the Department of Quantitative Biology. He obtained his Ph.D. in Chemistry from the University of California—San Diego and completed a postdoctoral fellowship at the Roche Institute of Molecular Biology where he investigated structure–function studies of solute transporters using biophysical and molecular approaches. Jonathan was a member of the Macromolecular Sciences Department of SmithKline Beecham from 1989 to 1998 where he was involved in GPCR modeling/structure–function studies and the identification and characterization of orphan GPCRs. Since joining Lilly in 1998, Jonathan has been involved in the development/deployment of multiple discovery technologies. His current focus is on cellular imaging, cell based assay technologies, and phenotypic drug discovery.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Mark T. Uhlik</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=bio2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mark T. Uhlik</b> is a Principal Research Scientist in Oncology Discovery Research at Eli Lilly and Company. Mark received his Ph.D. in Microbiology and Immunology from the Pennsylvania State University College of Medicine. After completing postdoctoral training fellowships at University of Colorado Health Sciences Center and University of North Carolina College of Medicine, Dr. Uhlik joined Eli Lilly in the fall of 2004. As a research scientist with Lilly he has led several oncology drug discovery projects, including the Angiogenesis Phenotypic Drug Discovery Project. Dr. Uhlik is also leading multiple efforts in the development and implementation of high content cellular imaging assays and quantitative, multiplexed analysis of tissues.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Christopher M. Moxham</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=bio3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Christopher M. Moxham</b> is currently Associate Vice President at ImClone Systems, a wholly owned subsidiary of Eli Lilly and Co. He received a doctorate in Molecular and Cellular Pharmacology from the State University of New York at Stony Brook in 1993. After completing his postdoctoral training, he joined Wyeth-Ayerst Research in 1996 as a Senior Scientist in the Division of Cardiovascular and Metabolic Diseases. Since joining Lilly as a research scientist in 1999, Dr. Moxham has made significant contributions to programs across multiple therapeutic areas. In addition, he is a scientific leader in Lead Generation and Phenotypic Drug Discovery.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Dirk Tomandl</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=bio4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Dirk Tomandl</b>is an in silico scientist working in the Discovery Informatics Department of Eli Lilly and Company. He obtained his Ph.D. in Physics from the Institute of Molecular Biotechnology in Jena (Germany) and completed postdoctoral studies at Merck KGaA where he investigated sophisticated algorithms for iterative screening using machine learning and evolutionary algorithms. At Graffinity Pharmaceuticals GmBH, Dirk developed a software package to analyze large chemical screening data sets and provided data analysis support for screening projects. Dirk is currently a Senior Research Scientist at Eli Lilly and is involved in cheminformatics support of early phase drug discovery projects as well as method development in the fields of virtual screening, de novo design, and building predictive models.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Daniel J. Sall</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=bio5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Daniel J. Sall</b>is currently a Senior Research Advisor in the Department of Discovery Chemistry Research and Technologies at Eli Lilly & Company. Under the guidance of Professor Gary Grunewald, he obtained a Ph.D. in Medicinal Chemistry from the University of Kansas in 1987. After conducting postdoctoral studies with Professor A. R. Chamberlin at the University of California—Irvine, he joined Lilly in 1989. He has worked on projects in cardiovascular, inflammation, neurosciences, and endocrine research. Currently, Daniel Sall is working in oncology.</p></figure></div><div class="ack" id="ACK-d7e902-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18348" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18348" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Alan Palkowitz, Thomas Engler, Horst Hemmerle, Louis Stancato, and Francis Willard for stimulating discussions on phenotypic drug discovery. We are grateful for the scientific input of Shaoyou Chu, Craig Hammond, Ken Henry, Patrick May, Kuldeep Neote, Jianyong Shou, and Jeffrey Sutherland. We appreciate the expert support of Wendy Gough, Renee Lynch, and Sarah Oliver with the angiogenesis assay. We thank Richard Brier, Yuefeng Chen, Patti Gonzalez-DeWhitt, Jack Eastridge, Julie Stewart, and Kevin Tichenor for technical assistance.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i23" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i23"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i24" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i24"> Abbreviations Used</h2><tr><td class="NLM_term">AA</td><td class="NLM_def"><p class="first last">antiangiogenic</p></td></tr><tr><td class="NLM_term">ACC</td><td class="NLM_def"><p class="first last">acetyl CoA carboxylase</p></td></tr><tr><td class="NLM_term">ADSC</td><td class="NLM_def"><p class="first last">adipose derived stem cell</p></td></tr><tr><td class="NLM_term">β-sec</td><td class="NLM_def"><p class="first last">β-secretase</p></td></tr><tr><td class="NLM_term">ECF</td><td class="NLM_def"><p class="first last">endothelial cord formation</p></td></tr><tr><td class="NLM_term">EST</td><td class="NLM_def"><p class="first last">expressed sequence tag</p></td></tr><tr><td class="NLM_term">ECFC</td><td class="NLM_def"><p class="first last">endothelial colony forming cell</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">IgG</td><td class="NLM_def"><p class="first last">immunoglobulin G</p></td></tr><tr><td class="NLM_term">MOA</td><td class="NLM_def"><p class="first last">mechanism of action</p></td></tr><tr><td class="NLM_term">MTS</td><td class="NLM_def"><p class="first last">medium throughput screen</p></td></tr><tr><td class="NLM_term">NHR</td><td class="NLM_def"><p class="first last">nuclear hormone receptor</p></td></tr><tr><td class="NLM_term">NME</td><td class="NLM_def"><p class="first last">new molecular entity</p></td></tr><tr><td class="NLM_term">PDD</td><td class="NLM_def"><p class="first last">phenotypic drug discovery</p></td></tr><tr><td class="NLM_term">Pharma</td><td class="NLM_def"><p class="first last">pharmaceutical industry</p></td></tr><tr><td class="NLM_term">pTS</td><td class="NLM_def"><p class="first last">probability of technical success</p></td></tr><tr><td class="NLM_term">PDE</td><td class="NLM_def"><p class="first last">phosphodiesterase</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SOC</td><td class="NLM_def"><p class="first last">standard of care</p></td></tr><tr><td class="NLM_term">SP</td><td class="NLM_def"><p class="first last">single point</p></td></tr><tr><td class="NLM_term">TDD</td><td class="NLM_def"><p class="first last">targeted drug discovery</p></td></tr><tr><td class="NLM_term">TV</td><td class="NLM_def"><p class="first last">target validation</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06773" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06773" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 68 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Munos, B.</span><span> </span><span class="NLM_article-title">Lessons from 60 years of pharmaceutical innovation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">968</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnrd2961" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=19949401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2gtrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=959-968&author=B.+Munos&title=Lessons+from+60+years+of+pharmaceutical+innovation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from 60 years of pharmaceutical innovation</span></div><div class="casAuthors">Munos, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">959-968</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite unprecedented investment in pharmaceutical research and development (R&D), the no. of new drugs approved by the US Food and Drug Administration (FDA) remains low.  To help understand this conundrum, this article investigates the record of pharmaceutical innovation by analyzing data on the companies that introduced the ∼1,200 new drugs that have been approved by the FDA since 1950.  This anal. shows that the new-drug output from pharmaceutical companies in this period has essentially been const., and remains so despite the attempts to increase it.  This suggests that, contrary to common perception, the new-drug output is not depressed, but may simply reflect the limitations of the current R&D model.  The implications of these findings and options to achieve sustain-ability for the pharmaceutical industry are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5CrUftSjUirVg90H21EOLACvtfcHk0lgcKXXZwmvbrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2gtrbK&md5=dd36497b2a0788257333322f77df81bc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd2961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2961%26sid%3Dliteratum%253Aachs%26aulast%3DMunos%26aufirst%3DB.%26atitle%3DLessons%2520from%252060%2520years%2520of%2520pharmaceutical%2520innovation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D959%26epage%3D968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Booth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zemmel, R.</span><span> </span><span class="NLM_article-title">Prospects for productivity</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnrd1384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=15136792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlCrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=451-456&author=B.+Boothauthor=R.+Zemmel&title=Prospects+for+productivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Prospects for productivity</span></div><div class="casAuthors">Booth, Bruce; Zemmel, Rodney</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">451-456</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Long-term declines in the productivity of pharmaceutical R&D threaten the sustainability of the current business model.  A major driver of the decline has been the rising cost, and increased rate of failure, of projects across the industry, caused in part by the confluence of new approaches, novel technologies, higher go/no-go hurdles and organizational challenges.  Here we examine several of the top culprits that are charged with driving this decline and the merits of the cases against them, and speculate on the emerging trends that will underpin the industry's future productivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc_IXtrQEaVbVg90H21EOLACvtfcHk0lgcKXXZwmvbrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlCrt7g%253D&md5=1d6d46ca196aecbd4bf95b57e00592e2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd1384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1384%26sid%3Dliteratum%253Aachs%26aulast%3DBooth%26aufirst%3DB.%26aulast%3DZemmel%26aufirst%3DR.%26atitle%3DProspects%2520for%2520productivity%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D451%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Yildirim, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusick, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabasi, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, M.</span><span> </span><span class="NLM_article-title">Drug–target network</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1119-1126&author=M.+A.+Yildirimauthor=K.+I.+Gohauthor=M.+E.+Cusickauthor=A.+L.+Barabasiauthor=M.+Vidal&title=Drug%E2%80%93target+network"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYildirim%26aufirst%3DM.%2BA.%26aulast%3DGoh%26aufirst%3DK.%2BI.%26aulast%3DCusick%26aufirst%3DM.%2BE.%26aulast%3DBarabasi%26aufirst%3DA.%2BL.%26aulast%3DVidal%26aufirst%3DM.%26atitle%3DDrug%25E2%2580%2593target%2520network%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D1119%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Paul, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mytelka, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunwiddie, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persinger, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munos, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindborg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schacht, A. L.</span><span> </span><span class="NLM_article-title">How to improve R&D productivity: the pharmaceutical industry’s grand challenge</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnrd3078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=20168317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=203-214&author=S.+M.+Paulauthor=D.+S.+Mytelkaauthor=C.+T.+Dunwiddieauthor=C.+C.+Persingerauthor=B.+H.+Munosauthor=S.+R.+Lindborgauthor=A.+L.+Schacht&title=How+to+improve+R%26D+productivity%3A+the+pharmaceutical+industry%E2%80%99s+grand+challenge"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">How to improve R&D productivity: the pharmaceutical industry's grand challenge</span></div><div class="casAuthors">Paul, Steven M.; Mytelka, Daniel S.; Dunwiddie, Christopher T.; Persinger, Charles C.; Munos, Bernard H.; Lindborg, Stacy R.; Schacht, Aaron L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The pharmaceutical industry is under growing pressure from a range of environmental issues, including major losses of revenue owing to patent expirations, increasingly cost-constrained healthcare systems and more demanding regulatory requirements.  In our view, the key to tackling the challenges such issues pose to both the future viability of the pharmaceutical industry and advances in healthcare is to substantially increase the no. and quality of innovative, cost-effective new medicines, without incurring unsustainable R&D costs.  However, it is widely acknowledged that trends in industry R&D productivity have been moving in the opposite direction for a no. of years.  Here, we present a detailed anal. based on comprehensive, recent, industry-wide data to identify the relative contributions of each of the steps in the drug discovery and development process to overall R&D productivity.  We then propose specific strategies that could have the most substantial impact in improving R&D productivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY67PCIhaBVLVg90H21EOLACvtfcHk0lgxk_15VxTwfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D&md5=2f32bcc48c869290eef18ff9400afcc5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd3078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3078%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DMytelka%26aufirst%3DD.%2BS.%26aulast%3DDunwiddie%26aufirst%3DC.%2BT.%26aulast%3DPersinger%26aufirst%3DC.%2BC.%26aulast%3DMunos%26aufirst%3DB.%2BH.%26aulast%3DLindborg%26aufirst%3DS.%2BR.%26aulast%3DSchacht%26aufirst%3DA.%2BL.%26atitle%3DHow%2520to%2520improve%2520R%2526D%2520productivity%253A%2520the%2520pharmaceutical%2520industry%25E2%2580%2599s%2520grand%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D203%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Lechleiter, J. C.</span><span> </span><span class="NLM_article-title">Lilly COE Lechleiter Calls for Repair of the “Engine of Biopharma Innovation”</span>;<span class="NLM_x"> </span><span class="NLM_year">2009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+C.+Lechleiter&title=Lilly+COE+Lechleiter+Calls+for+Repair+of+the+%E2%80%9CEngine+of+Biopharma+Innovation%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLechleiter%26aufirst%3DJ.%2BC.%26atitle%3DLilly%2520COE%2520Lechleiter%2520Calls%2520for%2520Repair%2520of%2520the%2520%25E2%2580%259CEngine%2520of%2520Biopharma%2520Innovation%25E2%2580%259D%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Macarron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojanic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirovic, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garyantes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertzberg, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paslay, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schopfer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sittampalam, G. S.</span><span> </span><span class="NLM_article-title">Impact of high-throughput screening in biomedical research</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnrd3368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=21358738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFensbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=188-195&author=R.+Macarronauthor=M.+N.+Banksauthor=D.+Bojanicauthor=D.+J.+Burnsauthor=D.+A.+Cirovicauthor=T.+Garyantesauthor=D.+V.+Greenauthor=R.+P.+Hertzbergauthor=W.+P.+Janzenauthor=J.+W.+Paslayauthor=U.+Schopferauthor=G.+S.+Sittampalam&title=Impact+of+high-throughput+screening+in+biomedical+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of high-throughput screening in biomedical research</span></div><div class="casAuthors">Macarron, Ricardo; Banks, Martyn N.; Bojanic, Dejan; Burns, David J.; Cirovic, Dragan A.; Garyantes, Tina; Green, Darren V. S.; Hertzberg, Robert P.; Janzen, William P.; Paslay, Jeff W.; Schopfer, Ulrich; Sittampalam, G. Sitta</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">188-195</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  High-throughput screening (HTS) has been postulated in several quarters to be a contributory factor to the decline in productivity in the pharmaceutical industry.  Moreover, it has been blamed for stifling the creativity that drug discovery demands.  In this article, we aim to dispel these myths and present the case for the use of HTS as part of a proven scientific tool kit, the wider use of which is essential for the discovery of new chemotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLnrSVehADbLVg90H21EOLACvtfcHk0lgxk_15VxTwfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFensbY%253D&md5=cb9853227506f3a3d774791cff9fd79d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd3368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3368%26sid%3Dliteratum%253Aachs%26aulast%3DMacarron%26aufirst%3DR.%26aulast%3DBanks%26aufirst%3DM.%2BN.%26aulast%3DBojanic%26aufirst%3DD.%26aulast%3DBurns%26aufirst%3DD.%2BJ.%26aulast%3DCirovic%26aufirst%3DD.%2BA.%26aulast%3DGaryantes%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DD.%2BV.%26aulast%3DHertzberg%26aufirst%3DR.%2BP.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DPaslay%26aufirst%3DJ.%2BW.%26aulast%3DSchopfer%26aufirst%3DU.%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26atitle%3DImpact%2520of%2520high-throughput%2520screening%2520in%2520biomedical%2520research%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D188%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Adams, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gocayne, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubnick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polymeropoulos, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merril, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, R. F.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Complementary DNA sequencing: expressed sequence tags and human genome project</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">252</span><span class="NLM_x">, </span> <span class="NLM_fpage">1651</span><span class="NLM_x">–</span> <span class="NLM_lpage">1656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=1991&pages=1651-1656&author=M.+D.+Adamsauthor=J.+M.+Kelleyauthor=J.+D.+Gocayneauthor=M.+Dubnickauthor=M.+H.+Polymeropoulosauthor=H.+Xiaoauthor=C.+R.+Merrilauthor=A.+Wuauthor=B.+Oldeauthor=R.+F.+Moreno&title=Complementary+DNA+sequencing%3A+expressed+sequence+tags+and+human+genome+project"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DM.%2BD.%26aulast%3DKelley%26aufirst%3DJ.%2BM.%26aulast%3DGocayne%26aufirst%3DJ.%2BD.%26aulast%3DDubnick%26aufirst%3DM.%26aulast%3DPolymeropoulos%26aufirst%3DM.%2BH.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DMerril%26aufirst%3DC.%2BR.%26aulast%3DWu%26aufirst%3DA.%26aulast%3DOlde%26aufirst%3DB.%26aulast%3DMoreno%26aufirst%3DR.%2BF.%26atitle%3DComplementary%2520DNA%2520sequencing%253A%2520expressed%2520sequence%2520tags%2520and%2520human%2520genome%2520project%26jtitle%3DScience%26date%3D1991%26volume%3D252%26spage%3D1651%26epage%3D1656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">International Human Genome Sequencing Consortium.</span><span> </span><span class="NLM_article-title">Finishing the euchromatic sequence of the human genome</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">431</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnature03001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=15496913" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=2004&pages=931-945&author=International+Human+Genome+Sequencing+Consortium.&title=Finishing+the+euchromatic+sequence+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature03001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03001%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DFinishing%2520the%2520euchromatic%2520sequence%2520of%2520the%2520human%2520genome%26jtitle%3DNature%26date%3D2004%26volume%3D431%26spage%3D931%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Stancato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhlik, M.</span><span> </span><span class="NLM_article-title">Enabling phenotypic lead generation through high content imaging</span> <span class="citation_source-journal">Eur. Biopharm. Rev. Digital</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=38-43&author=L.+Stancatoauthor=M.+Uhlik&title=Enabling+phenotypic+lead+generation+through+high+content+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStancato%26aufirst%3DL.%26aulast%3DUhlik%26aufirst%3DM.%26atitle%3DEnabling%2520phenotypic%2520lead%2520generation%2520through%2520high%2520content%2520imaging%26jtitle%3DEur.%2520Biopharm.%2520Rev.%2520Digital%26date%3D2008%26volume%3D1%26spage%3D38%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, J.</span><span> </span><span class="NLM_article-title">How were new medicines discovered?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=507-519&author=D.+C.+Swinneyauthor=J.+Anthony&title=How+were+new+medicines+discovered%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DAnthony%26aufirst%3DJ.%26atitle%3DHow%2520were%2520new%2520medicines%2520discovered%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D507%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Quintavalle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heynen-Genel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtneidge, S. A.</span><span> </span><span class="NLM_article-title">A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion</span> <span class="citation_source-journal">Sci Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">ra49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1126%2Fscisignal.2002032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=21791703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOis7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=ra49&author=M.+Quintavalleauthor=L.+Eliaauthor=J.+H.+Priceauthor=S.+Heynen-Genelauthor=S.+A.+Courtneidge&title=A+cell-based+high-content+screening+assay+reveals+activators+and+inhibitors+of+cancer+cell+invasion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion</span></div><div class="casAuthors">Quintavalle, Manuela; Elia, Leonardo; Price, Jeffrey H.; Heynen-Genel, Susanne; Courtneidge, Sara A.</div><div class="citationInfo"><span class="NLM_cas:title">Science Signaling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">183</span>),
    <span class="NLM_cas:pages">ra49</span>CODEN:
                <span class="NLM_cas:coden">SSCICM</span>;
        ISSN:<span class="NLM_cas:issn">1937-9145</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Acquisition of invasive cell behavior underlies tumor progression and metastasis.  To further define the mol. mechanisms underlying invasive behavior, we developed a high-throughput screening strategy to quantitate invadopodia, which are actin-rich membrane protrusions of cancer cells that contribute to tissue invasion and matrix remodeling.  We tested the LOPAC 1280 collection of pharmacol. active agents in a high-content, image-based assay and identified compds. that inhibited invadopodium formation without overt toxicity, as well as compds. that increased invadopodia no.  The chemotherapeutic agent paclitaxel increased both the no. of invadopodia and the invasive behavior of various human cancer cell lines, effects that have potential clin. implications for its use before surgical removal of a primary tumor (neoadjuvant therapy) or in patients with chemoresistant tumors.  Several compds. that inhibited invasion have been characterized as cyclin-dependent kinase (Cdk) inhibitors, and loss-of-function expts. detd. that Cdk5 was the relevant target.  We further detd. that Cdk5 promoted both invadopodium formation and cancer cell invasion by phosphorylating and thus decreasing the abundance of the actin regulatory protein caldesmon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbv3mC0BCilrVg90H21EOLACvtfcHk0liULllrs08O-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOis7bL&md5=cce5501983fe3dabbba27a66edc1abc8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2002032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2002032%26sid%3Dliteratum%253Aachs%26aulast%3DQuintavalle%26aufirst%3DM.%26aulast%3DElia%26aufirst%3DL.%26aulast%3DPrice%26aufirst%3DJ.%2BH.%26aulast%3DHeynen-Genel%26aufirst%3DS.%26aulast%3DCourtneidge%26aufirst%3DS.%2BA.%26atitle%3DA%2520cell-based%2520high-content%2520screening%2520assay%2520reveals%2520activators%2520and%2520inhibitors%2520of%2520cancer%2520cell%2520invasion%26jtitle%3DSci%2520Signaling%26date%3D2011%26volume%3D4%26spage%3Dra49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Mayer, T. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggarty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchison, T. J.</span><span> </span><span class="NLM_article-title">Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1126%2Fscience.286.5441.971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=10542155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADyaK1MXntFaqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=971-974&author=T.+U.+Mayerauthor=T.+M.+Kapoorauthor=S.+J.+Haggartyauthor=R.+W.+Kingauthor=S.+L.+Schreiberauthor=T.+J.+Mitchison&title=Small+molecule+inhibitor+of+mitotic+spindle+bipolarity+identified+in+a+phenotype-based+screen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen</span></div><div class="casAuthors">Mayer, Thomas U.; Kapoor, Tarun M.; Haggarty, Stephen J.; King, Randall W.; Schreiber, Stuart L.; Mitchison, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5441</span>),
    <span class="NLM_cas:pages">971-974</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Small mols. that perturb specific protein functions are valuable tools for dissecting complex processes in mammalian cells.  A combination of two phenotype-based screens, one based on a specific posttranslational modification, the other visualizing microtubules and chromatin, was used to identify compds. that affect mitosis.  One compd., here named monastrol, arrested mammalian cells in mitosis with monopolar spindles.  In vitro, monastrol specifically inhibited the motility of the mitotic kinesin Eg5, a motor protein required for spindle bipolarity.  All previously known small mols. that specifically affect the mitotic machinery target tubulin.  Monastrol will therefore be a particularly useful tool for studying mitotic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogQtim1hvM_LVg90H21EOLACvtfcHk0liULllrs08O-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFaqu7o%253D&md5=d1c47a3e2af49f229e5bf618ca2835f5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5441.971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5441.971%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DT.%2BU.%26aulast%3DKapoor%26aufirst%3DT.%2BM.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DKing%26aufirst%3DR.%2BW.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DSmall%2520molecule%2520inhibitor%2520of%2520mitotic%2520spindle%2520bipolarity%2520identified%2520in%2520a%2520phenotype-based%2520screen%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D971%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Yarrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totsukawa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charras, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchison, T. J.</span><span> </span><span class="NLM_article-title">Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1016%2Fj.chembiol.2005.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=15797222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1Kms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=385-395&author=J.+C.+Yarrowauthor=G.+Totsukawaauthor=G.+T.+Charrasauthor=T.+J.+Mitchison&title=Screening+for+cell+migration+inhibitors+via+automated+microscopy+reveals+a+Rho-kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor</span></div><div class="casAuthors">Yarrow, Justin C.; Totsukawa, Go; Charras, Guillaume T.; Mitchison, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">385-395</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Small-mol. kinase inhibitors are predominantly discovered in pure protein assays.  We have discovered an inhibitor of Rho-kinase (ROCK) through an image-based, high-throughput screen of cell monolayer wound healing.  Using automated microscopy, we screened a library of ∼16,000 compds. finding many that affected cell migration or cell morphol. as well as compds. that blocked mitotic progression.  We tested ∼200 compds. in a series of subassays and chose one, 3-(4-pyridyl)indole (Rockout), for more detailed characterization.  Rockout inhibits blebbing and causes dissoln. of actin stress fibers, phenocopying Rho-kinase inhibitors.  Testing Rho-kinase activity in vitro, Rockout inhibits with an IC50 of 25 μM (∼5-fold less potent than Y-27632) but has a similar specificity profile.  We also profile the wound healing assay with a library of compds. with known bioactivities, revealing multiple pathways involved in the biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB6y0EsQGnMrVg90H21EOLACvtfcHk0liULllrs08O-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1Kms7s%253D&md5=d923ac2e8b63eed510caf7ffff04f501</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DYarrow%26aufirst%3DJ.%2BC.%26aulast%3DTotsukawa%26aufirst%3DG.%26aulast%3DCharras%26aufirst%3DG.%2BT.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DScreening%2520for%2520cell%2520migration%2520inhibitors%2520via%2520automated%2520microscopy%2520reveals%2520a%2520Rho-kinase%2520inhibitor%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D385%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholer, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span> </span><span class="NLM_article-title">Self-renewal of embryonic stem cells by a small molecule</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17266</span><span class="NLM_x">–</span> <span class="NLM_lpage">17271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17266-17271&author=S.+Chenauthor=J.+T.+Doauthor=Q.+Zhangauthor=S.+Yaoauthor=F.+Yanauthor=E.+C.+Petersauthor=H.+R.+Scholerauthor=P.+G.+Schultzauthor=S.+Ding&title=Self-renewal+of+embryonic+stem+cells+by+a+small+molecule"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DDo%26aufirst%3DJ.%2BT.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DPeters%26aufirst%3DE.%2BC.%26aulast%3DScholer%26aufirst%3DH.%2BR.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DDing%26aufirst%3DS.%26atitle%3DSelf-renewal%2520of%2520embryonic%2520stem%2520cells%2520by%2520a%2520small%2520molecule%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17266%26epage%3D17271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span> </span><span class="NLM_article-title">Dedifferentiation of lineage-committed cells by a small molecule</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja037390k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=410-411&author=S.+Chenauthor=Q.+Zhangauthor=X.+Wuauthor=P.+G.+Schultzauthor=S.+Ding&title=Dedifferentiation+of+lineage-committed+cells+by+a+small+molecule"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fja037390k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja037390k%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DDing%26aufirst%3DS.%26atitle%3DDedifferentiation%2520of%2520lineage-committed%2520cells%2520by%2520a%2520small%2520molecule%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D410%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Carmeliet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">Molecular mechanisms and clinical applications of angiogenesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">473</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=473&publication_year=2011&pages=298-307&author=P.+Carmelietauthor=R.+K.+Jain&title=Molecular+mechanisms+and+clinical+applications+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DMolecular%2520mechanisms%2520and%2520clinical%2520applications%2520of%2520angiogenesis%26jtitle%3DNature%26date%3D2011%26volume%3D473%26spage%3D298%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Folkman, J.</span><span> </span><span class="NLM_article-title">Angiogenesis: an organizing principle for drug discovery?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=273-286&author=J.+Folkman&title=Angiogenesis%3A+an+organizing+principle+for+drug+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DAngiogenesis%253A%2520an%2520organizing%2520principle%2520for%2520drug%2520discovery%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D273%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lee, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sells Galvin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peery, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidler, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gough, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palkowitz, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moxham, C. M.</span><span> </span><span class="NLM_article-title">Open innovation for phenotypic drug discovery: the PD2 assay panel</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">588</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1177%2F1087057111405379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=21521801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFWmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=588-602&author=J.+A.+Leeauthor=S.+Chuauthor=F.+S.+Willardauthor=K.+L.+Coxauthor=R.+J.+Sells+Galvinauthor=R.+B.+Peeryauthor=S.+E.+Oliverauthor=J.+Olerauthor=T.+D.+Meredithauthor=S.+A.+Heidlerauthor=W.+H.+Goughauthor=S.+Husainauthor=A.+D.+Palkowitzauthor=C.+M.+Moxham&title=Open+innovation+for+phenotypic+drug+discovery%3A+the+PD2+assay+panel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Open innovation for phenotypic drug discovery: the PD2 assay panel</span></div><div class="casAuthors">Lee, Jonathan A.; Chu, Shaoyou; Willard, Francis S.; Cox, Karen L.; Sells Galvin, Rachelle J.; Peery, Robert B.; Oliver, Sarah E.; Oler, Jennifer; Meredith, Tamika D.; Heidler, Steven A.; Gough, Wendy H.; Husain, Saba; Palkowitz, Alan D.; Moxham, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">588-602</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Phenotypic lead generation strategies seek to identify compds. that modulate complex, physiol. relevant systems, an approach that is complementary to traditional, target-directed strategies.  Unlike gene-specific assays, phenotypic assays interrogate multiple mol. targets and signaling pathways in a target "agnostic" fashion, which may reveal novel functions for well-studied proteins and discover new pathways of therapeutic value.  Significantly, existing compd. libraries may not have sufficient chem. diversity to fully leverage a phenotypic strategy.  To address this issue, Eli Lilly and Company launched the Phenotypic Drug Discovery Initiative (PD2), a model of open innovation whereby external research groups can submit compds. for testing in a panel of Lilly phenotypic assays.  This communication describes the statistical validation, operations, and initial screening results from the first PD2 assay panel.  Anal. of PD2 submissions indicates that chem. diversity from open source collaborations complements internal sources.  Screening results for the first 4691 compds. submitted to PD2 have confirmed hit rates from 1.6% to 10%, with the majority of active compds. exhibiting acceptable potency and selectivity.  Phenotypic lead generation strategies, in conjunction with novel chem. diversity obtained via open-source initiatives such as PD2, may provide a means to identify compds. that modulate biol. by novel mechanisms and expand the innovation potential of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXGGH-5y93H7Vg90H21EOLACvtfcHk0ljdr18b8wYJ8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFWmtb0%253D&md5=091f68b96728f356ddbc30461531878b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1177%2F1087057111405379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057111405379%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DChu%26aufirst%3DS.%26aulast%3DWillard%26aufirst%3DF.%2BS.%26aulast%3DCox%26aufirst%3DK.%2BL.%26aulast%3DSells%2BGalvin%26aufirst%3DR.%2BJ.%26aulast%3DPeery%26aufirst%3DR.%2BB.%26aulast%3DOliver%26aufirst%3DS.%2BE.%26aulast%3DOler%26aufirst%3DJ.%26aulast%3DMeredith%26aufirst%3DT.%2BD.%26aulast%3DHeidler%26aufirst%3DS.%2BA.%26aulast%3DGough%26aufirst%3DW.%2BH.%26aulast%3DHusain%26aufirst%3DS.%26aulast%3DPalkowitz%26aufirst%3DA.%2BD.%26aulast%3DMoxham%26aufirst%3DC.%2BM.%26atitle%3DOpen%2520innovation%2520for%2520phenotypic%2520drug%2520discovery%253A%2520the%2520PD2%2520assay%2520panel%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2011%26volume%3D16%26spage%3D588%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Traktuev, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merfeld-Clauss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolonin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arap, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasqualini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traktuev, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merfeld-Clauss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolonin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arap, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasqualini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, K. L.</span><span> </span><span class="NLM_article-title">A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2008&pages=77-85&author=D.+O.+Traktuevauthor=S.+Merfeld-Claussauthor=J.+Liauthor=M.+Koloninauthor=W.+Arapauthor=R.+Pasqualiniauthor=B.+H.+Johnstoneauthor=K.+L.+Marchauthor=D.+O.+Traktuevauthor=S.+Merfeld-Claussauthor=J.+Liauthor=M.+Koloninauthor=W.+Arapauthor=R.+Pasqualiniauthor=B.+H.+Johnstoneauthor=K.+L.+March&title=A+population+of+multipotent+CD34-positive+adipose+stromal+cells+share+pericyte+and+mesenchymal+surface+markers%2C+reside+in+a+periendothelial+location%2C+and+stabilize+endothelial+networks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraktuev%26aufirst%3DD.%2BO.%26aulast%3DMerfeld-Clauss%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DKolonin%26aufirst%3DM.%26aulast%3DArap%26aufirst%3DW.%26aulast%3DPasqualini%26aufirst%3DR.%26aulast%3DJohnstone%26aufirst%3DB.%2BH.%26aulast%3DMarch%26aufirst%3DK.%2BL.%26aulast%3DTraktuev%26aufirst%3DD.%2BO.%26aulast%3DMerfeld-Clauss%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DKolonin%26aufirst%3DM.%26aulast%3DArap%26aufirst%3DW.%26aulast%3DPasqualini%26aufirst%3DR.%26aulast%3DJohnstone%26aufirst%3DB.%2BH.%26aulast%3DMarch%26aufirst%3DK.%2BL.%26atitle%3DA%2520population%2520of%2520multipotent%2520CD34-positive%2520adipose%2520stromal%2520cells%2520share%2520pericyte%2520and%2520mesenchymal%2520surface%2520markers%252C%2520reside%2520in%2520a%2520periendothelial%2520location%252C%2520and%2520stabilize%2520endothelial%2520networks%26jtitle%3DCirc.%2520Res.%26date%3D2008%26volume%3D102%26spage%3D77%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Traktuev, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prater, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merfeld-Clauss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanjeevaiah, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saadatzadeh, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, K. L.</span><span> </span><span class="NLM_article-title">Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">1410</span><span class="NLM_x">–</span> <span class="NLM_lpage">1420</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=1410-1420&author=D.+O.+Traktuevauthor=D.+N.+Praterauthor=S.+Merfeld-Claussauthor=A.+R.+Sanjeevaiahauthor=M.+R.+Saadatzadehauthor=M.+Murphyauthor=B.+H.+Johnstoneauthor=D.+A.+Ingramauthor=K.+L.+March&title=Robust+functional+vascular+network+formation+in+vivo+by+cooperation+of+adipose+progenitor+and+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraktuev%26aufirst%3DD.%2BO.%26aulast%3DPrater%26aufirst%3DD.%2BN.%26aulast%3DMerfeld-Clauss%26aufirst%3DS.%26aulast%3DSanjeevaiah%26aufirst%3DA.%2BR.%26aulast%3DSaadatzadeh%26aufirst%3DM.%2BR.%26aulast%3DMurphy%26aufirst%3DM.%26aulast%3DJohnstone%26aufirst%3DB.%2BH.%26aulast%3DIngram%26aufirst%3DD.%2BA.%26aulast%3DMarch%26aufirst%3DK.%2BL.%26atitle%3DRobust%2520functional%2520vascular%2520network%2520formation%2520in%2520vivo%2520by%2520cooperation%2520of%2520adipose%2520progenitor%2520and%2520endothelial%2520cells%26jtitle%3DCirc.%2520Res.%26date%3D2009%26volume%3D104%26spage%3D1410%26epage%3D1420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Crawford, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span> </span><span class="NLM_article-title">VEGF inhibition: insights from preclinical and clinical studies</span> <span class="citation_source-journal">Cell Tissue Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1007%2Fs00441-008-0675-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=18766380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOru7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2009&pages=261-269&author=Y.+Crawfordauthor=N.+Ferrara&title=VEGF+inhibition%3A+insights+from+preclinical+and+clinical+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">VEGF inhibition: insights from preclinical and clinical studies</span></div><div class="casAuthors">Crawford, Yongping; Ferrara, Napoleone</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">261-269</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Angiogenesis, the growth of new blood vessels, is required for a variety of normal proliferative processes.  Furthermore, angiogenesis is well established as also playing an important role in neoplastic growth and metastasis.  Numerous regulators of angiogenesis have been identified and characterized over the last few decades.  Among these, vascular endothelial growth factor (VEGF)-A appears esp. important in several pathophysiol. processes.  Several VEGF inhibitors have been approved, by the US Food and Drug Administration, for the treatment of tumors or age-releted macular degeneration.  This review examines the various mouse tumor models in which VEGF inhibitors have been tested and the lessons learned from these studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC9mphpYUfmrVg90H21EOLACvtfcHk0liKT_c_7Ty5yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOru7vP&md5=6ed8038e44bf8a90f4e38c2fe0a08b80</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00441-008-0675-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-008-0675-8%26sid%3Dliteratum%253Aachs%26aulast%3DCrawford%26aufirst%3DY.%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DVEGF%2520inhibition%253A%2520insights%2520from%2520preclinical%2520and%2520clinical%2520studies%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2009%26volume%3D335%26spage%3D261%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Low, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stancato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, J. J.</span><span> </span><span class="NLM_article-title">Prioritizing hits from phenotypic high-content screens</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=338-345&author=J.+Lowauthor=L.+Stancatoauthor=J.+Leeauthor=J.+J.+Sutherland&title=Prioritizing+hits+from+phenotypic+high-content+screens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLow%26aufirst%3DJ.%26aulast%3DStancato%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSutherland%26aufirst%3DJ.%2BJ.%26atitle%3DPrioritizing%2520hits%2520from%2520phenotypic%2520high-content%2520screens%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26spage%3D338%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Adams, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span> </span><span class="NLM_article-title">Molecular regulation of angiogenesis and lymphangiogenesis</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnrm2183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=17522591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFOhsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=464-78&author=R.+H.+Adamsauthor=K.+Alitalo&title=Molecular+regulation+of+angiogenesis+and+lymphangiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular regulation of angiogenesis and lymphangiogenesis</span></div><div class="casAuthors">Adams, Ralf H.; Alitalo, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">464-478</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Blood vessels and lymphatic vessels form extensive networks that are essential for the transport of fluids, gases, macromols. and cells within the large and complex bodies of vertebrates.  Both of these vascular structures are lined with endothelial cells that integrate functionally into different organs, acquire tissue-specific specialization and retain plasticity; thereby, they permit growth during tissue repair or in disease settings.  The angiogenic growth of blood vessels and lymphatic vessels coordinates several biol. processes such as cell proliferation, guided migration, differentiation and cell-cell communication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDGRnfeGDxYLVg90H21EOLACvtfcHk0liKT_c_7Ty5yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFOhsb4%253D&md5=0e4f15ad376fb7a34a783efb77f4fdc5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrm2183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2183%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DR.%2BH.%26aulast%3DAlitalo%26aufirst%3DK.%26atitle%3DMolecular%2520regulation%2520of%2520angiogenesis%2520and%2520lymphangiogenesis%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D464%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Terstappen, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlupen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raggiaschi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaviraghi, G.</span><span> </span><span class="NLM_article-title">Target deconvolution strategies in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">–</span> <span class="NLM_lpage">903</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=891-903&author=G.+C.+Terstappenauthor=C.+Schlupenauthor=R.+Raggiaschiauthor=G.+Gaviraghi&title=Target+deconvolution+strategies+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerstappen%26aufirst%3DG.%2BC.%26aulast%3DSchlupen%26aufirst%3DC.%26aulast%3DRaggiaschi%26aufirst%3DR.%26aulast%3DGaviraghi%26aufirst%3DG.%26atitle%3DTarget%2520deconvolution%2520strategies%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D891%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hart, C. P.</span><span> </span><span class="NLM_article-title">Finding the target after screening the phenotype</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1016%2FS1359-6446%2805%2903415-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=15809197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivV2hs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=513-519&author=C.+P.+Hart&title=Finding+the+target+after+screening+the+phenotype"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Finding the target after screening the phenotype</span></div><div class="casAuthors">Hart, Charles P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">513-519</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Phenotype-based screening is accompanied by the challenge of identifying the mol. target or targets bound by the drug leads.  There are several techniques available for target identification after phenotypic screening, including direct and indirect approaches.  Here, the advantages and limitations assocd. with these technologies are reviewed.  Although most screening for new drug leads is being directed at known or emerging mol. targets, there has been a renaissance in screening based on changes in cell or organismal phenotypes.  Phenotype-based screening is accompanied by the challenge of identifying the mol. target or targets bound by the drug leads and responsible for their pharmacol. activity.  A variety of technologies and approaches are being explored for target identification after phenotypic screening.  Direct approaches employing affinity chromatog., expression cloning and protein microarrays analyze the compd. bound to its target.  Indirect approaches are based on comparison of the genome-wide activity profile of the compd. with databases of the activity profiles of other compds. with known targets or activity profiles following specific genetic changes.  This review will use case studies of target identification efforts and highlight the advantages and disadvantages of the various approaches to target identification after phenotypic screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqpg6P5ire9rVg90H21EOLACvtfcHk0lgvrd0uUrRw7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivV2hs7Y%253D&md5=6cc0459ae66b2ea689f130bc10eee804</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903415-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903415-X%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DC.%2BP.%26atitle%3DFinding%2520the%2520target%2520after%2520screening%2520the%2520phenotype%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D513%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Targeting the cancer kinome through polypharmacology</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnrc2787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=20094047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Clug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=130-137&author=Z.+A.+Knightauthor=H.+Linauthor=K.+M.+Shokat&title=Targeting+the+cancer+kinome+through+polypharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cancer kinome through polypharmacology</span></div><div class="casAuthors">Knight, Zachary A.; Lin, Henry; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-137</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Kinase inhibitors are the largest class of new cancer drugs.  However, it is already apparent that most tumors can escape from the inhibition of any single kinase.  If it is necessary to inhibit multiple kinases, how do we choose which ones.  In this Opinion article, we discuss some of the strategies that are currently being used to identify new therapeutic combinations of kinase targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkDv2FeeH58rVg90H21EOLACvtfcHk0lgvrd0uUrRw7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Clug%253D%253D&md5=9aaa314e54b43889e147a9f11ac77072</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrc2787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2787%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DTargeting%2520the%2520cancer%2520kinome%2520through%2520polypharmacology%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D130%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Lee, J. A.; Cox, K.; Kriauciunas, A.; Chu, S.</span><span> </span><span class="NLM_article-title">The Roles of High Content Cellular Imaging in Lead Optimization</span>. In  <span class="citation_source-book">High Content Screening: Science, Techniques, and Applications</span>; <span class="NLM_contrib-group">Haney, S.</span>, Ed.; <span class="NLM_publisher-name">Wiley-Interscience</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1002%2F9780470229866.ch11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=249-268&author=J.+A.+Lee&author=K.+Cox&author=A.+Kriauciunas&author=S.+Chuauthor=S.+Haney&title=High+Content+Screening%3A+Science%2C+Techniques%2C+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2F9780470229866.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470229866.ch11%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520Roles%2520of%2520High%2520Content%2520Cellular%2520Imaging%2520in%2520Lead%2520Optimization%26btitle%3DHigh%2520Content%2520Screening%253A%2520Science%252C%2520Techniques%252C%2520and%2520Applications%26aulast%3DHaney%26aufirst%3DS.%26pub%3DWiley-Interscience%26date%3D2008%26spage%3D249%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Gough, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulkower, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlynn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhlik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. A.</span><span> </span><span class="NLM_article-title">A quantitative, facile, and high-throughput image-based cell migration method is a robust alternative to the scratch assay</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1177%2F1087057110393340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=21297103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A280%3ADC%252BC3M7ntFOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=155-163&author=W.+Goughauthor=K.+I.+Hulkowerauthor=R.+Lynchauthor=P.+McGlynnauthor=M.+Uhlikauthor=L.+Yanauthor=J.+A.+Lee&title=A+quantitative%2C+facile%2C+and+high-throughput+image-based+cell+migration+method+is+a+robust+alternative+to+the+scratch+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative, facile, and high-throughput image-based cell migration method is a robust alternative to the scratch assay</span></div><div class="casAuthors">Gough Wendy; Hulkower Keren I; Lynch Renee; McGlynn Patrick; Uhlik Mark; Yan Lei; Lee Jonathan A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-63</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cell migration is a key phenotype for a number of therapeutically important biological responses, including angiogenesis.  A commonly used method to assess cell migration is the scratch assay, which measures the movement of cells into a wound made by physically scoring a confluent cell monolayer to create an area devoid of cells.  Although this method has been adequate for qualitative characterization of migration inhibitors, it does not provide the highly reproducible results required for quantitative compound structure-activity relationship evaluation because of the inconsistent size and placement of the wound area within the microplate well.  The Oris® Cell Migration Assay presents a superior alternative to the scratch assay, permitting formation of precisely placed and homogeneously sized cell-free areas into which migration can occur without releasing factors from wounded or dead cells or damaging the underlying extracellular matrix.  Herein the authors compare results from the scratch and Oris® cell migration assays using an endothelial progenitor cell line and the Src kinase inhibitor dasatinib.  They find that using the Acumen® Explorer laser microplate cytometer in combination with the Oris® Cell Migration Assay plate provides a robust, efficient, and cost-effective cell migration assay exhibiting excellent signal to noise, plate uniformity, and statistical validation metrics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTNP3aK0jreAmyYR5VtavbzfW6udTcc2ebcnULZcvqe17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7ntFOltA%253D%253D&md5=ec6e7c0f4b0e855f43fbf6d8d33da8d2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1177%2F1087057110393340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057110393340%26sid%3Dliteratum%253Aachs%26aulast%3DGough%26aufirst%3DW.%26aulast%3DHulkower%26aufirst%3DK.%2BI.%26aulast%3DLynch%26aufirst%3DR.%26aulast%3DMcGlynn%26aufirst%3DP.%26aulast%3DUhlik%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DJ.%2BA.%26atitle%3DA%2520quantitative%252C%2520facile%252C%2520and%2520high-throughput%2520image-based%2520cell%2520migration%2520method%2520is%2520a%2520robust%2520alternative%2520to%2520the%2520scratch%2520assay%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2011%26volume%3D16%26spage%3D155%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Eastwood, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmen, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iversen, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallwood, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbison, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delapp, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. F.</span><span> </span><span class="NLM_article-title">The minimum significant ratio: a statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1177%2F1087057105285611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=16490778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A280%3ADC%252BD283mvVyhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=253-261&author=B.+J.+Eastwoodauthor=M.+W.+Farmenauthor=P.+W.+Iversenauthor=T.+J.+Craftauthor=J.+K.+Smallwoodauthor=K.+E.+Garbisonauthor=N.+W.+Delappauthor=G.+F.+Smith&title=The+minimum+significant+ratio%3A+a+statistical+parameter+to+characterize+the+reproducibility+of+potency+estimates+from+concentration-response+assays+and+estimation+by+replicate-experiment+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The minimum significant ratio: a statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies</span></div><div class="casAuthors">Eastwood Brian J; Farmen Mark W; Iversen Philip W; Craft Trelia J; Smallwood Jeffrey K; Garbison Kim E; Delapp Neil W; Smith Gerald F</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-61</span>
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    </div><div class="casAbstract">The authors show by illustration that procedures used to validate the reliability of single-concentration high-throughput screens such as the signal window and Z' factor do not ensure sufficient reliability in potency estimates from concentration response assays.  They develop the minimum significant ratio as a statistical parameter to characterize the fold change between 2 compounds run in the same experiment that can be considered a real difference and use this parameter to characterize the reliability of the assay.  They adapt methods described by Bland and Altman to develop a simple set of 2 experiments to estimate the minimum significant ratio and show that this protocol can identify assays that lack reproducibility.  The methods are then extended to validate the equivalency of the same assay run by multiple laboratories.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcE509f3H8OukdrW1FkXG-fW6udTcc2eZrOzUew8jnlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283mvVyhug%253D%253D&md5=df12ee03e938b7b16652a0ddd77a1a93</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1177%2F1087057105285611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057105285611%26sid%3Dliteratum%253Aachs%26aulast%3DEastwood%26aufirst%3DB.%2BJ.%26aulast%3DFarmen%26aufirst%3DM.%2BW.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DCraft%26aufirst%3DT.%2BJ.%26aulast%3DSmallwood%26aufirst%3DJ.%2BK.%26aulast%3DGarbison%26aufirst%3DK.%2BE.%26aulast%3DDelapp%26aufirst%3DN.%2BW.%26aulast%3DSmith%26aufirst%3DG.%2BF.%26atitle%3DThe%2520minimum%2520significant%2520ratio%253A%2520a%2520statistical%2520parameter%2520to%2520characterize%2520the%2520reproducibility%2520of%2520potency%2520estimates%2520from%2520concentration-response%2520assays%2520and%2520estimation%2520by%2520replicate-experiment%2520studies%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2006%26volume%3D11%26spage%3D253%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delves, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magny, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandel, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3827</span><span class="NLM_x">–</span> <span class="NLM_lpage">3838</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200108t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3827-3838&author=C.+W.+Chungauthor=H.+Costeauthor=J.+H.+Whiteauthor=O.+Mirguetauthor=J.+Wildeauthor=R.+L.+Gosminiauthor=C.+Delvesauthor=S.+M.+Magnyauthor=R.+Woodwardauthor=S.+A.+Hughesauthor=E.+V.+Boursierauthor=H.+Flynnauthor=A.+M.+Bouillotauthor=P.+Bamboroughauthor=J.+M.+Brusqauthor=F.+J.+Gellibertauthor=E.+J.+Jonesauthor=A.+M.+Riouauthor=P.+Homesauthor=S.+L.+Martinauthor=I.+J.+Uingsauthor=J.+Toumauthor=C.+A.+Clementauthor=A.+B.+Boullayauthor=R.+L.+Grimleyauthor=F.+M.+Blandelauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=J.+Kirilovskyauthor=E.+Nicodeme&title=Discovery+and+characterization+of+small+molecule+inhibitors+of+the+BET+family+bromodomains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span></div><div class="casAuthors">Chung, Chun-wa; Coste, Herve; White, Julia H.; Mirguet, Olivier; Wilde, Jonathan; Gosmini, Romain L.; Delves, Chris; Magny, Sylvie M.; Woodward, Robert; Hughes, Stephen A.; Boursier, Eric V.; Flynn, Helen; Bouillot, Anne M.; Bamborough, Paul; Brusq, Jean-Marie G.; Gellibert, Francoise J.; Jones, Emma J.; Riou, Alizon M.; Homes, Paul; Martin, Sandrine L.; Uings, Iain J.; Toum, Jerome; Clement, Catherine A.; Boullay, Anne-Benedicte; Grimley, Rachel L.; Blandel, Florence M.; Prinjha, Rab K.; Lee, Kevin; Kirilovsky, Jorge; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3827-3838</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epigenetic mechanisms of gene regulation have a profound role in normal development and disease processes.  An integral part of this mechanism occurs through lysine acetylation of histone tails which are recognized by bromodomains.  While the biol. and structural characterization of many bromodomain contg. proteins has advanced considerably, the therapeutic tractability of this protein family is only now becoming understood.  This paper describes the discovery and mol. characterization of potent (nM) small mol. inhibitors that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4).  By using a combination of phenotypic screening, chemoproteomics, and biophys. studies, we have discovered that the protein-protein interactions between bromodomains and acetylated histones can be antagonized by selective small mols. that bind at the acetylated lysine recognition pocket.  X-ray crystal structures of compds. bound into bromodomains of Brd2 and Brd4 elucidate the mol. interactions of binding and explain the precisely defined stereochem. required for activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8VauuYkT5YLVg90H21EOLACvtfcHk0ljRrlnMGO3Hzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D&md5=ebc0f6062321dece877259d775f1c19b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm200108t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200108t%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%2BH.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DWilde%26aufirst%3DJ.%26aulast%3DGosmini%26aufirst%3DR.%2BL.%26aulast%3DDelves%26aufirst%3DC.%26aulast%3DMagny%26aufirst%3DS.%2BM.%26aulast%3DWoodward%26aufirst%3DR.%26aulast%3DHughes%26aufirst%3DS.%2BA.%26aulast%3DBoursier%26aufirst%3DE.%2BV.%26aulast%3DFlynn%26aufirst%3DH.%26aulast%3DBouillot%26aufirst%3DA.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DGellibert%26aufirst%3DF.%2BJ.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DRiou%26aufirst%3DA.%2BM.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%2BL.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DC.%2BA.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DGrimley%26aufirst%3DR.%2BL.%26aulast%3DBlandel%26aufirst%3DF.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520small%2520molecule%2520inhibitors%2520of%2520the%2520BET%2520family%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3827%26epage%3D3838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Park, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Y.</span><span> </span><span class="NLM_article-title">Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1alpha protein-dependent mechanism</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">2306</span><span class="NLM_x">–</span> <span class="NLM_lpage">2316</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1002%2Fijc.25589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=20715173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVSrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2011&pages=2306-2316&author=S.+Y.+Parkauthor=J.+H.+Kangauthor=K.+J.+Jeongauthor=J.+Leeauthor=J.+W.+Hanauthor=W.+S.+Choiauthor=Y.+K.+Kimauthor=J.+Kangauthor=C.+G.+Parkauthor=H.+Y.+Lee&title=Norepinephrine+induces+VEGF+expression+and+angiogenesis+by+a+hypoxia-inducible+factor-1alpha+protein-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism</span></div><div class="casAuthors">Park, Soon-Young; Kang, Joo-Hee; Jeong, Kang-Jin; Lee, Jang-Soon; Han, Jeong-Whan; Choi, Wahn-Soo; Kim, Yong-Kee; Kang, Jae-Ku; Park, Chang-Gyo; Lee, Hoi Young</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2306-2316</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A growing no. of studies have demonstrated that physiol. factors can influence the progression of several cancers via cellular immune function, angiogenesis and metastasis.  Recently, stress-induced catecholamines have been shown to increase the expression of various cancer progressive factors, including vascular endothelial growth factor (VEGF), matrix metalloproteinases and interleukins.  However, a detailed mechanism remains to be identified.  In this study, we investigated the role of adrenergic receptors and hypoxia-inducible factor (HIF)-1α protein in catecholamine-induced VEGF expression and angiogenesis.  Treatment of the cells with norepinephrine (NE) or isoproterenol induced VEGF expression and HIF-1α protein amt. in a dose-dependent manner.  Induction of VEGF expression by NE was abrogated when the cells were transfected with HIF-1α-specific siRNA.  Similarly, adenylate cyclase activator forskolin and cAMP-dependent protein kinase A inhibitor H-89 enhanced and decreased HIF-1α protein amt., resp.  More importantly, conditioned medium of NE-stimulated cancer cells induced angiogenesis in a HIF-1α protein-dependent manner.  In addn., pretreatment of cells with propranolol, a β-adrenergic receptor (AR) blocker, completely abolished induction of VEGF expression and HIF-1α protein amt. by NE in all of the tested cancer cells.  However, treatment with the α1-AR blocker prazosin inhibited NE-induced HIF-1α protein amt. and angiogenesis in SK-Hep1 and PC-3 but not MDA-MB-231 cells.  Collectively, our results suggest that ARs and HIF-1α protein have crit. roles in NE-induced VEGF expression in cancer cells, leading to stimulation of angiogenesis.  These findings will help to understand the mechanism of cancer progression by stress-induced catecholamines and design therapeutic strategies for cancer angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdNsc4TlCL8bVg90H21EOLACvtfcHk0ljRrlnMGO3Hzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVSrs70%253D&md5=ca91c902a32df0c253d920aa8ff03de6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fijc.25589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25589%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DKang%26aufirst%3DJ.%2BH.%26aulast%3DJeong%26aufirst%3DK.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DJ.%2BW.%26aulast%3DChoi%26aufirst%3DW.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BK.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DC.%2BG.%26aulast%3DLee%26aufirst%3DH.%2BY.%26atitle%3DNorepinephrine%2520induces%2520VEGF%2520expression%2520and%2520angiogenesis%2520by%2520a%2520hypoxia-inducible%2520factor-1alpha%2520protein-dependent%2520mechanism%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2011%26volume%3D128%26spage%3D2306%26epage%3D2316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Asada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sora, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span> </span><span class="NLM_article-title">Depletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1/2 phosphorylation</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=408-417&author=M.+Asadaauthor=S.+Ebiharaauthor=S.+Yamandaauthor=K.+Niuauthor=T.+Okazakiauthor=I.+Soraauthor=H.+Arai&title=Depletion+of+serotonin+and+selective+inhibition+of+2B+receptor+suppressed+tumor+angiogenesis+by+inhibiting+endothelial+nitric+oxide+synthase+and+extracellular+signal-regulated+kinase+1%2F2+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsada%26aufirst%3DM.%26aulast%3DEbihara%26aufirst%3DS.%26aulast%3DYamanda%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DK.%26aulast%3DOkazaki%26aufirst%3DT.%26aulast%3DSora%26aufirst%3DI.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DDepletion%2520of%2520serotonin%2520and%2520selective%2520inhibition%2520of%25202B%2520receptor%2520suppressed%2520tumor%2520angiogenesis%2520by%2520inhibiting%2520endothelial%2520nitric%2520oxide%2520synthase%2520and%2520extracellular%2520signal-regulated%2520kinase%25201%252F2%2520phosphorylation%26jtitle%3DNeoplasia%26date%3D2009%26volume%3D11%26spage%3D408%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Muthig, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilsbach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haubold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivacevic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hein, L.</span><span> </span><span class="NLM_article-title">Upregulation of soluble vascular endothelial growth factor receptor 1 contributes to angiogenesis defects in the placenta of alpha 2B-adrenoceptor deficient mice</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=682-691&author=V.+Muthigauthor=R.+Gilsbachauthor=M.+Hauboldauthor=M.+Philippauthor=T.+Ivacevicauthor=M.+Gesslerauthor=L.+Hein&title=Upregulation+of+soluble+vascular+endothelial+growth+factor+receptor+1+contributes+to+angiogenesis+defects+in+the+placenta+of+alpha+2B-adrenoceptor+deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuthig%26aufirst%3DV.%26aulast%3DGilsbach%26aufirst%3DR.%26aulast%3DHaubold%26aufirst%3DM.%26aulast%3DPhilipp%26aufirst%3DM.%26aulast%3DIvacevic%26aufirst%3DT.%26aulast%3DGessler%26aufirst%3DM.%26aulast%3DHein%26aufirst%3DL.%26atitle%3DUpregulation%2520of%2520soluble%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%25201%2520contributes%2520to%2520angiogenesis%2520defects%2520in%2520the%2520placenta%2520of%2520alpha%25202B-adrenoceptor%2520deficient%2520mice%26jtitle%3DCirc.%2520Res.%26date%3D2007%26volume%3D101%26spage%3D682%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Vahlensieck, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pridzun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichenbach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinnen, A.</span><span> </span><span class="NLM_article-title">Identification of the yeast ACC1 gene product (acetyl-CoA carboxylase) as the target of the polyketide fungicide soraphen A</span> <span class="citation_source-journal">Curr. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1007%2FBF00309532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=7916271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADyaK2cXksFekt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=95-100&author=H.+F.+Vahlensieckauthor=L.+Pridzunauthor=H.+Reichenbachauthor=A.+Hinnen&title=Identification+of+the+yeast+ACC1+gene+product+%28acetyl-CoA+carboxylase%29+as+the+target+of+the+polyketide+fungicide+soraphen+A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the yeast ACC1 gene product (acetyl-CoA carboxylase) as the target of the polyketide fungicide soraphen A</span></div><div class="casAuthors">Vahlensieck, H. F.; Pridzun, L.; Reichenbach, H.; Hinnen, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Genetics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-100</span>CODEN:
                <span class="NLM_cas:coden">CUGED5</span>;
        ISSN:<span class="NLM_cas:issn">0172-8083</span>.
    </div><div class="casAbstract">Soraphen A, a polyketide isolated from the myxobacterium Sorangium cellulosum, is a potent inhibitor of fungal growth.  The authors have used a genetic approach to localize the target of this drug, employing Saccharomyces cerevisiae as a model organism.  The authors have isolated soraphen A-resistant mutants and found that all of them map at the same genetic locus and exhibit a broad range of semidominant phenotypes.  Data from genetic crosses of soraphen A-resistant clones with an acc1 mutant revealed that ACC1, coding for acetyl-CoA carboxylase (E.C. 6.4.1.2), is tightly linked to soraphen A resistance.  Partially-purified enzyme exts. contg. acetyl-CoA carboxylase were prepd. and assayed for their soraphen A sensitivity.  The authors' expts. showed that the catalytic activity of the wild-type enzyme is inhibited in vitro by soraphen A while the mutant enzyme remains catalytically active.  Taken together these data strongly suggest that the ACC1 gene product is the primary target for soraphen A in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqPfaLATS617Vg90H21EOLACvtfcHk0lhElyINhRvffA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFekt7k%253D&md5=c635af44a644c11be2966f1841801640</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2FBF00309532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00309532%26sid%3Dliteratum%253Aachs%26aulast%3DVahlensieck%26aufirst%3DH.%2BF.%26aulast%3DPridzun%26aufirst%3DL.%26aulast%3DReichenbach%26aufirst%3DH.%26aulast%3DHinnen%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520the%2520yeast%2520ACC1%2520gene%2520product%2520%2528acetyl-CoA%2520carboxylase%2529%2520as%2520the%2520target%2520of%2520the%2520polyketide%2520fungicide%2520soraphen%2520A%26jtitle%3DCurr.%2520Genet.%26date%3D1994%26volume%3D25%26spage%3D95%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Jump, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres-Gonzalez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, L. K.</span><span> </span><span class="NLM_article-title">Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2011&pages=649-660&author=D.+B.+Jumpauthor=M.+Torres-Gonzalezauthor=L.+K.+Olson&title=Soraphen+A%2C+an+inhibitor+of+acetyl+CoA+carboxylase+activity%2C+interferes+with+fatty+acid+elongation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJump%26aufirst%3DD.%2BB.%26aulast%3DTorres-Gonzalez%26aufirst%3DM.%26aulast%3DOlson%26aufirst%3DL.%2BK.%26atitle%3DSoraphen%2520A%252C%2520an%2520inhibitor%2520of%2520acetyl%2520CoA%2520carboxylase%2520activity%252C%2520interferes%2520with%2520fatty%2520acid%2520elongation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D81%26spage%3D649%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Izumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusakabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hikita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwao, H.</span><span> </span><span class="NLM_article-title">Pravastatin accelerates ischemia-induced angiogenesis through AMP-activated protein kinase</span> <span class="citation_source-journal">Hypertens. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fhr.2009.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=19498441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1WksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=675-679&author=Y.+Izumiauthor=M.+Shiotaauthor=H.+Kusakabeauthor=Y.+Hikitaauthor=T.+Nakaoauthor=Y.+Nakamuraauthor=T.+Muroauthor=K.+Miuraauthor=M.+Yoshiyamaauthor=H.+Iwao&title=Pravastatin+accelerates+ischemia-induced+angiogenesis+through+AMP-activated+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Pravastatin accelerates ischemia-induced angiogenesis through AMP-activated protein kinase</span></div><div class="casAuthors">Izumi, Yasukatsu; Shiota, Masayuki; Kusakabe, Hiromi; Hikita, Yuko; Nakao, Takafumi; Nakamura, Yasuhiro; Muro, Takashi; Miura, Katsuyuki; Yoshiyama, Minoru; Iwao, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">675-679</span>CODEN:
                <span class="NLM_cas:coden">HRESE4</span>;
        ISSN:<span class="NLM_cas:issn">0916-9636</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Statins exert pleiotropic effects on the cardiovascular system, in part through an increase in nitric oxide (NO) bioavailability.  In this study, we examd. the role of pravastatin in ischemia-induced angiogenesis.  Unilateral hindlimb ischemia was surgically induced in C57BL/6J mice.  Phosphorylation of AMP-activated protein kinase (AMPK), acetyl-CoA carboxylase (ACC) and endothelial NO synthase (eNOS) was increased in ischemic tissues.  Furthermore, mice treated with pravastatin showed higher increases in phosphorylation than did untreated mice.  Laser Doppler anal. has shown that pravastatin treatment accelerates the development of collateral vessels and angiogenesis in response to hindlimb ischemia.  Capillary d. in the ischemic hindlimb was also increased by pravastatin treatment.  An in vitro study on human umbilical vein endothelial cells (HUVECs) revealed that pravastatin increased the phosphorylation of AMPK.  Pravastatin-induced phosphorylation of eNOS, one of the downstreams of AMPK, was inhibited by compd. C, an AMPK antagonist.  The increased migration and tube formation of HUVECs by pravastatin were significantly blocked by compd. C treatment.  The accelerated angiogenesis by pravastatin after hindlimb ischemia was significantly reduced after treatment with compd. C. Thus, ischemia induced AMPK phosphorylation in vivo.  Furthermore, pravastatin could also activate AMPK in vivo and in vitro.  Such phosphorylation results in eNOS activation and angiogenesis, which provide a novel explanation for one of the pleiotropic effects of statins that is beneficial for angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4xmsXTCyuTLVg90H21EOLACvtfcHk0lhElyINhRvffA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1WksLo%253D&md5=37bbbe7e8e123fbc22493d1f7fa3e3f9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fhr.2009.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fhr.2009.77%26sid%3Dliteratum%253Aachs%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DShiota%26aufirst%3DM.%26aulast%3DKusakabe%26aufirst%3DH.%26aulast%3DHikita%26aufirst%3DY.%26aulast%3DNakao%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DMuro%26aufirst%3DT.%26aulast%3DMiura%26aufirst%3DK.%26aulast%3DYoshiyama%26aufirst%3DM.%26aulast%3DIwao%26aufirst%3DH.%26atitle%3DPravastatin%2520accelerates%2520ischemia-induced%2520angiogenesis%2520through%2520AMP-activated%2520protein%2520kinase%26jtitle%3DHypertens.%2520Res.%26date%3D2009%26volume%3D32%26spage%3D675%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Stahmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spengler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heslegrave, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viollet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, R.</span><span> </span><span class="NLM_article-title">Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">10638</span><span class="NLM_x">–</span> <span class="NLM_lpage">10652</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=10638-10652&author=N.+Stahmannauthor=A.+Woodsauthor=K.+Spenglerauthor=A.+Heslegraveauthor=R.+Bauerauthor=S.+Krauseauthor=B.+Violletauthor=D.+Carlingauthor=R.+Heller&title=Activation+of+AMP-activated+protein+kinase+by+vascular+endothelial+growth+factor+mediates+endothelial+angiogenesis+independently+of+nitric-oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStahmann%26aufirst%3DN.%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DSpengler%26aufirst%3DK.%26aulast%3DHeslegrave%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DR.%26aulast%3DKrause%26aufirst%3DS.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DCarling%26aufirst%3DD.%26aulast%3DHeller%26aufirst%3DR.%26atitle%3DActivation%2520of%2520AMP-activated%2520protein%2520kinase%2520by%2520vascular%2520endothelial%2520growth%2520factor%2520mediates%2520endothelial%2520angiogenesis%2520independently%2520of%2520nitric-oxide%2520synthase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D10638%26epage%3D10652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=Beta-secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0ljoKO_RqnHQ3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DBeta-secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Kopan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeter, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weintraub, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nye, J. S.</span><span> </span><span class="NLM_article-title">Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1683</span><span class="NLM_x">–</span> <span class="NLM_lpage">1688</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=1683-1688&author=R.+Kopanauthor=E.+H.+Schroeterauthor=H.+Weintraubauthor=J.+S.+Nye&title=Signal+transduction+by+activated+mNotch%3A+importance+of+proteolytic+processing+and+its+regulation+by+the+extracellular+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopan%26aufirst%3DR.%26aulast%3DSchroeter%26aufirst%3DE.%2BH.%26aulast%3DWeintraub%26aufirst%3DH.%26aulast%3DNye%26aufirst%3DJ.%2BS.%26atitle%3DSignal%2520transduction%2520by%2520activated%2520mNotch%253A%2520importance%2520of%2520proteolytic%2520processing%2520and%2520its%2520regulation%2520by%2520the%2520extracellular%2520domain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D1683%26epage%3D1688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Boulton, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, M. B.</span><span> </span><span class="NLM_article-title">gamma-Secretase: a multifaceted regulator of angiogenesis</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1111%2Fj.1582-4934.2008.00274.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=18266961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlCrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=781-795&author=M.+E.+Boultonauthor=J.+Caiauthor=M.+B.+Grant&title=gamma-Secretase%3A+a+multifaceted+regulator+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase: a multifaceted regulator of angiogenesis</span></div><div class="casAuthors">Boulton, Michael E.; Cai, Jun; Grant, Maria B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">781-795</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Physiol. angiogenesis is essential for development, homeostasis and tissue repair but pathol. neovascularization is a major feature of tumors, rheumatoid arthritis, and ocular complications.  Studies over the last decade have identified γ-secretase (I), a presenilin-dependent protease, as a key regulator of angiogenesis through: (1) regulated intramembrane proteolysis and transmembrane cleavage of receptors (e.g., VEGFR-1, Notch, ErbB-4, and IGFI-R) followed by translocation of the intracellular domain to the nucleus; (2) translocation of full length membrane-bound receptors to the nucleus (VEGFR-1); (3) phosphorylation of membrane bound proteins (VEGFR-1 and ErbB-4); (4) modulation of adherens junctions (cadherin) and regulation of permeability; and (5) cleavage of amyloid precursor protein to amyloid-β which is able to regulate the angiogenic process.  The I-induced translocation of receptors to the nucleus provides an alternative intracellular signaling pathway, which acts as a potent regulator of transcription.  I is a complex composed of 4 different integral proteins (presenilin, nicastrin, Aph-1, and Pen-2), which det. the stability, substrate binding, substrate specificity, and proteolytic activity of I.  This seeming complexity allows numerous possibilities for the development of targeted I agonists/antagonists, which can specifically regulate the angiogenic process.  Here, the authors consider the structure and function of I, the growing evidence for its role in angiogenesis and the substrates involved, I as a therapeutic target, and future challenges in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofMkO5vC81e7Vg90H21EOLACvtfcHk0ljoKO_RqnHQ3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlCrt7g%253D&md5=3ee783ce0b1a3a4d8ea356553a6dd885</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00274.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00274.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoulton%26aufirst%3DM.%2BE.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DGrant%26aufirst%3DM.%2BB.%26atitle%3Dgamma-Secretase%253A%2520a%2520multifaceted%2520regulator%2520of%2520angiogenesis%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2008%26volume%3D12%26spage%3D781%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Majercak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolffe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getty, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shughrue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosahl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabrook, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, D. J.</span><span> </span><span class="NLM_article-title">LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer’s disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17967</span><span class="NLM_x">–</span> <span class="NLM_lpage">17972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17967-17972&author=J.+Majercakauthor=W.+J.+Rayauthor=A.+Espesethauthor=A.+Simonauthor=X.+P.+Shiauthor=C.+Wolffeauthor=K.+Gettyauthor=S.+Marineauthor=E.+Stecauthor=M.+Ferrerauthor=B.+Struloviciauthor=S.+Bartzauthor=A.+Gatesauthor=M.+Xuauthor=Q.+Huangauthor=L.+Maauthor=P.+Shughrueauthor=J.+Burchardauthor=D.+Colussiauthor=B.+Pietrakauthor=J.+Kahanaauthor=D.+Beherauthor=T.+Rosahlauthor=M.+Shearmanauthor=D.+Hazudaauthor=A.+B.+Sachsauthor=K.+S.+Koblanauthor=G.+R.+Seabrookauthor=D.+J.+Stone&title=LRRTM3+promotes+processing+of+amyloid-precursor+protein+by+BACE1+and+is+a+positional+candidate+gene+for+late-onset+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMajercak%26aufirst%3DJ.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DEspeseth%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DShi%26aufirst%3DX.%2BP.%26aulast%3DWolffe%26aufirst%3DC.%26aulast%3DGetty%26aufirst%3DK.%26aulast%3DMarine%26aufirst%3DS.%26aulast%3DStec%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DStrulovici%26aufirst%3DB.%26aulast%3DBartz%26aufirst%3DS.%26aulast%3DGates%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DShughrue%26aufirst%3DP.%26aulast%3DBurchard%26aufirst%3DJ.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DKahana%26aufirst%3DJ.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DRosahl%26aufirst%3DT.%26aulast%3DShearman%26aufirst%3DM.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DSachs%26aufirst%3DA.%2BB.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DStone%26aufirst%3DD.%2BJ.%26atitle%3DLRRTM3%2520promotes%2520processing%2520of%2520amyloid-precursor%2520protein%2520by%2520BACE1%2520and%2520is%2520a%2520positional%2520candidate%2520gene%2520for%2520late-onset%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17967%26epage%3D17972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Child, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divito, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span> </span><span class="NLM_article-title">Loss of function of ATXN1 increases amyloid beta-protein levels by potentiating beta-secretase processing of beta-amyloid precursor protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">8515</span><span class="NLM_x">–</span> <span class="NLM_lpage">8526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=8515-8526&author=C.+Zhangauthor=A.+Browneauthor=D.+Childauthor=J.+R.+Divitoauthor=J.+A.+Stevensonauthor=R.+E.+Tanzi&title=Loss+of+function+of+ATXN1+increases+amyloid+beta-protein+levels+by+potentiating+beta-secretase+processing+of+beta-amyloid+precursor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DBrowne%26aufirst%3DA.%26aulast%3DChild%26aufirst%3DD.%26aulast%3DDivito%26aufirst%3DJ.%2BR.%26aulast%3DStevenson%26aufirst%3DJ.%2BA.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26atitle%3DLoss%2520of%2520function%2520of%2520ATXN1%2520increases%2520amyloid%2520beta-protein%2520levels%2520by%2520potentiating%2520beta-secretase%2520processing%2520of%2520beta-amyloid%2520precursor%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D8515%26epage%3D8526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Westmeyer, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Multhaup, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assfalg-Machleidt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Dimerization of beta-site beta-amyloid precursor protein-cleaving enzyme</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">53205</span><span class="NLM_x">–</span> <span class="NLM_lpage">53212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=53205-53212&author=G.+G.+Westmeyerauthor=M.+Willemauthor=S.+F.+Lichtenthalerauthor=G.+Lurmanauthor=G.+Multhaupauthor=I.+Assfalg-Machleidtauthor=K.+Reissauthor=P.+Saftigauthor=C.+Haass&title=Dimerization+of+beta-site+beta-amyloid+precursor+protein-cleaving+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestmeyer%26aufirst%3DG.%2BG.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DLurman%26aufirst%3DG.%26aulast%3DMulthaup%26aufirst%3DG.%26aulast%3DAssfalg-Machleidt%26aufirst%3DI.%26aulast%3DReiss%26aufirst%3DK.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DDimerization%2520of%2520beta-site%2520beta-amyloid%2520precursor%2520protein-cleaving%2520enzyme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D53205%26epage%3D53212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Multhaup, G.</span><span> </span><span class="NLM_article-title">Amyloid precursor protein and BACE function as oligomers</span> <span class="citation_source-journal">Neurodegener. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1159%2F000095266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=17047367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2hu7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=270-274&author=G.+Multhaup&title=Amyloid+precursor+protein+and+BACE+function+as+oligomers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid precursor protein and BACE function as oligomers</span></div><div class="casAuthors">Multhaup, Gerd</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">270-274</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Processing of the amyloid precursor protein (APP) by β- and γ-secretases leads to the generation of amyloid-β (Aβ) peptides, which are the toxic agents in the pathogenesis of Alzheimer's disease.  The mol. reasons for the sequential Aβ generation by secretase activities have remained unclear.  Our studies support an oligomerization-dependent mechanism for the conversion of APP into Aβ.  By different lines of evidence, we showed that APP is capable of forming homodimers and tetramers.  Oligomerization of APP occurs in a zipper-like mechanism primarily mediated by two highly conserved sites of the ectodomain.  We also found that in human brain tissue β-secretase (BACE) occurred as a dimer, whereas the sol. ectodomain of truncated BACE exclusively occurred in the monomeric form.  A mutational anal. of the active sites supports the idea that BACE might have acquired a specific catalytic activity by oligomerization, which is stabilized through the transmembrane and the cytoplasmic domains.  Our results predict that APP homodimers are functionally active within the plasma membrane and most likely represent substrates for BACE oligomers.  Understanding the mol. tasks of homophilic binding of substrates and secretases will allow to find secretase inhibitors which specifically bind to contact sites of dimers and thus inhibit Aβ formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmaKif2dpsC7Vg90H21EOLACvtfcHk0lhfF0t38iL5xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2hu7nO&md5=1e910cfa116440363488a03b85977438</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1159%2F000095266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000095266%26sid%3Dliteratum%253Aachs%26aulast%3DMulthaup%26aufirst%3DG.%26atitle%3DAmyloid%2520precursor%2520protein%2520and%2520BACE%2520function%2520as%2520oligomers%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2006%26volume%3D3%26spage%3D270%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Paris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadros, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelleDonne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullan, M.</span><span> </span><span class="NLM_article-title">Inhibition of angiogenesis and tumor growth by beta and gamma-secretase inhibitors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">514</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1016%2Fj.ejphar.2005.02.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=15878319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=514&publication_year=2005&pages=1-15&author=D.+Parisauthor=A.+Quadrosauthor=N.+Patelauthor=A.+DelleDonneauthor=J.+Humphreyauthor=M.+Mullan&title=Inhibition+of+angiogenesis+and+tumor+growth+by+beta+and+gamma-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of angiogenesis and tumor growth by β and γ-secretase inhibitors</span></div><div class="casAuthors">Paris, Daniel; Quadros, Amita; Patel, Nikunj; DelleDonne, Anthony; Humphrey, James; Mullan, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">514</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The involvement of β-secretase and γ-secretase in producing the β-amyloid component of senile plaques found in the brain of Alzheimer's patients has fueled a major research effort to design selective inhibitors of these proteases.  Interestingly, γ-secretase cleaves several proteins including Notch, E-cadherin, CD44 and ErbB-4 (erythroblastic leukemia viral oncogene homolog 4), which are important modulators of angiogenesis.  The β-amyloid precursor protein, which is cleaved by β-secretase and γ-secretase to produce β-amyloid, is highly expressed in the endothelium of neoforming vessels suggesting that it might play a role during angiogenesis.  These data prompted us to explore the effects of β and γ-secretase inhibitors of different structures on angiogenesis and tumor growth.  Both the γ and β-secretase inhibitors tested reduce endothelial cell proliferation without inducing cellular toxicity, suppress the formation of capillary structures in vitro and oppose the sprouting of microvessel outgrowths in the rat aortic ring model of angiogenesis.  Moreover, they potently inhibit the growth and vascularization of human glioblastoma and human lung adenocarcinoma tumors xenotransplanted into nude mice.  Altogether these data suggest that the γ and β-secretases play an essential role during angiogenesis and that inhibitors of the β and γ-secretases may constitute new classes of anti-angiogenic and anti-tumoral compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1y0XOIrQfe7Vg90H21EOLACvtfcHk0lhmPtZ9aKoWlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOhtrs%253D&md5=ae559ec177f22f9bcaf3f47cf5b3a081</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.02.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.02.050%26sid%3Dliteratum%253Aachs%26aulast%3DParis%26aufirst%3DD.%26aulast%3DQuadros%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DDelleDonne%26aufirst%3DA.%26aulast%3DHumphrey%26aufirst%3DJ.%26aulast%3DMullan%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520angiogenesis%2520and%2520tumor%2520growth%2520by%2520beta%2520and%2520gamma-secretase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D514%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Prinz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlange, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asadullah, K.</span><span> </span><span class="NLM_article-title">Believe it or not: how much can we rely on published data on potential drug targets?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=712&author=F.+Prinzauthor=T.+Schlangeauthor=K.+Asadullah&title=Believe+it+or+not%3A+how+much+can+we+rely+on+published+data+on+potential+drug+targets%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrinz%26aufirst%3DF.%26aulast%3DSchlange%26aufirst%3DT.%26aulast%3DAsadullah%26aufirst%3DK.%26atitle%3DBelieve%2520it%2520or%2520not%253A%2520how%2520much%2520can%2520we%2520rely%2520on%2520published%2520data%2520on%2520potential%2520drug%2520targets%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Lumpkin, M.; Woodcock, J.; Zoon, K.</span> <span class="citation_source-book">Guidance for Industry: Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well Characterized, Therapeutic, Biotechnology-Derived Products</span>; <span class="NLM_publisher-name">Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research</span>: <span class="NLM_publisher-loc">Rockville, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">1995</span><span class="NLM_x">; </span>p 10.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=M.+Lumpkin&author=J.+Woodcock&author=K.+Zoon&title=Guidance+for+Industry%3A+Content+and+Format+of+Investigational+New+Drug+Applications+%28INDs%29+for+Phase+1+Studies+of+Drugs%2C+Including+Well+Characterized%2C+Therapeutic%2C+Biotechnology-Derived+Products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLumpkin%26aufirst%3DM.%26btitle%3DGuidance%2520for%2520Industry%253A%2520Content%2520and%2520Format%2520of%2520Investigational%2520New%2520Drug%2520Applications%2520%2528INDs%2529%2520for%2520Phase%25201%2520Studies%2520of%2520Drugs%252C%2520Including%2520Well%2520Characterized%252C%2520Therapeutic%252C%2520Biotechnology-Derived%2520Products%26pub%3DCenter%2520for%2520Drug%2520Evaluation%2520and%2520Research%2520and%2520Center%2520for%2520Biologics%2520Evaluation%2520and%2520Research%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span> </span><span class="NLM_article-title">Biochemical mechanisms of new molecular entities (NMEs) approved by United States FDA during 2001–2004: mechanisms leading to optimal efficacy and safety</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.2174%2F156802606776743093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=16719803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtV2jurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=461-478&author=D.+C.+Swinney&title=Biochemical+mechanisms+of+new+molecular+entities+%28NMEs%29+approved+by+United+States+FDA+during+2001%E2%80%932004%3A+mechanisms+leading+to+optimal+efficacy+and+safety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical mechanisms of new molecular entities (NMEs) approved by United States FDA during 2001-2004: mechanisms leading to optimal efficacy and safety</span></div><div class="casAuthors">Swinney, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">461-478</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The United States FDA approved 85 New Mol. Entities (NMEs) during the period from Jan. 2001 to Nov. 2004 of which 60 were pharmaceuticals with known mol. targets.  The majority targeted enzymes (48%) or G-protein coupled receptors (GPCRs) (33%).  Eighty percent of the NMEs interacted at the same site as endogenous effector; either as competitive inhibitor/antagonist (67%) or agonist (13%).  Three biochem. operations defined the modes of action of the NMEs: (1) mass action competition (equil.), (2) a drug stabilized conformational change in the target that is important to the response (conformational), and(or) (3) drug action is less-responsive to mass action competition with effectors due to non-equil. kinetics (non-equil. kinetic).  Approx. 80% of the NMEs elicit a response utilizing conformational and(or) non-equil. kinetic mechanisms.  The remaining 20% of NMEs find mass action competition with the endogenous substrate or ligand sufficient for therapeutic utility.  These observations indicate that for the majority of drug targets, mass action-driven equil. binding alone may not be sufficient for maximal therapeutic utility.  A key determinant of the biochem. mode of action for these NMEs was to minimize the potential for toxicity, either by providing a maximal response at a low dose to minimize off-target toxicities, or by providing a mechanism to minimize the incidence of mechanism-based toxicity while retaining a sufficiently efficacious response.  This principle appears to be independent of target class and provides insight as to intrinsic biochem. features and approaches required for a maximal therapeutic index.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7meEijEZ3GrVg90H21EOLACvtfcHk0lhmPtZ9aKoWlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtV2jurs%253D&md5=091dc5bf90bf465ccf21160bd9140067</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F156802606776743093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776743093%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26atitle%3DBiochemical%2520mechanisms%2520of%2520new%2520molecular%2520entities%2520%2528NMEs%2529%2520approved%2520by%2520United%2520States%2520FDA%2520during%25202001%25E2%2580%25932004%253A%2520mechanisms%2520leading%2520to%2520optimal%2520efficacy%2520and%2520safety%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D461%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Can we rationally design promiscuous drugs?</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1016%2Fj.sbi.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=16442279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=127-136&author=A.+L.+Hopkinsauthor=J.+S.+Masonauthor=J.+P.+Overington&title=Can+we+rationally+design+promiscuous+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Can we rationally design promiscuous drugs?</span></div><div class="casAuthors">Hopkins, Andrew L.; Mason, Jonathan S.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug design is now used widely in modern medicinal chem.  The application of structural biol. to medicinal chem. has heralded the 'rational drug design' vision of discovering exquisitely selective ligands.  However, recent advances in post-genomic biol. are indicating that polypharmacol. may be a necessary trait for the efficacy of many drugs, therefore questioning the 'one drug, one target' assumption of current rational drug design.  By combining advances in chemoinformatics and structural biol., it might be possible to rationally design the next generation of promiscuous drugs with polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWdh60x9AHrVg90H21EOLACvtfcHk0lhmPtZ9aKoWlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D&md5=8f9e95a41976b8e3ac790f2fff2c406f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCan%2520we%2520rationally%2520design%2520promiscuous%2520drugs%253F%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Mestres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregori-Puigjane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valverde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sole, R. V.</span><span> </span><span class="NLM_article-title">The topology of drug–target interaction networks: implicit dependence on drug properties and target families</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1051</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1039%2Fb905821b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=19668871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1Kksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=1051-1057&author=J.+Mestresauthor=E.+Gregori-Puigjaneauthor=S.+Valverdeauthor=R.+V.+Sole&title=The+topology+of+drug%E2%80%93target+interaction+networks%3A+implicit+dependence+on+drug+properties+and+target+families"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The topology of drug-target interaction networks: Implicit dependence on drug properties and target families</span></div><div class="casAuthors">Mestres, Jordi; Gregori-Puigjane, Elisabet; Valverde, Sergi; Sole, Ricard V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1051-1057</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The availability of interaction data between small mol. drugs and protein targets has increased substantially in recent years.  Using seven different databases, we were able to assemble a total of 4767 unique interactions between 802 drugs and 480 targets, which means that on av. every drug is currently acknowledged to interact with 6 targets.  The application of network theory to the anal. of these data reveals an unexpectedly complex picture of drug-target interactions.  The results confirm that the topol. of drug-target networks depends implicitly on data completeness, drug properties, and target families.  The implications for drug discovery are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNAnnU4e6Jl7Vg90H21EOLACvtfcHk0lh76PC-gCUJ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1Kksbo%253D&md5=a0999bf0521936fba03400554411e8d7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1039%2Fb905821b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb905821b%26sid%3Dliteratum%253Aachs%26aulast%3DMestres%26aufirst%3DJ.%26aulast%3DGregori-Puigjane%26aufirst%3DE.%26aulast%3DValverde%26aufirst%3DS.%26aulast%3DSole%26aufirst%3DR.%2BV.%26atitle%3DThe%2520topology%2520of%2520drug%25E2%2580%2593target%2520interaction%2520networks%253A%2520implicit%2520dependence%2520on%2520drug%2520properties%2520and%2520target%2520families%26jtitle%3DMol.%2520BioSyst.%26date%3D2009%26volume%3D5%26spage%3D1051%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Garnier, J. P.</span><span> </span><span class="NLM_article-title">Rebuilding the R&D engine in big pharma</span> <span class="citation_source-journal">Harv. Bus. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><div class="note"><p class="first last">72–6, 128.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=18543809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A280%3ADC%252BD1czns1arug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=68-70&author=J.+P.+Garnier&title=Rebuilding+the+R%26D+engine+in+big+pharma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Rebuilding the R&D engine in big pharma</span></div><div class="casAuthors">Garnier Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Harvard business review</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">68-70, 72-6, 128</span>
        ISSN:<span class="NLM_cas:issn">0017-8012</span>.
    </div><div class="casAbstract">From December 2000 to February 2008, the top 15 companies in the pharmaceutical industry lost roughly $850 billion in shareholder value.  Although a number of factors--including the rise of generics, pricing pressures, regulatory requirements, and legal entanglements--are to blame, Garnier, the CEO of GlaxoSmithKline, believes that declining R&D productivity is his industry's primary problem.  The way to solve it, he says, is to return power to the scientists--by reorganizing R&D into highly focused groups headed by inspirational leaders, seeking the best science outside as well as inside a company, fixing broken processes, and promoting a strong culture of innovation and passion for excellence.  GSK has replaced its organizational pyramid with 12 "centers of excellence.  The company has worked to untangle the quest for breakthrough drugs from the effort to develop best-in-class offerings and has overhauled incentives for the scientists who actually make discoveries.  It has also pursued contractual relationships with academia and biotech companies in a bid to secure the best science, wherever it may reside.  When the company began a sweeping reengineering of its R&D, it had only two products in late-stage development.  Today it has 34--the most in the industry.  But much more remains to be done, the author says.  Significant cost efficiencies could be achieved by offshoring clinical trials.  Development of new blockbuster drugs could be simplified and accelerated if researchers targeted only a limited segment of the potential patient population and then expanded to others over time.  The innovation malaise in pharmaceuticals is not unique, Garnier says.  Many other industries face the same challenges.  A cultural revolution and a broad transformation of the organization are necessary first steps to rebuilding the R&D engine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvsDraBS9Q3YHWj6b1v8uTfW6udTcc2eYoW5YkuIu1lbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czns1arug%253D%253D&md5=c7c719004c9b33d42944a20cdfa53b28</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarnier%26aufirst%3DJ.%2BP.%26atitle%3DRebuilding%2520the%2520R%2526D%2520engine%2520in%2520big%2520pharma%26jtitle%3DHarv.%2520Bus.%2520Rev.%26date%3D2008%26volume%3D86%26spage%3D68%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Munos, B.</span><span> </span><span class="NLM_article-title">Can open-source drug R&D repower pharmaceutical innovation?</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fclpt.2010.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=20407458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A280%3ADC%252BC3c3nslamtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2010&pages=534-536&author=B.+Munos&title=Can+open-source+drug+R%26D+repower+pharmaceutical+innovation%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Can open-source drug R&D repower pharmaceutical innovation?</span></div><div class="casAuthors">Munos B</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">534-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Open-source R&D initiatives are multiplying across biomedical research.  Some of them-such as public-private partnerships-have achieved notable success in bringing new drugs to market economically, whereas others reflect the pharmaceutical industry's efforts to retool its R&D model.  Is open innovation the answer to the innovation crisis? This Commentary argues that although it may likely be part of the solution, significant cultural, scientific, and regulatory barriers can prevent it from delivering on its promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAiiHGLxu2vpagfuraLLzSfW6udTcc2eYoW5YkuIu1lbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3nslamtQ%253D%253D&md5=1b4605c16a25e79195e5fa3cb7a66a8f</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2010.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2010.26%26sid%3Dliteratum%253Aachs%26aulast%3DMunos%26aufirst%3DB.%26atitle%3DCan%2520open-source%2520drug%2520R%2526D%2520repower%2520pharmaceutical%2520innovation%253F%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2010%26volume%3D87%26spage%3D534%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Ma, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zemmel, R.</span><span> </span><span class="NLM_article-title">Value of novelty?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=571-572&author=P.+Maauthor=R.+Zemmel&title=Value+of+novelty%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%26aulast%3DZemmel%26aufirst%3DR.%26atitle%3DValue%2520of%2520novelty%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D571%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Flordellis, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manolis, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paris, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karabinis, A.</span><span> </span><span class="NLM_article-title">Rethinking target discovery in polygenic diseases</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1791</span><span class="NLM_x">–</span> <span class="NLM_lpage">1798</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.2174%2F156802606778194226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=17017957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCgsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1791-1798&author=C.+S.+Flordellisauthor=A.+S.+Manolisauthor=H.+Parisauthor=A.+Karabinis&title=Rethinking+target+discovery+in+polygenic+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Rethinking target discovery in polygenic diseases</span></div><div class="casAuthors">Flordellis, Christodoulos S.; Manolis, Antonis S.; Paris, Herve; Karabinis, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1791-1798</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Despite an extraordinary investment in R&D the yield of successful new drugs has been disproportionately low in recent years, suggesting that the whole process of drug development requires rethinking and reform.  Most analyses on this issue focus on mol. target discovery considerations.  Target identification is characterized by a surplus of potential targets, but there is a translational bottleneck primarily due to limitations of currently employed target validation platforms.  Meanwhile, the clin. entities, to which treatments are directed, are also highly complex in terms of pathophysiol. mechanisms and manifestations.  In the present study we discuss the limitations of current mol. target discovery approaches mainly in regard to selectivity and efficacy.  We also describe the constraints imposed on drug development by the current diagnostic constructs and the tendency towards dissecting the complex clin. phenotypes to component intermediate phenotypes.  Finally, we describe how the reconsideration of mol. and clin. targets in polygenic diseases may lead to new strategies of pharmacol. intervention directed against component dysfunctions, rather than the whole complex phenotype.  Such strategies involve the combination of single ligands that act selectively on multiple mols. involved in a particular disease, or the employment of "multi-targeted" drugs, i.e. single drug mols. that hit selectively multiple receptors sharing common binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNNx-xJ_B6bVg90H21EOLACvtfcHk0lh76PC-gCUJ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCgsLnP&md5=360d99f61a2dd180aa83f05f79b1f250</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F156802606778194226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778194226%26sid%3Dliteratum%253Aachs%26aulast%3DFlordellis%26aufirst%3DC.%2BS.%26aulast%3DManolis%26aufirst%3DA.%2BS.%26aulast%3DParis%26aufirst%3DH.%26aulast%3DKarabinis%26aufirst%3DA.%26atitle%3DRethinking%2520target%2520discovery%2520in%2520polygenic%2520diseases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1791%26epage%3D1798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Lindsay, M. A.</span><span> </span><span class="NLM_article-title">Target discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=831-8&author=M.+A.+Lindsay&title=Target+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindsay%26aufirst%3DM.%2BA.%26atitle%3DTarget%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D831%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Edwards, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span> </span><span class="NLM_article-title">Open access chemical and clinical probes to support drug discovery</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnchembio0709-436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=19536100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVags7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=436-40&author=A.+M.+Edwardsauthor=C.+Bountraauthor=D.+J.+Kerrauthor=T.+M.+Willson&title=Open+access+chemical+and+clinical+probes+to+support+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Open access chemical and clinical probes to support drug discovery</span></div><div class="casAuthors">Edwards, Aled M.; Bountra, Chas; Kerr, David J.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">436-440</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society.  Duplication could be reduced, and productivity could be increased, by performing basic biol. and clin. proofs of concept within open access industry-academia partnerships.  Chem. biologists could play a central role in this effort.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEVfmfLQWObLVg90H21EOLACvtfcHk0lixS3JPU8Gwvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVags7g%253D&md5=fada9d85153aeb065c0130889be2160f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnchembio0709-436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio0709-436%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DKerr%26aufirst%3DD.%2BJ.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DOpen%2520access%2520chemical%2520and%2520clinical%2520probes%2520to%2520support%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D436%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Fishman, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. A.</span><span> </span><span class="NLM_article-title">Pharmaceuticals: a new grammar for drug discovery</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2005&pages=491-493&author=M.+C.+Fishmanauthor=J.+A.+Porter&title=Pharmaceuticals%3A+a+new+grammar+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFishman%26aufirst%3DM.%2BC.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26atitle%3DPharmaceuticals%253A%2520a%2520new%2520grammar%2520for%2520drug%2520discovery%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D491%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Mullard, A.</span><span> </span><span class="NLM_article-title">Reliability of “new drug target” claims called into question</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=643-644&author=A.+Mullard&title=Reliability+of+%E2%80%9Cnew+drug+target%E2%80%9D+claims+called+into+question"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DReliability%2520of%2520%25E2%2580%259Cnew%2520drug%2520target%25E2%2580%259D%2520claims%2520called%2520into%2520question%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D643%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Appels, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beijnen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schellens, J. H.</span><span> </span><span class="NLM_article-title">Development of farnesyl transferase inhibitors: a review</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=565-578&author=N.+M.+Appelsauthor=J.+H.+Beijnenauthor=J.+H.+Schellens&title=Development+of+farnesyl+transferase+inhibitors%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppels%26aufirst%3DN.%2BM.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26atitle%3DDevelopment%2520of%2520farnesyl%2520transferase%2520inhibitors%253A%2520a%2520review%26jtitle%3DOncologist%26date%3D2005%26volume%3D10%26spage%3D565%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Fingleton, B.</span><span> </span><span class="NLM_article-title">MMPs as therapeutic targets—still a viable option?</span> <span class="citation_source-journal">Semin. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=61-68&author=B.+Fingleton&title=MMPs+as+therapeutic+targets%E2%80%94still+a+viable+option%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFingleton%26aufirst%3DB.%26atitle%3DMMPs%2520as%2520therapeutic%2520targets%25E2%2580%2594still%2520a%2520viable%2520option%253F%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2008%26volume%3D19%26spage%3D61%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Boyce, S.; Hill, R.</span> <span class="citation_source-book">Proceedings of the 9th World Congress on Pain</span>; <span class="NLM_contrib-group">Devor, M.</span>, Ed.; <span class="NLM_publisher-name">International Association for the Study of Pain Press</span>: <span class="NLM_publisher-loc">Vienna, Austria</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=313-324&author=S.+Boyce&author=R.+Hillauthor=M.+Devor&title=Proceedings+of+the+9th+World+Congress+on+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBoyce%26aufirst%3DS.%26btitle%3DProceedings%2520of%2520the%25209th%2520World%2520Congress%2520on%2520Pain%26aulast%3DDevor%26aufirst%3DM.%26pub%3DInternational%2520Association%2520for%2520the%2520Study%2520of%2520Pain%2520Press%26date%3D2000%26spage%3D313%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Overington, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">How many drug targets are there?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=993-996&author=J.+P.+Overingtonauthor=B.+Al-Lazikaniauthor=A.+L.+Hopkins&title=How+many+drug+targets+are+there%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DHow%2520many%2520drug%2520targets%2520are%2520there%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D993%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Martin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kofron, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traphagen, L. M.</span><span> </span><span class="NLM_article-title">Do Structurally Similar Molecules Have Similar Biological Activity?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4350</span><span class="NLM_x">–</span> <span class="NLM_lpage">4358</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020155c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4350-4358&author=Y.+C.+Martinauthor=J.+L.+Kofronauthor=L.+M.+Traphagen&title=Do+Structurally+Similar+Molecules+Have+Similar+Biological+Activity%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm020155c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020155c%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DY.%2BC.%26aulast%3DKofron%26aufirst%3DJ.%2BL.%26aulast%3DTraphagen%26aufirst%3DL.%2BM.%26atitle%3DDo%2520Structurally%2520Similar%2520Molecules%2520Have%2520Similar%2520Biological%2520Activity%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4350%26epage%3D4358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Yoder, M. C.</span><span> </span><span class="NLM_article-title">Is endothelium the origin of endothelial progenitor cells?</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1161%2FATVBAHA.109.191635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=20453169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1alsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=1094-1103&author=M.+C.+Yoder&title=Is+endothelium+the+origin+of+endothelial+progenitor+cells%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Is Endothelium the Origin of Endothelial Progenitor Cells?</span></div><div class="casAuthors">Yoder, Mervin C.</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1094-1103</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Endothelial cells provide the dynamic lining of blood vessels throughout the body and provide many tissue-specific functions, in addn. to providing a nonthrombogenic surface for blood cells and conduit for oxygen and nutrient delivery.  As might be expected, some endothelial cells are injured or become senescent and are sloughed into the bloodstream, and most circulating endothelial cells display evidence of undergoing apoptosis or necrosis.  However, there are rare viable circulating endothelial cells that display properties consistent with those of a progenitor cell for the endothelial lineage.  This article reviews historical and current literature to present some evidence that the endothelial lining of blood vessels may serve as a source for rare endothelial colony-forming cells that display clonal proliferative potential, self-renewal, and in vivo vessel forming ability.  The article also discusses the current gaps in our knowledge to prove whether the colony-forming cells are in fact derived from vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtajvMrsPh2LVg90H21EOLACvtfcHk0lj24RCwtKrCWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1alsbg%253D&md5=8ea613403cbd88dbc71c9af4d29daa1b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.109.191635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.109.191635%26sid%3Dliteratum%253Aachs%26aulast%3DYoder%26aufirst%3DM.%2BC.%26atitle%3DIs%2520endothelium%2520the%2520origin%2520of%2520endothelial%2520progenitor%2520cells%253F%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2010%26volume%3D30%26spage%3D1094%26epage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Alberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennessy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagelos, P. R.</span><span> </span><span class="NLM_article-title">Regulation of lipid synthesis in cultured animal cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">249</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=249&publication_year=1974&pages=5241-5249&author=A.+W.+Albertsauthor=K.+Fergusonauthor=S.+Hennessyauthor=P.+R.+Vagelos&title=Regulation+of+lipid+synthesis+in+cultured+animal+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlberts%26aufirst%3DA.%2BW.%26aulast%3DFerguson%26aufirst%3DK.%26aulast%3DHennessy%26aufirst%3DS.%26aulast%3DVagelos%26aufirst%3DP.%2BR.%26atitle%3DRegulation%2520of%2520lipid%2520synthesis%2520in%2520cultured%2520animal%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1974%26volume%3D249%26spage%3D5241%26epage%3D5249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Bijleveld, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geelen, M. J.</span><span> </span><span class="NLM_article-title">Measurement of acetyl-CoA carboxylase activity in isolated hepatocytes</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">918</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=918&publication_year=1987&pages=274-283&author=C.+Bijleveldauthor=M.+J.+Geelen&title=Measurement+of+acetyl-CoA+carboxylase+activity+in+isolated+hepatocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBijleveld%26aufirst%3DC.%26aulast%3DGeelen%26aufirst%3DM.%2BJ.%26atitle%3DMeasurement%2520of%2520acetyl-CoA%2520carboxylase%2520activity%2520in%2520isolated%2520hepatocytes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1987%26volume%3D918%26spage%3D274%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Zhang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldenburg, K. R.</span><span> </span><span class="NLM_article-title">A simple statistical parameter for use in evaluation and validation of high throughput screening assays</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1177%2F108705719900400206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=10838414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=67-73&author=J.+H.+Zhangauthor=T.+D.+Chungauthor=K.+R.+Oldenburg&title=A+simple+statistical+parameter+for+use+in+evaluation+and+validation+of+high+throughput+screening+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span></div><div class="casAuthors">Zhang; Chung; Oldenburg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ability to identify active compounds (3hits2) from large chemical libraries accurately and rapidly has been the ultimate goal in developing high-throughput screening (HTS) assays.  The ability to identify hits from a particular HTS assay depends largely on the suitability or quality of the assay used in the screening.  The criteria or parameters for evaluating the 3suitability2 of an HTS assay for hit identification are not well defined and hence it still remains difficult to compare the quality of assays directly.  In this report, a screening window coefficient, called 3Z-factor,2 is defined.  This coefficient is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements, and therefore is suitable for assay quality assessment.  The Z-factor is a dimensionless, simple statistical characteristic for each HTS assay.  The Z-factor provides a useful tool for comparison and evaluation of the quality of assays, and can be utilized in assay optimization and validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkwW5JDdXnbsNIRw0GKUoEfW6udTcc2eZrzJ0tYr7DYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D&md5=0ec4ed2ccdd3b4a16521567a0975d31f</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1177%2F108705719900400206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400206%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DChung%26aufirst%3DT.%2BD.%26aulast%3DOldenburg%26aufirst%3DK.%2BR.%26atitle%3DA%2520simple%2520statistical%2520parameter%2520for%2520use%2520in%2520evaluation%2520and%2520validation%2520of%2520high%2520throughput%2520screening%2520assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26spage%3D67%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Butina, D.</span><span> </span><span class="NLM_article-title">Unsupervised data base clustering based on Daylight’s fingerprint and Tanimoto similarity: a fast and automated way to cluster small and large data sets</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci9803381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADyaK1MXktVWhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1999&pages=747-750&author=D.+Butina&title=Unsupervised+data+base+clustering+based+on+Daylight%E2%80%99s+fingerprint+and+Tanimoto+similarity%3A+a+fast+and+automated+way+to+cluster+small+and+large+data+sets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Unsupervised data base clustering based on Daylight's fingerprint and Tanimoto similarity: a fast and automated way to cluster small and large data sets</span></div><div class="casAuthors">Butina, Darko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">747-750</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Jarvis-Patrick's (J-P) algorithm is one of the most commonly used clustering algorithms within the global pharmaceutical industry.  The implementation of the J-P under Daylight software, using Daylight's fingerprints and the Tanimoto similarity index, can deal with sets of 100 k mols. in a matter of a few hours.  However, the J-P clustering algorithm has several assocd. problems which make it difficult to cluster large data sets in a consistent and timely manner.  The clusters produced are greatly dependent on the choice of the two parameters needed to run J-P clustering, such that this method tends to produce clusters which are either very large and heterogeneous or homogeneous but too small.  In any case, J-P always requires time-consuming manual tuning.  An algorithm which will identify dense clusters where similarity within each cluster reflects the Tanimoto value used for the clustering and, more importantly, where the cluster centroid will be at least similar, at the given Tanimoto value, to every other mol. within the cluster in a consistent and automated manner, is presented.  The similarity term used throughout the paper reflects the overall similarity between two given mols., as defined by Daylight's fingerprints and the Tanimoto similarity index.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCrA2wdJndA7Vg90H21EOLACvtfcHk0lj24RCwtKrCWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVWhtLw%253D&md5=e11c02e1e777f88e208ec5fdc5405c47</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fci9803381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci9803381%26sid%3Dliteratum%253Aachs%26aulast%3DButina%26aufirst%3DD.%26atitle%3DUnsupervised%2520data%2520base%2520clustering%2520based%2520on%2520Daylight%25E2%2580%2599s%2520fingerprint%2520and%2520Tanimoto%2520similarity%253A%2520a%2520fast%2520and%2520automated%2520way%2520to%2520cluster%2520small%2520and%2520large%2520data%2520sets%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D1999%26volume%3D39%26spage%3D747%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 137 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Min Ho Jeon, Young-Do Kwon, Min Pyeong Kim, Gianluca Bartolini Torres, Jeong Kon Seo, Jeongmin Son, Young Hoon Ryu, Sung You Hong, <span class="NLM_string-name hlFld-ContribAuthor">Joong-Hyun Chun</span>. </span><span class="cited-content_cbyCitation_article-title">Late-Stage 18F/19F Isotopic Exchange for the Synthesis of 18F-Labeled Sulfamoyl Fluorides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (7)
                                     , 2766-2771. <a href="https://doi.org/10.1021/acs.orglett.1c00671" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00671%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DLate-Stage%252B18F%25252F19F%252BIsotopic%252BExchange%252Bfor%252Bthe%252BSynthesis%252Bof%252B18F-Labeled%252BSulfamoyl%252BFluorides%26aulast%3DJeon%26aufirst%3DMin%2BHo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D25022021%26date%3D16032021%26volume%3D23%26issue%3D7%26spage%3D2766%26epage%3D2771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Noelle S. Williams, Stephen Gonzales, Jacinth Naidoo, Giomar Rivera-Cancel, Sukesh Voruganti, Prema Mallipeddi, Panayotis C. Theodoropoulos, Sophie Geboers, Hong Chen, Francisco Ortiz, Bruce Posner, Deepak Nijhawan, <span class="NLM_string-name hlFld-ContribAuthor">Joseph M. Ready</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor-Activated Benzothiazole Inhibitors of Stearoyl-CoA Desaturase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9773-9786. <a href="https://doi.org/10.1021/acs.jmedchem.0c00899" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00899%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTumor-Activated%252BBenzothiazole%252BInhibitors%252Bof%252BStearoyl-CoA%252BDesaturase%26aulast%3DWilliams%26aufirst%3DNoelle%2BS.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03062020%26date%3D19082020%26date%3D05082020%26volume%3D63%26issue%3D17%26spage%3D9773%26epage%3D9786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Junting Zhou, Xueyang Jiang, Siyu He, Hongli Jiang, Feng Feng, Wenyuan Liu, Wei Qu, <span class="NLM_string-name hlFld-ContribAuthor">Haopeng Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 8881-8914. <a href="https://doi.org/10.1021/acs.jmedchem.9b00017" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252BDesign%252Bof%252BMultitarget-Directed%252BLigands%25253A%252BStrategies%252Band%252BEmerging%252BParadigms%26aulast%3DZhou%26aufirst%3DJunting%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04012019%26date%3D28052019%26date%3D13052019%26volume%3D62%26issue%3D20%26spage%3D8881%26epage%3D8914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ewgenij Proschak, Holger Stark, <span class="NLM_string-name hlFld-ContribAuthor">Daniel Merk</span>. </span><span class="cited-content_cbyCitation_article-title">Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 420-444. <a href="https://doi.org/10.1021/acs.jmedchem.8b00760" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00760%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPolypharmacology%252Bby%252BDesign%25253A%252BA%252BMedicinal%252BChemist%2525E2%252580%252599s%252BPerspective%252Bon%252BMultitargeting%252BCompounds%26aulast%3DProschak%26aufirst%3DEwgenij%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D11052018%26date%3D03082018%26date%3D23072018%26volume%3D62%26issue%3D2%26spage%3D420%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Petr Šimon, Tomáš Knedlík, Kristýna Blažková, Petra Dvořáková, Anna Březinová, Libor Kostka, Vladimír Šubr, Jan Konvalinka, <span class="NLM_string-name hlFld-ContribAuthor">Pavel Šácha</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Protein Targets of Bioactive Small Molecules Using Randomly Photomodified Probes. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2018,</strong> <em>13 </em>
                                    (12)
                                     , 3333-3342. <a href="https://doi.org/10.1021/acschembio.8b00791" title="DOI URL">https://doi.org/10.1021/acschembio.8b00791</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.8b00791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.8b00791%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DIdentification%252Bof%252BProtein%252BTargets%252Bof%252BBioactive%252BSmall%252BMolecules%252BUsing%252BRandomly%252BPhotomodified%252BProbes%26aulast%3D%25C5%25A0imon%26aufirst%3DPetr%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D24082018%26date%3D29112018%26date%3D07122018%26date%3D29112018%26volume%3D13%26issue%3D12%26spage%3D3333%26epage%3D3342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Teresa Valero, Antonio Delgado-González, Juan Diego Unciti-Broceta, Victoria Cano-Cortés, Ana M. Pérez-López, Asier Unciti-Broceta, <span class="NLM_string-name hlFld-ContribAuthor">Rosario M. Sánchez Martín</span>. </span><span class="cited-content_cbyCitation_article-title">Drug “Clicking” on Cell-Penetrating Fluorescent Nanoparticles for In Cellulo Chemical Proteomics. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2018,</strong> <em>29 </em>
                                    (9)
                                     , 3154-3160. <a href="https://doi.org/10.1021/acs.bioconjchem.8b00481" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.8b00481</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.8b00481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.8b00481%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DDrug%252B%2525E2%252580%25259CClicking%2525E2%252580%25259D%252Bon%252BCell-Penetrating%252BFluorescent%252BNanoparticles%252Bfor%252BIn%252BCellulo%252BChemical%252BProteomics%26aulast%3DValero%26aufirst%3DTeresa%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06072018%26date%3D16082018%26date%3D04092018%26date%3D18082018%26volume%3D29%26issue%3D9%26spage%3D3154%26epage%3D3160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Samuel
H. Myers, Carolin Temps, Douglas R. Houston, Valerie G. Brunton, <span class="NLM_string-name hlFld-ContribAuthor">Asier Unciti-Broceta</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Potent Inhibitors of Receptor Tyrosine Kinases by Ligand-Based Drug Design and Target-Biased Phenotypic Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 2104-2110. <a href="https://doi.org/10.1021/acs.jmedchem.7b01605" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01605</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01605%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BPotent%252BInhibitors%252Bof%252BReceptor%252BTyrosine%252BKinases%252Bby%252BLigand-Based%252BDrug%252BDesign%252Band%252BTarget-Biased%252BPhenotypic%252BScreening%26aulast%3DMyers%26aufirst%3DSamuel%2BH.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D30102017%26date%3D21022018%26volume%3D61%26issue%3D5%26spage%3D2104%26epage%3D2110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carla F.  Newman</span>, <span class="hlFld-ContribAuthor ">Rasmus  Havelund</span>, <span class="hlFld-ContribAuthor ">Melissa K.  Passarelli</span>, <span class="hlFld-ContribAuthor ">Peter S.  Marshall</span>, <span class="hlFld-ContribAuthor ">Ian  Francis</span>, <span class="hlFld-ContribAuthor ">Andy  West</span>, <span class="hlFld-ContribAuthor ">Morgan R.  Alexander</span>, <span class="hlFld-ContribAuthor ">Ian S.  Gilmore</span>, and <span class="hlFld-ContribAuthor ">Colin T.  Dollery</span>  . </span><span class="cited-content_cbyCitation_article-title">Intracellular Drug Uptake—A Comparison of Single Cell Measurements Using ToF-SIMS Imaging and Quantification from Cell Populations with LC/MS/MS. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2017,</strong> <em>89 </em>
                                    (22)
                                     , 11944-11953. <a href="https://doi.org/10.1021/acs.analchem.7b01436" title="DOI URL">https://doi.org/10.1021/acs.analchem.7b01436</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.7b01436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.7b01436%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DIntracellular%252BDrug%252BUptake%2525E2%252580%252594A%252BComparison%252Bof%252BSingle%252BCell%252BMeasurements%252BUsing%252BToF-SIMS%252BImaging%252Band%252BQuantification%252Bfrom%252BCell%252BPopulations%252Bwith%252BLC%25252FMS%25252FMS%26aulast%3DNewman%26aufirst%3DCarla%2BF.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18042017%26date%3D17102017%26date%3D08112017%26date%3D21112017%26date%3D17102017%26volume%3D89%26issue%3D22%26spage%3D11944%26epage%3D11953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryo  Kunimoto</span>, <span class="hlFld-ContribAuthor ">Dilyana  Dimova</span>, and <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>  . </span><span class="cited-content_cbyCitation_article-title">Application of a New Scaffold Concept for Computational Target Deconvolution of Chemical Cancer Cell Line Screens. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2017,</strong> <em>2 </em>
                                    (4)
                                     , 1463-1468. <a href="https://doi.org/10.1021/acsomega.7b00215" title="DOI URL">https://doi.org/10.1021/acsomega.7b00215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.7b00215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.7b00215%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DApplication%252Bof%252Ba%252BNew%252BScaffold%252BConcept%252Bfor%252BComputational%252BTarget%252BDeconvolution%252Bof%252BChemical%252BCancer%252BCell%252BLine%252BScreens%26aulast%3DKunimoto%26aufirst%3DRyo%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D24022017%26date%3D06042017%26date%3D30042017%26volume%3D2%26issue%3D4%26spage%3D1463%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew D.  Cheeseman</span>, <span class="hlFld-ContribAuthor ">Nicola E. A.  Chessum</span>, <span class="hlFld-ContribAuthor ">Carl S.  Rye</span>, <span class="hlFld-ContribAuthor ">A. Elisa  Pasqua</span>, <span class="hlFld-ContribAuthor ">Michael J.  Tucker</span>, <span class="hlFld-ContribAuthor ">Birgit  Wilding</span>, <span class="hlFld-ContribAuthor ">Lindsay E.  Evans</span>, <span class="hlFld-ContribAuthor ">Susan  Lepri</span>, <span class="hlFld-ContribAuthor ">Meirion  Richards</span>, <span class="hlFld-ContribAuthor ">Swee Y.  Sharp</span>, <span class="hlFld-ContribAuthor ">Salyha  Ali</span>, <span class="hlFld-ContribAuthor ">Martin  Rowlands</span>, <span class="hlFld-ContribAuthor ">Lisa  O’Fee</span>, <span class="hlFld-ContribAuthor ">Asadh  Miah</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Alan T.  Henley</span>, <span class="hlFld-ContribAuthor ">Marissa  Powers</span>, <span class="hlFld-ContribAuthor ">Robert  te Poele</span>, <span class="hlFld-ContribAuthor ">Emmanuel  De Billy</span>, <span class="hlFld-ContribAuthor ">Loredana  Pellegrino</span>, <span class="hlFld-ContribAuthor ">Florence  Raynaud</span>, <span class="hlFld-ContribAuthor ">Rosemary  Burke</span>, <span class="hlFld-ContribAuthor ">Rob L. M.  van Montfort</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, and <span class="hlFld-ContribAuthor ">Keith  Jones</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic Screen. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (1)
                                     , 180-201. <a href="https://doi.org/10.1021/acs.jmedchem.6b01055" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01055%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BChemical%252BProbe%252BBisamide%252B%252528CCT251236%252529%25253A%252BAn%252BOrally%252BBioavailable%252BEfficacious%252BPirin%252BLigand%252Bfrom%252Ba%252BHeat%252BShock%252BTranscription%252BFactor%252B1%252B%252528HSF1%252529%252BPhenotypic%252BScreen%26aulast%3DCheeseman%26aufirst%3DMatthew%2BD.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D15072016%26date%3D22122016%26date%3D12012017%26date%3D23112016%26volume%3D60%26issue%3D1%26spage%3D180%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rogério V.  Trindade</span>, <span class="hlFld-ContribAuthor ">Antônio F. M.  Pinto</span>, <span class="hlFld-ContribAuthor ">Diógenes S.  Santos</span>, and <span class="hlFld-ContribAuthor ">Cristiano V.  Bizarro</span>  . </span><span class="cited-content_cbyCitation_article-title">Pulse Proteolysis and Precipitation for Target Identification. </span><span class="cited-content_cbyCitation_journal-name">Journal of Proteome Research</span><span> <strong>2016,</strong> <em>15 </em>
                                    (7)
                                     , 2236-2245. <a href="https://doi.org/10.1021/acs.jproteome.6b00214" title="DOI URL">https://doi.org/10.1021/acs.jproteome.6b00214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jproteome.6b00214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jproteome.6b00214%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Proteome%2520Research%26atitle%3DPulse%252BProteolysis%252Band%252BPrecipitation%252Bfor%252BTarget%252BIdentification%26aulast%3DTrindade%26aufirst%3DRog%25C3%25A9rio%2BV.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D09032016%26date%3D20062016%26date%3D01072016%26date%3D02062016%26volume%3D15%26issue%3D7%26spage%3D2236%26epage%3D2245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig  Fraser</span>, <span class="hlFld-ContribAuthor ">John C.  Dawson</span>, <span class="hlFld-ContribAuthor ">Reece  Dowling</span>, <span class="hlFld-ContribAuthor ">Douglas R.  Houston</span>, <span class="hlFld-ContribAuthor ">Jason T.  Weiss</span>, <span class="hlFld-ContribAuthor ">Alison F.  Munro</span>, <span class="hlFld-ContribAuthor ">Morwenna  Muir</span>, <span class="hlFld-ContribAuthor ">Lea  Harrington</span>, <span class="hlFld-ContribAuthor ">Scott P.  Webster</span>, <span class="hlFld-ContribAuthor ">Margaret C.  Frame</span>, <span class="hlFld-ContribAuthor ">Valerie G.  Brunton</span>, <span class="hlFld-ContribAuthor ">E. Elizabeth  Patton</span>, <span class="hlFld-ContribAuthor ">Neil O.  Carragher</span>, and <span class="hlFld-ContribAuthor ">Asier  Unciti-Broceta</span>  . </span><span class="cited-content_cbyCitation_article-title">Rapid Discovery and Structure–Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4697-4710. <a href="https://doi.org/10.1021/acs.jmedchem.6b00065" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00065%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRapid%252BDiscovery%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BPyrazolopyrimidines%252BThat%252BPotently%252BSuppress%252BBreast%252BCancer%252BCell%252BGrowth%252Bvia%252BSRC%252BKinase%252BInhibition%252Bwith%252BExceptional%252BSelectivity%252Bover%252BABL%252BKinase%26aulast%3DFraser%26aufirst%3DCraig%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14012016%26date%3D04052016%26date%3D26052016%26date%3D26042016%26volume%3D59%26issue%3D10%26spage%3D4697%26epage%3D4710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter M.  Njogu</span>, <span class="hlFld-ContribAuthor ">Eric M.  Guantai</span>, <span class="hlFld-ContribAuthor ">Elumalai  Pavadai</span>, and <span class="hlFld-ContribAuthor ">Kelly  Chibale</span>  . </span><span class="cited-content_cbyCitation_article-title">Computer-Aided Drug Discovery Approaches against the Tropical Infectious Diseases Malaria, Tuberculosis, Trypanosomiasis, and Leishmaniasis. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2016,</strong> <em>2 </em>
                                    (1)
                                     , 8-31. <a href="https://doi.org/10.1021/acsinfecdis.5b00093" title="DOI URL">https://doi.org/10.1021/acsinfecdis.5b00093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.5b00093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.5b00093%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DComputer-Aided%252BDrug%252BDiscovery%252BApproaches%252Bagainst%252Bthe%252BTropical%252BInfectious%252BDiseases%252BMalaria%25252C%252BTuberculosis%25252C%252BTrypanosomiasis%25252C%252Band%252BLeishmaniasis%26aulast%3DNjogu%26aufirst%3DPeter%2BM.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D13082015%26date%3D16112015%26date%3D08012016%26date%3D09112015%26volume%3D2%26issue%3D1%26spage%3D8%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Gerald    Maggiora </span><span class="hlFld-ContribAuthor "> Vijay    Gokhale </span>. </span><span class="cited-content_cbyCitation_article-title">Non-Specificity of Drug-Target Interactions – Consequences for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 91-142. <a href="https://doi.org/10.1021/bk-2016-1222.ch007" title="DOI URL">https://doi.org/10.1021/bk-2016-1222.ch007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1222.ch007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1222.ch007%26sid%3Dliteratum%253Aachs%26atitle%3DNon-Specificity%252Bof%252BDrug-Target%252BInteractions%252B%2525E2%252580%252593%252BConsequences%252Bfor%252BDrug%252BDiscovery%26aulast%3DMaggiora%26aufirst%3DGerald%26date%3D2016%26date%3D2016%26spage%3D91%26epage%3D142%26atitle%3DFrontiers%252Bin%252BMolecular%252BDesign%252Band%252BChemical%252BInformation%252BScience%252B-%252BHerman%252BSkolnik%252BAward%252BSymposium%252B2015%25253A%252BJ%2525C3%2525BCrgen%252BBajorath%26aulast%3DBienstock%26aufirst%3DRachelle%2BJ.%26date%3D2016%26date%3D2016%26volume%3D1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Song Wei Benjamin  Tan</span>, <span class="hlFld-ContribAuthor ">Christina L. L.  Chai</span>, <span class="hlFld-ContribAuthor ">Mark G.  Moloney</span>, and <span class="hlFld-ContribAuthor ">Amber L.  Thompson</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Mimics of Pramanicin from Pyroglutamic Acid and Their Antibacterial Activity. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (5)
                                     , 2661-2675. <a href="https://doi.org/10.1021/jo502810b" title="DOI URL">https://doi.org/10.1021/jo502810b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo502810b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo502810b%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BMimics%252Bof%252BPramanicin%252Bfrom%252BPyroglutamic%252BAcid%252Band%252BTheir%252BAntibacterial%252BActivity%26aulast%3DTan%26aufirst%3DSong%2BWei%2BBenjamin%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D18122014%26date%3D23022015%26date%3D06032015%26date%3D03022015%26volume%3D80%26issue%3D5%26spage%3D2661%26epage%3D2675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guillaume  Médard</span>, <span class="hlFld-ContribAuthor ">Fiona  Pachl</span>, <span class="hlFld-ContribAuthor ">Benjamin  Ruprecht</span>, <span class="hlFld-ContribAuthor ">Susan  Klaeger</span>, <span class="hlFld-ContribAuthor ">Stephanie  Heinzlmeir</span>, <span class="hlFld-ContribAuthor ">Dominic  Helm</span>, <span class="hlFld-ContribAuthor ">Huichao  Qiao</span>, <span class="hlFld-ContribAuthor ">Xin  Ku</span>, <span class="hlFld-ContribAuthor ">Mathias  Wilhelm</span>, <span class="hlFld-ContribAuthor ">Thomas  Kuehne</span>, <span class="hlFld-ContribAuthor ">Zhixiang  Wu</span>, <span class="hlFld-ContribAuthor ">Antje  Dittmann</span>, <span class="hlFld-ContribAuthor ">Carsten  Hopf</span>, <span class="hlFld-ContribAuthor ">Karl  Kramer</span>, and <span class="hlFld-ContribAuthor ">Bernhard  Kuster</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimized Chemical Proteomics Assay for Kinase Inhibitor Profiling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Proteome Research</span><span> <strong>2015,</strong> <em>14 </em>
                                    (3)
                                     , 1574-1586. <a href="https://doi.org/10.1021/pr5012608" title="DOI URL">https://doi.org/10.1021/pr5012608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/pr5012608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fpr5012608%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Proteome%2520Research%26atitle%3DOptimized%252BChemical%252BProteomics%252BAssay%252Bfor%252BKinase%252BInhibitor%252BProfiling%26aulast%3DM%25C3%25A9dard%26aufirst%3DGuillaume%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05122014%26date%3D20022015%26date%3D06032015%26date%3D08022015%26volume%3D14%26issue%3D3%26spage%3D1574%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahul  Hameed P</span>, <span class="hlFld-ContribAuthor ">Murugan  Chinnapattu</span>, <span class="hlFld-ContribAuthor ">Gajanan  Shanbag</span>, <span class="hlFld-ContribAuthor ">Praveena  Manjrekar</span>, <span class="hlFld-ContribAuthor ">Krishna  Koushik</span>, <span class="hlFld-ContribAuthor ">Anandkumar  Raichurkar</span>, <span class="hlFld-ContribAuthor ">Vikas  Patil</span>, <span class="hlFld-ContribAuthor ">Sandesh  Jatheendranath</span>, <span class="hlFld-ContribAuthor ">Suresh S.  Rudrapatna</span>, <span class="hlFld-ContribAuthor ">Shubhada P.  Barde</span>, <span class="hlFld-ContribAuthor ">Nikhil  Rautela</span>, <span class="hlFld-ContribAuthor ">Disha  Awasthy</span>, <span class="hlFld-ContribAuthor ">Sapna  Morayya</span>, <span class="hlFld-ContribAuthor ">Chandan  Narayan</span>, <span class="hlFld-ContribAuthor ">Stefan  Kavanagh</span>, <span class="hlFld-ContribAuthor ">Ramanatha  Saralaya</span>, <span class="hlFld-ContribAuthor ">Sowmya  Bharath</span>, <span class="hlFld-ContribAuthor ">Pavithra  Viswanath</span>, <span class="hlFld-ContribAuthor ">Kakoli  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Balachandra  Bandodkar</span>, <span class="hlFld-ContribAuthor ">Abhishek  Srivastava</span>, <span class="hlFld-ContribAuthor ">Vijender  Panduga</span>, <span class="hlFld-ContribAuthor ">Jitender  Reddy</span>, <span class="hlFld-ContribAuthor ">K. R.  Prabhakar</span>, <span class="hlFld-ContribAuthor ">Achyut  Sinha</span>, <span class="hlFld-ContribAuthor ">María Belén  Jiménez-Díaz</span>, <span class="hlFld-ContribAuthor ">María Santos  Martínez</span>, <span class="hlFld-ContribAuthor ">Iñigo  Angulo-Barturen</span>, <span class="hlFld-ContribAuthor ">Santiago  Ferrer</span>, <span class="hlFld-ContribAuthor ">Laura María  Sanz</span>, <span class="hlFld-ContribAuthor ">Francisco Javier  Gamo</span>, <span class="hlFld-ContribAuthor ">Sandra  Duffy</span>, <span class="hlFld-ContribAuthor ">Vicky M.  Avery</span>, <span class="hlFld-ContribAuthor ">Pamela A.  Magistrado</span>, <span class="hlFld-ContribAuthor ">Amanda K.  Lukens</span>, <span class="hlFld-ContribAuthor ">Dyann F.  Wirth</span>, <span class="hlFld-ContribAuthor ">David  Waterson</span>, <span class="hlFld-ContribAuthor ">V.  Balasubramanian</span>, <span class="hlFld-ContribAuthor ">Pravin S.  Iyer</span>, <span class="hlFld-ContribAuthor ">Shridhar  Narayanan</span>, <span class="hlFld-ContribAuthor ">Vinayak  Hosagrahara</span>, <span class="hlFld-ContribAuthor ">Vasan K.  Sambandamurthy</span>, and <span class="hlFld-ContribAuthor ">Sreekanth  Ramachandran</span>  . </span><span class="cited-content_cbyCitation_article-title">Aminoazabenzimidazoles, a Novel Class of Orally Active Antimalarial Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (13)
                                     , 5702-5713. <a href="https://doi.org/10.1021/jm500535j" title="DOI URL">https://doi.org/10.1021/jm500535j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500535j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500535j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAminoazabenzimidazoles%25252C%252Ba%252BNovel%252BClass%252Bof%252BOrally%252BActive%252BAntimalarial%252BAgents%26aulast%3DHameed%2BP%26aufirst%3DShahul%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D04042014%26date%3D24062014%26date%3D10072014%26date%3D10062014%26volume%3D57%26issue%3D13%26spage%3D5702%26epage%3D5713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raphael M.  Franzini</span>, <span class="hlFld-ContribAuthor ">Dario  Neri</span>, and <span class="hlFld-ContribAuthor ">Jörg  Scheuermann</span>  . </span><span class="cited-content_cbyCitation_article-title">DNA-Encoded Chemical Libraries: Advancing beyond Conventional Small-Molecule Libraries. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2014,</strong> <em>47 </em>
                                    (4)
                                     , 1247-1255. <a href="https://doi.org/10.1021/ar400284t" title="DOI URL">https://doi.org/10.1021/ar400284t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ar400284t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Far400284t%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DDNA-Encoded%252BChemical%252BLibraries%25253A%252BAdvancing%252Bbeyond%252BConventional%252BSmall-Molecule%252BLibraries%26aulast%3DFranzini%26aufirst%3DRaphael%2BM.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D27112013%26date%3D28032014%26date%3D15042014%26volume%3D47%26issue%3D4%26spage%3D1247%26epage%3D1255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa L.  Sykes</span> and <span class="hlFld-ContribAuthor ">Vicky M.  Avery</span>  . </span><span class="cited-content_cbyCitation_article-title">Approaches to Protozoan Drug Discovery: Phenotypic Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (20)
                                     , 7727-7740. <a href="https://doi.org/10.1021/jm4004279" title="DOI URL">https://doi.org/10.1021/jm4004279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4004279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4004279%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApproaches%252Bto%252BProtozoan%252BDrug%252BDiscovery%25253A%252BPhenotypic%252BScreening%26aulast%3DSykes%26aufirst%3DMelissa%2BL.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D25032013%26date%3D20082013%26date%3D24102013%26date%3D08082013%26volume%3D56%26issue%3D20%26spage%3D7727%26epage%3D7740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John A.  Butera</span>  . </span><span class="cited-content_cbyCitation_article-title">Phenotypic Screening as a Strategic Component of Drug Discovery Programs Targeting Novel Antiparasitic and Antimycobacterial Agents: An Editorial. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (20)
                                     , 7715-7718. <a href="https://doi.org/10.1021/jm400443k" title="DOI URL">https://doi.org/10.1021/jm400443k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400443k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400443k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhenotypic%252BScreening%252Bas%252Ba%252BStrategic%252BComponent%252Bof%252BDrug%252BDiscovery%252BPrograms%252BTargeting%252BNovel%252BAntiparasitic%252Band%252BAntimycobacterial%252BAgents%25253A%252BAn%252BEditorial%26aulast%3DButera%26aufirst%3DJohn%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D27032013%26date%3D27082013%26date%3D24102013%26date%3D08082013%26volume%3D56%26issue%3D20%26spage%3D7715%26epage%3D7718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maoquan  Zhou</span>, <span class="hlFld-ContribAuthor ">Ye-Jin  Eun</span>, <span class="hlFld-ContribAuthor ">Ilia A.  Guzei</span>, and <span class="hlFld-ContribAuthor ">Douglas B.  Weibel</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Studies of Divin: An Inhibitor of Bacterial Cell Division. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (9)
                                     , 880-885. <a href="https://doi.org/10.1021/ml400234x" title="DOI URL">https://doi.org/10.1021/ml400234x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml400234x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml400234x%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Activity%252BStudies%252Bof%252BDivin%25253A%252BAn%252BInhibitor%252Bof%252BBacterial%252BCell%252BDivision%26aulast%3DZhou%26aufirst%3DMaoquan%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D19062013%26date%3D29072013%26date%3D31072013%26date%3D12092013%26date%3D29072013%26volume%3D4%26issue%3D9%26spage%3D880%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H. S. Santosh  Kumar</span>, <span class="hlFld-ContribAuthor ">S. Ravi  Kumar</span>, <span class="hlFld-ContribAuthor ">N. Naveen  Kumar</span>, <span class="hlFld-ContribAuthor ">S.  Ajith</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking studies of gyrase inhibitors: weighing earlier screening bedrock. </span><span class="cited-content_cbyCitation_journal-name">In Silico Pharmacology</span><span> <strong>2021,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1007/s40203-020-00064-9" title="DOI URL">https://doi.org/10.1007/s40203-020-00064-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40203-020-00064-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40203-020-00064-9%26sid%3Dliteratum%253Aachs%26jtitle%3DIn%2520Silico%2520Pharmacology%26atitle%3DMolecular%252Bdocking%252Bstudies%252Bof%252Bgyrase%252Binhibitors%25253A%252Bweighing%252Bearlier%252Bscreening%252Bbedrock%26aulast%3DKumar%26aufirst%3DH.%2BS.%2BSantosh%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuela  Jörg</span>, <span class="hlFld-ContribAuthor ">Katrina S.  Madden</span>. </span><span class="cited-content_cbyCitation_article-title">The right tools for the job: the central role for next generation chemical probes and chemistry-based target deconvolution methods in phenotypic drug discovery. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 646-665. <a href="https://doi.org/10.1039/D1MD00022E" title="DOI URL">https://doi.org/10.1039/D1MD00022E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00022E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00022E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bright%252Btools%252Bfor%252Bthe%252Bjob%25253A%252Bthe%252Bcentral%252Brole%252Bfor%252Bnext%252Bgeneration%252Bchemical%252Bprobes%252Band%252Bchemistry-based%252Btarget%252Bdeconvolution%252Bmethods%252Bin%252Bphenotypic%252Bdrug%252Bdiscovery%26aulast%3DJ%25C3%25B6rg%26aufirst%3DManuela%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D5%26spage%3D646%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayme L.  Dahlin</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Auld</span>, <span class="hlFld-ContribAuthor ">Ina  Rothenaigner</span>, <span class="hlFld-ContribAuthor ">Steve  Haney</span>, <span class="hlFld-ContribAuthor ">Jonathan Z.  Sexton</span>, <span class="hlFld-ContribAuthor ">J. Willem M.  Nissink</span>, <span class="hlFld-ContribAuthor ">Jarrod  Walsh</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Lee</span>, <span class="hlFld-ContribAuthor ">John M.  Strelow</span>, <span class="hlFld-ContribAuthor ">Francis S.  Willard</span>, <span class="hlFld-ContribAuthor ">Lori  Ferrins</span>, <span class="hlFld-ContribAuthor ">Jonathan B.  Baell</span>, <span class="hlFld-ContribAuthor ">Michael A.  Walters</span>, <span class="hlFld-ContribAuthor ">Bruce K.  Hua</span>, <span class="hlFld-ContribAuthor ">Kamyar  Hadian</span>, <span class="hlFld-ContribAuthor ">Bridget K.  Wagner</span>. </span><span class="cited-content_cbyCitation_article-title">Nuisance compounds in cellular assays. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>28 </em>
                                    (3)
                                     , 356-370. <a href="https://doi.org/10.1016/j.chembiol.2021.01.021" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.01.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.01.021%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DNuisance%252Bcompounds%252Bin%252Bcellular%252Bassays%26aulast%3DDahlin%26aufirst%3DJayme%2BL.%26date%3D2021%26volume%3D28%26issue%3D3%26spage%3D356%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sayan  Biswas</span>. </span><span class="cited-content_cbyCitation_article-title">High Content Analysis Across Signaling Modulation Treatments for Subcellular Target Identification Reveals Heterogeneity in Cellular Response. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.3389/fcell.2020.594750" title="DOI URL">https://doi.org/10.3389/fcell.2020.594750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2020.594750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2020.594750%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DHigh%252BContent%252BAnalysis%252BAcross%252BSignaling%252BModulation%252BTreatments%252Bfor%252BSubcellular%252BTarget%252BIdentification%252BReveals%252BHeterogeneity%252Bin%252BCellular%252BResponse%26aulast%3DBiswas%26aufirst%3DSayan%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Suba</span>. </span><span class="cited-content_cbyCitation_article-title">Reverse Pharmacology: A Tool for Drug Discovery from Traditional Medicine. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 299-310. <a href="https://doi.org/10.1007/978-981-15-8127-4_15" title="DOI URL">https://doi.org/10.1007/978-981-15-8127-4_15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-15-8127-4_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-15-8127-4_15%26sid%3Dliteratum%253Aachs%26atitle%3DReverse%252BPharmacology%25253A%252BA%252BTool%252Bfor%252BDrug%252BDiscovery%252Bfrom%252BTraditional%252BMedicine%26aulast%3DSuba%26aufirst%3DV.%26date%3D2021%26date%3D2021%26spage%3D299%26epage%3D310%26pub%3DSpringer%2520Singapore%26atitle%3DEvidence%252BBased%252BValidation%252Bof%252BTraditional%252BMedicines%26aulast%3DMandal%26aufirst%3DSubhash%2BC.%26date%3D2021%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Spencer J.  Léger</span>, <span class="hlFld-ContribAuthor ">Barbara  Marchetti</span>, <span class="hlFld-ContribAuthor ">Michael N. R.  Ashfold</span>, <span class="hlFld-ContribAuthor ">Tolga N. V.  Karsili</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Norrish Type-I Chemistry in Photoactive Drugs: An ab initio Study of a Cyclopropenone-Enediyne Drug Precursor. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.596590" title="DOI URL">https://doi.org/10.3389/fchem.2020.596590</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.596590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.596590%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DThe%252BRole%252Bof%252BNorrish%252BType-I%252BChemistry%252Bin%252BPhotoactive%252BDrugs%25253A%252BAn%252Bab%252Binitio%252BStudy%252Bof%252Ba%252BCyclopropenone-Enediyne%252BDrug%252BPrecursor%26aulast%3DL%25C3%25A9ger%26aufirst%3DSpencer%2BJ.%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason  Henry</span>, <span class="hlFld-ContribAuthor ">Donald  Wlodkowic</span>. </span><span class="cited-content_cbyCitation_article-title">High-throughput animal tracking in chemobehavioral phenotyping: Current limitations and future perspectives. </span><span class="cited-content_cbyCitation_journal-name">Behavioural Processes</span><span> <strong>2020,</strong> <em>180 </em>, 104226. <a href="https://doi.org/10.1016/j.beproc.2020.104226" title="DOI URL">https://doi.org/10.1016/j.beproc.2020.104226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.beproc.2020.104226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.beproc.2020.104226%26sid%3Dliteratum%253Aachs%26jtitle%3DBehavioural%2520Processes%26atitle%3DHigh-throughput%252Banimal%252Btracking%252Bin%252Bchemobehavioral%252Bphenotyping%25253A%252BCurrent%252Blimitations%252Band%252Bfuture%252Bperspectives%26aulast%3DHenry%26aufirst%3DJason%26date%3D2020%26volume%3D180%26spage%3D104226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucie  Cahlíková</span>, <span class="hlFld-ContribAuthor ">Marcela  Šafratová</span>, <span class="hlFld-ContribAuthor ">Anna  Hošťálková</span>, <span class="hlFld-ContribAuthor ">Jakub  Chlebek</span>, <span class="hlFld-ContribAuthor ">Daniela  Hulcová</span>, <span class="hlFld-ContribAuthor ">Kateřina  Breiterová</span>, <span class="hlFld-ContribAuthor ">Lubomír  Opletal</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacognosy and Its Role in the System of Profile Disciplines in Pharmacy. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Communications</span><span> <strong>2020,</strong> <em>15 </em>
                                    (9)
                                     , 1934578X2094545. <a href="https://doi.org/10.1177/1934578X20945450" title="DOI URL">https://doi.org/10.1177/1934578X20945450</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1934578X20945450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1934578X20945450%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Communications%26atitle%3DPharmacognosy%252Band%252BIts%252BRole%252Bin%252Bthe%252BSystem%252Bof%252BProfile%252BDisciplines%252Bin%252BPharmacy%26aulast%3DCahl%25C3%25ADkov%25C3%25A1%26aufirst%3DLucie%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D9%26spage%3D1934578X2094545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arif  Mohammed</span>, <span class="hlFld-ContribAuthor ">Othman A.  Alghamdi</span>. </span><span class="cited-content_cbyCitation_article-title">Phenotype screenings of drugs for combination therapy against multidrug resistance. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 207-220. <a href="https://doi.org/10.1016/B978-0-12-820576-1.00011-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-820576-1.00011-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820576-1.00011-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820576-1.00011-4%26sid%3Dliteratum%253Aachs%26atitle%3DPhenotype%252Bscreenings%252Bof%252Bdrugs%252Bfor%252Bcombination%252Btherapy%252Bagainst%252Bmultidrug%252Bresistance%26aulast%3DMohammed%26aufirst%3DArif%26date%3D2020%26spage%3D207%26epage%3D220%26pub%3DElsevier%26atitle%3DCombination%252BTherapy%252BAgainst%252BMultidrug%252BResistance%26date%3D2020%26volume%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angshuman  Bagchi</span>. </span><span class="cited-content_cbyCitation_article-title">Latest trends in structure based drug design with protein targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-23. <a href="https://doi.org/10.1016/bs.apcsb.2019.11.008" title="DOI URL">https://doi.org/10.1016/bs.apcsb.2019.11.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apcsb.2019.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apcsb.2019.11.008%26sid%3Dliteratum%253Aachs%26atitle%3DLatest%252Btrends%252Bin%252Bstructure%252Bbased%252Bdrug%252Bdesign%252Bwith%252Bprotein%252Btargets%26aulast%3DBagchi%26aufirst%3DAngshuman%26date%3D2020%26spage%3D1%26epage%3D23%26pub%3DElsevier%26date%3D2020%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David C.  Swinney</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in phenotypic drug discovery. </span><span class="cited-content_cbyCitation_journal-name">F1000Research</span><span> <strong>2020,</strong> <em>9 </em>, 944. <a href="https://doi.org/10.12688/f1000research.25813.1" title="DOI URL">https://doi.org/10.12688/f1000research.25813.1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12688/f1000research.25813.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12688%2Ff1000research.25813.1%26sid%3Dliteratum%253Aachs%26jtitle%3DF1000Research%26atitle%3DRecent%252Badvances%252Bin%252Bphenotypic%252Bdrug%252Bdiscovery%26aulast%3DSwinney%26aufirst%3DDavid%2BC.%26date%3D2020%26date%3D2020%26volume%3D9%26spage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Automatisierung in den Lebenswissenschaften – eine kritische Betrachtung. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 27-77. <a href="https://doi.org/10.1002/9783527822843.ch2" title="DOI URL">https://doi.org/10.1002/9783527822843.ch2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527822843.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527822843.ch2%26sid%3Dliteratum%253Aachs%26atitle%3DAutomatisierung%252Bin%252Bden%252BLebenswissenschaften%252B%2525E2%252580%252593%252Beine%252Bkritische%252BBetrachtung%26date%3D2019%26date%3D2020%26spage%3D27%26epage%3D77%26pub%3DWiley%26atitle%3DAutomationsl%2525C3%2525B6sungen%252Bin%252Bder%252Banalytischen%252BMesstechnik%26aulast%3DFleischer%26aufirst%3DHeidi%26date%3D2019%26date%3D2020%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Gumina</span>, <span class="hlFld-ContribAuthor ">Kristopher G.  Virga</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Drug Repurposing for Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (28)
                                     , 5340-5362. <a href="https://doi.org/10.2174/0929867325666180719144850" title="DOI URL">https://doi.org/10.2174/0929867325666180719144850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180719144850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180719144850%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bin%252BDrug%252BRepurposing%252Bfor%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DChen%26aufirst%3DXin%26date%3D2019%26volume%3D26%26issue%3D28%26spage%3D5340%26epage%3D5362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John C.  Dawson</span>, <span class="hlFld-ContribAuthor ">Neil O.  Carragher</span>. </span><span class="cited-content_cbyCitation_article-title">Elucidating Target Biology and Drug Mechanism of Action Across Human Cell‐Based Model Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 179-209. <a href="https://doi.org/10.1002/9783527818242.ch7" title="DOI URL">https://doi.org/10.1002/9783527818242.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527818242.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527818242.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DElucidating%252BTarget%252BBiology%252Band%252BDrug%252BMechanism%252Bof%252BAction%252BAcross%252BHuman%252BCell%2525E2%252580%252590Based%252BModel%252BSystems%26aulast%3DDawson%26aufirst%3DJohn%2BC.%26date%3D2019%26date%3D2019%26spage%3D179%26epage%3D209%26pub%3DWiley%26atitle%3DTarget%252BDiscovery%252Band%252BValidation%26aulast%3DPlowright%26aufirst%3DAlleyn%2BT%26date%3D2019%26date%3D2019%26volume%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David C.  Swinney</span>, <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery Strategies for Neglected Tropical Diseases: Repurposing Knowledge, Mechanisms and Therapeutics to Increase Discovery Efficiency. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-13. <a href="https://doi.org/10.1002/9783527808656.ch1" title="DOI URL">https://doi.org/10.1002/9783527808656.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527808656.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527808656.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BDiscovery%252BStrategies%252Bfor%252BNeglected%252BTropical%252BDiseases%25253A%252BRepurposing%252BKnowledge%25252C%252BMechanisms%252Band%252BTherapeutics%252Bto%252BIncrease%252BDiscovery%252BEfficiency%26aulast%3DSwinney%26aufirst%3DDavid%2BC.%26date%3D2019%26date%3D2019%26spage%3D1%26epage%3D13%26pub%3DWiley%26atitle%3DNeglected%252BTropical%252BDiseases%26aulast%3DSwinney%26aufirst%3DDavid%26date%3D2019%26date%3D2019%26volume%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nattakarn  Pobsuk</span>, <span class="hlFld-ContribAuthor ">Praphasri  Suphakun</span>, <span class="hlFld-ContribAuthor ">Supa  Hannongbua</span>, <span class="hlFld-ContribAuthor ">Chanin  Nantasenamat</span>, <span class="hlFld-ContribAuthor ">Kiattawee  Choowongkomon</span>, <span class="hlFld-ContribAuthor ">M. Paul  Gleeson</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Plasmodium falciparum Inhibitory Activity, Cytotoxicity and Solubility of N2 ,N4 -Disubstituted Quinazoline-2,4-diamines.. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry</span><span> <strong>2019,</strong> <em>15 </em>
                                    (6)
                                     , 693-704. <a href="https://doi.org/10.2174/1573406415666181219100307" title="DOI URL">https://doi.org/10.2174/1573406415666181219100307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573406415666181219100307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573406415666181219100307%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BPlasmodium%252Bfalciparum%252BInhibitory%252BActivity%25252C%252BCytotoxicity%252Band%252BSolubility%252Bof%252BN2%252B%25252CN4%252B-Disubstituted%252BQuinazoline-2%25252C4-diamines.%26aulast%3DPobsuk%26aufirst%3DNattakarn%26date%3D2019%26volume%3D15%26issue%3D6%26spage%3D693%26epage%3D704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allison  Berg</span>, <span class="hlFld-ContribAuthor ">Shawn  Hallowell</span>, <span class="hlFld-ContribAuthor ">Mark  Tibbetts</span>, <span class="hlFld-ContribAuthor ">Chad  Beasley</span>, <span class="hlFld-ContribAuthor ">Tracy  Brown-Phillips</span>, <span class="hlFld-ContribAuthor ">Anita  Healy</span>, <span class="hlFld-ContribAuthor ">Leslie  Pustilnik</span>, <span class="hlFld-ContribAuthor ">Regis  Doyonnas</span>, <span class="hlFld-ContribAuthor ">Marko  Pregel</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Surface Liquid Absorption and Secretion Assays to Identify F508del CFTR Correctors Using Patient Primary Airway Epithelial Cultures. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2019,</strong> <em>24 </em>
                                    (7)
                                     , 724-737. <a href="https://doi.org/10.1177/2472555219849375" title="DOI URL">https://doi.org/10.1177/2472555219849375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555219849375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555219849375%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DHigh-Throughput%252BSurface%252BLiquid%252BAbsorption%252Band%252BSecretion%252BAssays%252Bto%252BIdentify%252BF508del%252BCFTR%252BCorrectors%252BUsing%252BPatient%252BPrimary%252BAirway%252BEpithelial%252BCultures%26aulast%3DBerg%26aufirst%3DAllison%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D7%26spage%3D724%26epage%3D737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Abriola</span>, <span class="hlFld-ContribAuthor ">Denton  Hoyer</span>, <span class="hlFld-ContribAuthor ">Conor R.  Caffrey</span>, <span class="hlFld-ContribAuthor ">David L.  Williams</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Yoshino</span>, <span class="hlFld-ContribAuthor ">Jon J.  Vermeire</span>, . </span><span class="cited-content_cbyCitation_article-title">Development and optimization of a high-throughput screening method utilizing Ancylostoma ceylanicum egg hatching to identify novel anthelmintics. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2019,</strong> <em>14 </em>
                                    (6)
                                     , e0217019. <a href="https://doi.org/10.1371/journal.pone.0217019" title="DOI URL">https://doi.org/10.1371/journal.pone.0217019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0217019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0217019%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DDevelopment%252Band%252Boptimization%252Bof%252Ba%252Bhigh-throughput%252Bscreening%252Bmethod%252Butilizing%252BAncylostoma%252Bceylanicum%252Begg%252Bhatching%252Bto%252Bidentify%252Bnovel%252Banthelmintics%26aulast%3DAbriola%26aufirst%3DLaura%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D6%26spage%3De0217019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason  Henry</span>, <span class="hlFld-ContribAuthor ">Donald  Wlodkowic</span>. </span><span class="cited-content_cbyCitation_article-title">Towards High-Throughput Chemobehavioural Phenomics in Neuropsychiatric Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2019,</strong> <em>17 </em>
                                    (6)
                                     , 340. <a href="https://doi.org/10.3390/md17060340" title="DOI URL">https://doi.org/10.3390/md17060340</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md17060340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd17060340%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DTowards%252BHigh-Throughput%252BChemobehavioural%252BPhenomics%252Bin%252BNeuropsychiatric%252BDrug%252BDiscovery%26aulast%3DHenry%26aufirst%3DJason%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D6%26spage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana B.  Caballero</span>, <span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Caterina  Pont</span>, <span class="hlFld-ContribAuthor ">Maria Antònia  Busquets</span>, <span class="hlFld-ContribAuthor ">Joan  Estelrich</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>, <span class="hlFld-ContribAuthor ">Patrick  Gamez</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabate</span>. </span><span class="cited-content_cbyCitation_article-title">Bacterial Inclusion Bodies for Anti-Amyloid Drug Discovery: Current and Future Screening Methods. </span><span class="cited-content_cbyCitation_journal-name">Current Protein & Peptide Science</span><span> <strong>2019,</strong> <em>20 </em>
                                    (6)
                                     , 563-576. <a href="https://doi.org/10.2174/1389203720666190329120007" title="DOI URL">https://doi.org/10.2174/1389203720666190329120007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389203720666190329120007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389203720666190329120007%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Protein%2520%2526%2520Peptide%2520Science%26atitle%3DBacterial%252BInclusion%252BBodies%252Bfor%252BAnti-Amyloid%252BDrug%252BDiscovery%25253A%252BCurrent%252Band%252BFuture%252BScreening%252BMethods%26aulast%3DCaballero%26aufirst%3DAna%2BB.%26date%3D2019%26volume%3D20%26issue%3D6%26spage%3D563%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong-xuan  Feng</span>, <span class="hlFld-ContribAuthor ">Chun-pu  Li</span>, <span class="hlFld-ContribAuthor ">Shuang-jie  Shu</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Hai-yan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A11, a novel diaryl acylhydrazone derivative, exerts neuroprotection against ischemic injury in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2019,</strong> <em>40 </em>
                                    (2)
                                     , 160-169. <a href="https://doi.org/10.1038/s41401-018-0028-4" title="DOI URL">https://doi.org/10.1038/s41401-018-0028-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-018-0028-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-018-0028-4%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DA11%25252C%252Ba%252Bnovel%252Bdiaryl%252Bacylhydrazone%252Bderivative%25252C%252Bexerts%252Bneuroprotection%252Bagainst%252Bischemic%252Binjury%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DFeng%26aufirst%3DHong-xuan%26date%3D2019%26date%3D2018%26volume%3D40%26issue%3D2%26spage%3D160%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yeonhwa  Song</span>, <span class="hlFld-ContribAuthor ">Su‐Yeon  Lee</span>, <span class="hlFld-ContribAuthor ">A‐Ram  Kim</span>, <span class="hlFld-ContribAuthor ">Sanghwa  Kim</span>, <span class="hlFld-ContribAuthor ">Jinyeong  Heo</span>, <span class="hlFld-ContribAuthor ">David  Shum</span>, <span class="hlFld-ContribAuthor ">Se‐Hyuk  Kim</span>, <span class="hlFld-ContribAuthor ">Inhee  Choi</span>, <span class="hlFld-ContribAuthor ">Yoon‐Jin  Lee</span>, <span class="hlFld-ContribAuthor ">Haeng Ran  Seo</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of radiation‐induced EndMT inhibitors through cell‐based phenomic screening. </span><span class="cited-content_cbyCitation_journal-name">FEBS Open Bio</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     , 82-91. <a href="https://doi.org/10.1002/2211-5463.12552" title="DOI URL">https://doi.org/10.1002/2211-5463.12552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/2211-5463.12552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F2211-5463.12552%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Open%2520Bio%26atitle%3DIdentification%252Bof%252Bradiation%2525E2%252580%252590induced%252BEndMT%252Binhibitors%252Bthrough%252Bcell%2525E2%252580%252590based%252Bphenomic%252Bscreening%26aulast%3DSong%26aufirst%3DYeonhwa%26date%3D2019%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D82%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahira M.  Ezzat</span>, <span class="hlFld-ContribAuthor ">Jaison  Jeevanandam</span>, <span class="hlFld-ContribAuthor ">Chukwuebuka  Egbuna</span>, <span class="hlFld-ContribAuthor ">Shashank  Kumar</span>, <span class="hlFld-ContribAuthor ">Jonathan C.  Ifemeje</span>. </span><span class="cited-content_cbyCitation_article-title">Phytochemicals as Sources of Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 3-22. <a href="https://doi.org/10.1007/978-981-13-6920-9_1" title="DOI URL">https://doi.org/10.1007/978-981-13-6920-9_1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-6920-9_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-6920-9_1%26sid%3Dliteratum%253Aachs%26atitle%3DPhytochemicals%252Bas%252BSources%252Bof%252BDrugs%26aulast%3DEzzat%26aufirst%3DShahira%2BM.%26date%3D2019%26date%3D2019%26spage%3D3%26epage%3D22%26pub%3DSpringer%2520Singapore%26atitle%3DPhytochemistry%25253A%252BAn%252Bin-silico%252Band%252Bin-vitro%252BUpdate%26aulast%3DKumar%26aufirst%3DShashank%26date%3D2019%26volume%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arumugam  Jayamani</span>, <span class="hlFld-ContribAuthor ">Rajesh  Bellam</span>, <span class="hlFld-ContribAuthor ">Gopalakrishnan  Gopu</span>, <span class="hlFld-ContribAuthor ">Stephen O.  Ojwach</span>, <span class="hlFld-ContribAuthor ">Nallathambi  Sengottuvelan</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(II) complexes of bidentate mixed ligands as artificial nucleases: Synthesis, crystal structure, characterization and evaluation of biological properties. </span><span class="cited-content_cbyCitation_journal-name">Polyhedron</span><span> <strong>2018,</strong> <em>156 </em>, 138-149. <a href="https://doi.org/10.1016/j.poly.2018.09.011" title="DOI URL">https://doi.org/10.1016/j.poly.2018.09.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.poly.2018.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.poly.2018.09.011%26sid%3Dliteratum%253Aachs%26jtitle%3DPolyhedron%26atitle%3DCopper%252528II%252529%252Bcomplexes%252Bof%252Bbidentate%252Bmixed%252Bligands%252Bas%252Bartificial%252Bnucleases%25253A%252BSynthesis%25252C%252Bcrystal%252Bstructure%25252C%252Bcharacterization%252Band%252Bevaluation%252Bof%252Bbiological%252Bproperties%26aulast%3DJayamani%26aufirst%3DArumugam%26date%3D2018%26volume%3D156%26spage%3D138%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryusuke  Sawada</span>, <span class="hlFld-ContribAuthor ">Michio  Iwata</span>, <span class="hlFld-ContribAuthor ">Yasuo  Tabei</span>, <span class="hlFld-ContribAuthor ">Haruka  Yamato</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Yamanishi</span>. </span><span class="cited-content_cbyCitation_article-title">Predicting inhibitory and activatory drug targets by chemically and genetically perturbed transcriptome signatures. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-18315-9" title="DOI URL">https://doi.org/10.1038/s41598-017-18315-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-18315-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-18315-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DPredicting%252Binhibitory%252Band%252Bactivatory%252Bdrug%252Btargets%252Bby%252Bchemically%252Band%252Bgenetically%252Bperturbed%252Btranscriptome%252Bsignatures%26aulast%3DSawada%26aufirst%3DRyusuke%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thierry  Dorval</span>, <span class="hlFld-ContribAuthor ">Benjamin  Chanrion</span>, <span class="hlFld-ContribAuthor ">Marie-Elodie  Cattin</span>, <span class="hlFld-ContribAuthor ">Jean Philippe  Stephan</span>. </span><span class="cited-content_cbyCitation_article-title">Filling the drug discovery gap: is high-content screening the missing link?. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2018,</strong> <em>42 </em>, 40-45. <a href="https://doi.org/10.1016/j.coph.2018.07.002" title="DOI URL">https://doi.org/10.1016/j.coph.2018.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2018.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2018.07.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DFilling%252Bthe%252Bdrug%252Bdiscovery%252Bgap%25253A%252Bis%252Bhigh-content%252Bscreening%252Bthe%252Bmissing%252Blink%25253F%26aulast%3DDorval%26aufirst%3DThierry%26date%3D2018%26volume%3D42%26spage%3D40%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga  Lage</span>, <span class="hlFld-ContribAuthor ">María  Ramos</span>, <span class="hlFld-ContribAuthor ">Rita  Calisto</span>, <span class="hlFld-ContribAuthor ">Eduarda  Almeida</span>, <span class="hlFld-ContribAuthor ">Vitor  Vasconcelos</span>, <span class="hlFld-ContribAuthor ">Francisca  Vicente</span>. </span><span class="cited-content_cbyCitation_article-title">Current Screening Methodologies in Drug Discovery for Selected Human Diseases. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2018,</strong> <em>16 </em>
                                    (8)
                                     , 279. <a href="https://doi.org/10.3390/md16080279" title="DOI URL">https://doi.org/10.3390/md16080279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md16080279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd16080279%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DCurrent%252BScreening%252BMethodologies%252Bin%252BDrug%252BDiscovery%252Bfor%252BSelected%252BHuman%252BDiseases%26aulast%3DLage%26aufirst%3DOlga%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D8%26spage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amir Ata  Saei</span>, <span class="hlFld-ContribAuthor ">Pierre  Sabatier</span>, <span class="hlFld-ContribAuthor ">Ülkü Güler  Tokat</span>, <span class="hlFld-ContribAuthor ">Alexey  Chernobrovkin</span>, <span class="hlFld-ContribAuthor ">Mohammad  Pirmoradian</span>, <span class="hlFld-ContribAuthor ">Roman A.  Zubarev</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative Proteomics of Dying and Surviving Cancer Cells Improves the Identification of Drug Targets and Sheds Light on Cell Life/Death Decisions. </span><span class="cited-content_cbyCitation_journal-name">Molecular & Cellular Proteomics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (6)
                                     , 1144-1155. <a href="https://doi.org/10.1074/mcp.RA118.000610" title="DOI URL">https://doi.org/10.1074/mcp.RA118.000610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/mcp.RA118.000610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fmcp.RA118.000610%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520%2526%2520Cellular%2520Proteomics%26atitle%3DComparative%252BProteomics%252Bof%252BDying%252Band%252BSurviving%252BCancer%252BCells%252BImproves%252Bthe%252BIdentification%252Bof%252BDrug%252BTargets%252Band%252BSheds%252BLight%252Bon%252BCell%252BLife%25252FDeath%252BDecisions%26aulast%3DSaei%26aufirst%3DAmir%2BAta%26date%3D2018%26volume%3D17%26issue%3D6%26spage%3D1144%26epage%3D1155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Viviane  Silva</span>, <span class="hlFld-ContribAuthor ">Marcela  Rosa</span>, <span class="hlFld-ContribAuthor ">Aline  Tansini</span>, <span class="hlFld-ContribAuthor ">Renato  Oliveira</span>, <span class="hlFld-ContribAuthor ">Olga  Martinho</span>, <span class="hlFld-ContribAuthor ">Jo�o Paulo  Lima</span>, <span class="hlFld-ContribAuthor ">Luiz  Pianowski</span>, <span class="hlFld-ContribAuthor ">Rui  Reis</span>. </span><span class="cited-content_cbyCitation_article-title">In�vitro screening of cytotoxic activity of euphol from Euphorbia�tirucalli on a large panel of human cancer‑derived cell lines. </span><span class="cited-content_cbyCitation_journal-name">Experimental and Therapeutic Medicine</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.3892/etm.2018.6244" title="DOI URL">https://doi.org/10.3892/etm.2018.6244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/etm.2018.6244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fetm.2018.6244%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520and%2520Therapeutic%2520Medicine%26atitle%3DIn%2525EF%2525BF%2525BDvitro%252Bscreening%252Bof%252Bcytotoxic%252Bactivity%252Bof%252Beuphol%252Bfrom%252BEuphorbia%2525EF%2525BF%2525BDtirucalli%252Bon%252Ba%252Blarge%252Bpanel%252Bof%252Bhuman%252Bcancer%2525E2%252580%252591derived%252Bcell%252Blines%26aulast%3DSilva%26aufirst%3DViviane%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Darren  Rodenhizer</span>, <span class="hlFld-ContribAuthor ">Teresa  Dean</span>, <span class="hlFld-ContribAuthor ">Elisa  D'Arcangelo</span>, <span class="hlFld-ContribAuthor ">Alison P.  McGuigan</span>. </span><span class="cited-content_cbyCitation_article-title">The Current Landscape of 3D In Vitro Tumor Models: What Cancer Hallmarks Are Accessible for Drug Discovery?. </span><span class="cited-content_cbyCitation_journal-name">Advanced Healthcare Materials</span><span> <strong>2018,</strong> <em>7 </em>
                                    (8)
                                     , 1701174. <a href="https://doi.org/10.1002/adhm.201701174" title="DOI URL">https://doi.org/10.1002/adhm.201701174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adhm.201701174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadhm.201701174%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Healthcare%2520Materials%26atitle%3DThe%252BCurrent%252BLandscape%252Bof%252B3D%252BIn%252BVitro%252BTumor%252BModels%25253A%252BWhat%252BCancer%252BHallmarks%252BAre%252BAccessible%252Bfor%252BDrug%252BDiscovery%25253F%26aulast%3DRodenhizer%26aufirst%3DDarren%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D8%26spage%3D1701174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle  Swearingen</span>, <span class="hlFld-ContribAuthor ">Beverly  Falcon</span>, <span class="hlFld-ContribAuthor ">Sudhakar  Chintharlapalli</span>, <span class="hlFld-ContribAuthor ">Mark  Uhlik</span>. </span><span class="cited-content_cbyCitation_article-title">An Endothelial Cell/Mesenchymal Stem Cell Coculture Cord Formation Assay to Model Vascular Biology In Vitro. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 371-382. <a href="https://doi.org/10.1007/978-1-4939-7357-6_21" title="DOI URL">https://doi.org/10.1007/978-1-4939-7357-6_21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-7357-6_21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-7357-6_21%26sid%3Dliteratum%253Aachs%26atitle%3DAn%252BEndothelial%252BCell%25252FMesenchymal%252BStem%252BCell%252BCoculture%252BCord%252BFormation%252BAssay%252Bto%252BModel%252BVascular%252BBiology%252BIn%252BVitro%26aulast%3DSwearingen%26aufirst%3DMichelle%26date%3D2018%26date%3D2017%26spage%3D371%26epage%3D382%26pub%3DSpringer%2520New%2520York%26atitle%3DHigh%252BContent%252BScreening%26aulast%3DJohnston%26aufirst%3DPaul%2BA.%26date%3D2018%26volume%3D1683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Jeremy L.  Jenkins</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Prioritization of Tool Compounds for Phenotypic Screening. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 195-206. <a href="https://doi.org/10.1007/978-1-4939-7847-2_15" title="DOI URL">https://doi.org/10.1007/978-1-4939-7847-2_15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-7847-2_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-7847-2_15%26sid%3Dliteratum%253Aachs%26atitle%3DQuantitative%252BPrioritization%252Bof%252BTool%252BCompounds%252Bfor%252BPhenotypic%252BScreening%26aulast%3DWang%26aufirst%3DYuan%26date%3D2018%26date%3D2018%26spage%3D195%26epage%3D206%26pub%3DSpringer%2520New%2520York%26atitle%3DPhenotypic%252BScreening%26aulast%3DWagner%26aufirst%3DBridget%26date%3D2018%26volume%3D1787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Phurpa  Wangchuk</span>, <span class="hlFld-ContribAuthor ">Alex  Loukas</span>. </span><span class="cited-content_cbyCitation_article-title">Techniques and Technologies for the Biodiscovery of Novel Small Molecule Drug Lead Compounds From Natural Products. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 435-465. <a href="https://doi.org/10.1016/B978-0-08-102081-4.00016-2" title="DOI URL">https://doi.org/10.1016/B978-0-08-102081-4.00016-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102081-4.00016-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102081-4.00016-2%26sid%3Dliteratum%253Aachs%26atitle%3DTechniques%252Band%252BTechnologies%252Bfor%252Bthe%252BBiodiscovery%252Bof%252BNovel%252BSmall%252BMolecule%252BDrug%252BLead%252BCompounds%252BFrom%252BNatural%252BProducts%26aulast%3DWangchuk%26aufirst%3DPhurpa%26date%3D2018%26spage%3D435%26epage%3D465%26pub%3DElsevier%26atitle%3DNatural%252BProducts%252Band%252BDrug%252BDiscovery%26date%3D2018%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ye  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Cellular Assays. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 313-333. <a href="https://doi.org/10.1002/9783527674381.ch11" title="DOI URL">https://doi.org/10.1002/9783527674381.ch11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch11%26sid%3Dliteratum%253Aachs%26atitle%3DCellular%252BAssays%26aulast%3DFang%26aufirst%3DYe%26date%3D2017%26date%3D2017%26spage%3D313%26epage%3D333%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Costantino</span>, <span class="hlFld-ContribAuthor ">Daniela  Barlocco</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Approaches to Multitarget Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 161-205. <a href="https://doi.org/10.1002/9783527674381.ch7" title="DOI URL">https://doi.org/10.1002/9783527674381.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DDesigning%252BApproaches%252Bto%252BMultitarget%252BDrugs%26aulast%3DCostantino%26aufirst%3DLuca%26date%3D2017%26date%3D2017%26spage%3D161%26epage%3D205%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jubo  Wang</span>, <span class="hlFld-ContribAuthor ">Raoling  Ge</span>, <span class="hlFld-ContribAuthor ">Xiaqiu  Qiu</span>, <span class="hlFld-ContribAuthor ">Xi  Xu</span>, <span class="hlFld-ContribAuthor ">Libin  Wei</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>, <span class="hlFld-ContribAuthor ">Jinlei  Bian</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and synthesis of novel Wogonin derivatives with potent antitumor activity in vitro. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>140 </em>, 421-434. <a href="https://doi.org/10.1016/j.ejmech.2017.09.046" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.09.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.09.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.09.046%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bsynthesis%252Bof%252Bnovel%252BWogonin%252Bderivatives%252Bwith%252Bpotent%252Bantitumor%252Bactivity%252Bin%2525C2%2525A0vitro%26aulast%3DWang%26aufirst%3DJubo%26date%3D2017%26volume%3D140%26spage%3D421%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang  Yin</span>, <span class="hlFld-ContribAuthor ">Temesgen  Fufa</span>, <span class="hlFld-ContribAuthor ">Gayathri  Chandrasekar</span>, <span class="hlFld-ContribAuthor ">Madhu  Aeluri</span>, <span class="hlFld-ContribAuthor ">Verina  Zaky</span>, <span class="hlFld-ContribAuthor ">Shaimaa  Abdelhady</span>, <span class="hlFld-ContribAuthor ">Antonio B.  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Johan  Jakobsson</span>, <span class="hlFld-ContribAuthor ">Farzaneh Shahin  Varnoosfaderani</span>, <span class="hlFld-ContribAuthor ">Jayashri  Mahalingam</span>, <span class="hlFld-ContribAuthor ">Jianping  Liu</span>, <span class="hlFld-ContribAuthor ">Olle  Larsson</span>, <span class="hlFld-ContribAuthor ">Outi  Hovatta</span>, <span class="hlFld-ContribAuthor ">Frank  Gaunitz</span>, <span class="hlFld-ContribAuthor ">Anita  Göndör</span>, <span class="hlFld-ContribAuthor ">Michael  Andäng</span>, <span class="hlFld-ContribAuthor ">Satish S.  Kitambi</span>. </span><span class="cited-content_cbyCitation_article-title">Phenotypic Screen Identifies a Small Molecule Modulating ERK2 and Promoting Stem Cell Proliferation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2017,</strong> <em>8 </em><a href="https://doi.org/10.3389/fphar.2017.00726" title="DOI URL">https://doi.org/10.3389/fphar.2017.00726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2017.00726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2017.00726%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DPhenotypic%252BScreen%252BIdentifies%252Ba%252BSmall%252BMolecule%252BModulating%252BERK2%252Band%252BPromoting%252BStem%252BCell%252BProliferation%26aulast%3DYin%26aufirst%3DChang%26date%3D2017%26date%3D2017%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Faheem  Maqbool</span>, <span class="hlFld-ContribAuthor ">Amman  Abid</span>, <span class="hlFld-ContribAuthor ">Ishtiaq  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery Processes to Drug Targeting Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Pharmacology</span><span> <strong>2017,</strong> <em>13 </em>
                                    (7)
                                     , 773-784. <a href="https://doi.org/10.3923/ijp.2017.773.784" title="DOI URL">https://doi.org/10.3923/ijp.2017.773.784</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3923/ijp.2017.773.784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3923%2Fijp.2017.773.784%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Pharmacology%26atitle%3DDrug%252BDiscovery%252BProcesses%252Bto%252BDrug%252BTargeting%252BMechanisms%26aulast%3DMaqbool%26aufirst%3DFaheem%26date%3D2017%26volume%3D13%26issue%3D7%26spage%3D773%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Automation in Life Sciences - A Critical Review. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 25-71. <a href="https://doi.org/10.1002/9783527805297.ch2" title="DOI URL">https://doi.org/10.1002/9783527805297.ch2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527805297.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527805297.ch2%26sid%3Dliteratum%253Aachs%26atitle%3DAutomation%252Bin%252BLife%252BSciences%252B-%252BA%252BCritical%252BReview%26date%3D2017%26date%3D2017%26spage%3D25%26epage%3D71%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DAutomation%252BSolutions%252Bfor%252BAnalytical%252BMeasurements%26aulast%3DFleischer%26aufirst%3DHeidi%26date%3D2017%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Dichiara</span>, <span class="hlFld-ContribAuthor ">Agostino  Marrazzo</span>, <span class="hlFld-ContribAuthor ">Orazio  Prezzavento</span>, <span class="hlFld-ContribAuthor ">Simona  Collina</span>, <span class="hlFld-ContribAuthor ">Antonio  Rescifina</span>, <span class="hlFld-ContribAuthor ">Emanuele  Amata</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (16)
                                     , 1235-1253. <a href="https://doi.org/10.1002/cmdc.201700259" title="DOI URL">https://doi.org/10.1002/cmdc.201700259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700259%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DRepurposing%252Bof%252BHuman%252BKinase%252BInhibitors%252Bin%252BNeglected%252BProtozoan%252BDiseases%26aulast%3DDichiara%26aufirst%3DMaria%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D16%26spage%3D1235%26epage%3D1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lyn H.  Jones</span>, <span class="hlFld-ContribAuthor ">Mark E.  Bunnage</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of chemogenomic library screening in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2017,</strong> <em>16 </em>
                                    (4)
                                     , 285-296. <a href="https://doi.org/10.1038/nrd.2016.244" title="DOI URL">https://doi.org/10.1038/nrd.2016.244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd.2016.244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd.2016.244%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DApplications%252Bof%252Bchemogenomic%252Blibrary%252Bscreening%252Bin%252Bdrug%252Bdiscovery%26aulast%3DJones%26aufirst%3DLyn%2BH.%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D4%26spage%3D285%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan A.  Lee</span>, <span class="hlFld-ContribAuthor ">Neil O.  Carragher</span>, <span class="hlFld-ContribAuthor ">Ellen L.  Berg</span>. </span><span class="cited-content_cbyCitation_article-title">Empirical drug discovery: a view from the proteome. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2017,</strong> <em>23 </em>, 1-5. <a href="https://doi.org/10.1016/j.ddtec.2017.05.003" title="DOI URL">https://doi.org/10.1016/j.ddtec.2017.05.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2017.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2017.05.003%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DEmpirical%252Bdrug%252Bdiscovery%25253A%252Ba%252Bview%252Bfrom%252Bthe%252Bproteome%26aulast%3DLee%26aufirst%3DJonathan%2BA.%26date%3D2017%26volume%3D23%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Gaulton</span>, <span class="hlFld-ContribAuthor ">Anne  Hersey</span>, <span class="hlFld-ContribAuthor ">Michał  Nowotka</span>, <span class="hlFld-ContribAuthor ">A. Patrícia  Bento</span>, <span class="hlFld-ContribAuthor ">Jon  Chambers</span>, <span class="hlFld-ContribAuthor ">David  Mendez</span>, <span class="hlFld-ContribAuthor ">Prudence  Mutowo</span>, <span class="hlFld-ContribAuthor ">Francis  Atkinson</span>, <span class="hlFld-ContribAuthor ">Louisa J.  Bellis</span>, <span class="hlFld-ContribAuthor ">Elena  Cibrián-Uhalte</span>, <span class="hlFld-ContribAuthor ">Mark  Davies</span>, <span class="hlFld-ContribAuthor ">Nathan  Dedman</span>, <span class="hlFld-ContribAuthor ">Anneli  Karlsson</span>, <span class="hlFld-ContribAuthor ">María Paula  Magariños</span>, <span class="hlFld-ContribAuthor ">John P.  Overington</span>, <span class="hlFld-ContribAuthor ">George  Papadatos</span>, <span class="hlFld-ContribAuthor ">Ines  Smit</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Leach</span>. </span><span class="cited-content_cbyCitation_article-title">The ChEMBL database in 2017. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2017,</strong> <em>45 </em>
                                    (D1)
                                     , D945-D954. <a href="https://doi.org/10.1093/nar/gkw1074" title="DOI URL">https://doi.org/10.1093/nar/gkw1074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkw1074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkw1074%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DThe%252BChEMBL%252Bdatabase%252Bin%252B2017%26aulast%3DGaulton%26aufirst%3DAnna%26date%3D2017%26date%3D2016%26volume%3D45%26issue%3DD1%26spage%3DD945%26epage%3DD954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David C.  Swinney</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmaceutical Industry Performance. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 3-25. <a href="https://doi.org/10.1007/978-3-319-50042-3_1" title="DOI URL">https://doi.org/10.1007/978-3-319-50042-3_1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-50042-3_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-50042-3_1%26sid%3Dliteratum%253Aachs%26atitle%3DPharmaceutical%252BIndustry%252BPerformance%26aulast%3DSwinney%26aufirst%3DDavid%2BC.%26date%3D2017%26date%3D2017%26spage%3D3%26epage%3D25%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DTranslating%252BMolecules%252Binto%252BMedicines%26aulast%3DBhattachar%26aufirst%3DShobha%2BN.%26date%3D2017%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John S.  Morrison</span>, <span class="hlFld-ContribAuthor ">Michael J.  Hageman</span>. </span><span class="cited-content_cbyCitation_article-title">Outlook for the Future. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 421-447. <a href="https://doi.org/10.1007/978-3-319-50042-3_14" title="DOI URL">https://doi.org/10.1007/978-3-319-50042-3_14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-50042-3_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-50042-3_14%26sid%3Dliteratum%253Aachs%26atitle%3DOutlook%252Bfor%252Bthe%252BFuture%26aulast%3DMorrison%26aufirst%3DJohn%2BS.%26date%3D2017%26date%3D2017%26spage%3D421%26epage%3D447%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DTranslating%252BMolecules%252Binto%252BMedicines%26aulast%3DBhattachar%26aufirst%3DShobha%2BN.%26date%3D2017%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles  Gnanaraj</span>, <span class="hlFld-ContribAuthor ">Sivapragasam  Gothai</span>, <span class="hlFld-ContribAuthor ">Katyakyini  Muniandy</span>, <span class="hlFld-ContribAuthor ">Rengarajan  Thamaraiselvan</span>, <span class="hlFld-ContribAuthor ">Palanisamy  Arulselvan</span>. </span><span class="cited-content_cbyCitation_article-title">Toxicological and Pharmacological Use of Anticancer Compounds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 203-231. <a href="https://doi.org/10.1007/978-981-10-8216-0_7" title="DOI URL">https://doi.org/10.1007/978-981-10-8216-0_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-10-8216-0_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-10-8216-0_7%26sid%3Dliteratum%253Aachs%26atitle%3DToxicological%252Band%252BPharmacological%252BUse%252Bof%252BAnticancer%252BCompounds%26aulast%3DGnanaraj%26aufirst%3DCharles%26date%3D2017%26date%3D2018%26spage%3D203%26epage%3D231%26pub%3DSpringer%2520Singapore%26atitle%3DAnticancer%252BPlants%25253A%252BClinical%252BTrials%252Band%252BNanotechnology%26aulast%3DAkhtar%26aufirst%3DMohd%2BSayeed%26date%3D2017%26volume%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.H.  Simpson</span>, <span class="hlFld-ContribAuthor ">P.  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Antimicrobial Metallodrugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 205-243. <a href="https://doi.org/10.1016/B978-0-12-803814-7.00007-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-803814-7.00007-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803814-7.00007-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803814-7.00007-1%26sid%3Dliteratum%253Aachs%26atitle%3DAntimicrobial%252BMetallodrugs%26aulast%3DSimpson%26aufirst%3DD.H.%26date%3D2017%26spage%3D205%26epage%3D243%26pub%3DElsevier%26atitle%3DInorganic%252Band%252BOrganometallic%252BTransition%252BMetal%252BComplexes%252Bwith%252BBiological%252BMolecules%252Band%252BLiving%252BCells%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">You Hwa  Son</span>, <span class="hlFld-ContribAuthor ">Chi Hoon  Park</span>, <span class="hlFld-ContribAuthor ">Sang Un  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Mitotic Blockers by Phenotypic Screening of a Clinical Compound Library. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2016,</strong> <em>37 </em>
                                    (12)
                                     , 1942-1946. <a href="https://doi.org/10.1002/bkcs.10999" title="DOI URL">https://doi.org/10.1002/bkcs.10999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bkcs.10999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbkcs.10999%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DIdentification%252Bof%252BMitotic%252BBlockers%252Bby%252BPhenotypic%252BScreening%252Bof%252Ba%252BClinical%252BCompound%252BLibrary%26aulast%3DSon%26aufirst%3DYou%2BHwa%26date%3D2016%26date%3D2016%26volume%3D37%26issue%3D12%26spage%3D1942%26epage%3D1946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  McGown</span>, <span class="hlFld-ContribAuthor ">Dame Pamela J.  Shaw</span>, <span class="hlFld-ContribAuthor ">Tennore  Ramesh</span>. </span><span class="cited-content_cbyCitation_article-title">ZNStress: a high-throughput drug screening protocol for identification of compounds modulating neuronal stress in the transgenic mutant sod1G93R zebrafish model of amyotrophic lateral sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurodegeneration</span><span> <strong>2016,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13024-016-0122-3" title="DOI URL">https://doi.org/10.1186/s13024-016-0122-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13024-016-0122-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13024-016-0122-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurodegeneration%26atitle%3DZNStress%25253A%252Ba%252Bhigh-throughput%252Bdrug%252Bscreening%252Bprotocol%252Bfor%252Bidentification%252Bof%252Bcompounds%252Bmodulating%252Bneuronal%252Bstress%252Bin%252Bthe%252Btransgenic%252Bmutant%252Bsod1G93R%252Bzebrafish%252Bmodel%252Bof%252Bamyotrophic%252Blateral%252Bsclerosis%26aulast%3DMcGown%26aufirst%3DAlexander%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Möller</span>, <span class="hlFld-ContribAuthor ">Hendrikus W. G. M.  Boddeke</span>. </span><span class="cited-content_cbyCitation_article-title">Glial cells as drug targets: What does it take?. </span><span class="cited-content_cbyCitation_journal-name">Glia</span><span> <strong>2016,</strong> <em>64 </em>
                                    (10)
                                     , 1742-1754. <a href="https://doi.org/10.1002/glia.22993" title="DOI URL">https://doi.org/10.1002/glia.22993</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/glia.22993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fglia.22993%26sid%3Dliteratum%253Aachs%26jtitle%3DGlia%26atitle%3DGlial%252Bcells%252Bas%252Bdrug%252Btargets%25253A%252BWhat%252Bdoes%252Bit%252Btake%25253F%26aulast%3DM%25C3%25B6ller%26aufirst%3DThomas%26date%3D2016%26date%3D2016%26volume%3D64%26issue%3D10%26spage%3D1742%26epage%3D1754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wolfgang  Wohlleben</span>, <span class="hlFld-ContribAuthor ">Yvonne  Mast</span>, <span class="hlFld-ContribAuthor ">Evi  Stegmann</span>, <span class="hlFld-ContribAuthor ">Nadine  Ziemert</span>. </span><span class="cited-content_cbyCitation_article-title">Antibiotic drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Microbial Biotechnology</span><span> <strong>2016,</strong> <em>9 </em>
                                    (5)
                                     , 541-548. <a href="https://doi.org/10.1111/1751-7915.12388" title="DOI URL">https://doi.org/10.1111/1751-7915.12388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/1751-7915.12388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2F1751-7915.12388%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobial%2520Biotechnology%26atitle%3DAntibiotic%252Bdrug%252Bdiscovery%26aulast%3DWohlleben%26aufirst%3DWolfgang%26date%3D2016%26date%3D2016%26volume%3D9%26issue%3D5%26spage%3D541%26epage%3D548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Allen  Cornett</span>, <span class="hlFld-ContribAuthor ">Fred J.  King</span>, <span class="hlFld-ContribAuthor ">Yi  Mao</span>, <span class="hlFld-ContribAuthor ">Florian  Nigsch</span>, <span class="hlFld-ContribAuthor ">C. Gregory  Paris</span>, <span class="hlFld-ContribAuthor ">Gregory  McAllister</span>, <span class="hlFld-ContribAuthor ">Jeremy L.  Jenkins</span>. </span><span class="cited-content_cbyCitation_article-title">Evidence-Based and Quantitative Prioritization of Tool Compounds in Phenotypic Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2016,</strong> <em>23 </em>
                                    (7)
                                     , 862-874. <a href="https://doi.org/10.1016/j.chembiol.2016.05.016" title="DOI URL">https://doi.org/10.1016/j.chembiol.2016.05.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2016.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2016.05.016%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DEvidence-Based%252Band%252BQuantitative%252BPrioritization%252Bof%252BTool%252BCompounds%252Bin%252BPhenotypic%252BDrug%252BDiscovery%26aulast%3DWang%26aufirst%3DYuan%26date%3D2016%26volume%3D23%26issue%3D7%26spage%3D862%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronika F.S.  Pape</span>, <span class="hlFld-ContribAuthor ">Szilárd  Tóth</span>, <span class="hlFld-ContribAuthor ">András  Füredi</span>, <span class="hlFld-ContribAuthor ">Kornélia  Szebényi</span>, <span class="hlFld-ContribAuthor ">Anna  Lovrics</span>, <span class="hlFld-ContribAuthor ">Pál  Szabó</span>, <span class="hlFld-ContribAuthor ">Michael  Wiese</span>, <span class="hlFld-ContribAuthor ">Gergely  Szakács</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>117 </em>, 335-354. <a href="https://doi.org/10.1016/j.ejmech.2016.03.078" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.078%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bthiosemicarbazones%25252C%252Bhydrazinobenzothiazoles%252Band%252Barylhydrazones%252Bas%252Banticancer%252Bagents%252Bwith%252Ba%252Bpotential%252Bto%252Bovercome%252Bmultidrug%252Bresistance%26aulast%3DPape%26aufirst%3DVeronika%2BF.S.%26date%3D2016%26volume%3D117%26spage%3D335%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew M.  Stern</span>, <span class="hlFld-ContribAuthor ">Mark E.  Schurdak</span>, <span class="hlFld-ContribAuthor ">Ivet  Bahar</span>, <span class="hlFld-ContribAuthor ">Jeremy M.  Berg</span>, <span class="hlFld-ContribAuthor ">D. Lansing  Taylor</span>. </span><span class="cited-content_cbyCitation_article-title">A Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Screening</span><span> <strong>2016,</strong> <em>21 </em>
                                    (6)
                                     , 521-534. <a href="https://doi.org/10.1177/1087057116635818" title="DOI URL">https://doi.org/10.1177/1087057116635818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1087057116635818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1087057116635818%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Screening%26atitle%3DA%252BPerspective%252Bon%252BImplementing%252Ba%252BQuantitative%252BSystems%252BPharmacology%252BPlatform%252Bfor%252BDrug%252BDiscovery%252Band%252Bthe%252BAdvancement%252Bof%252BPersonalized%252BMedicine%26aulast%3DStern%26aufirst%3DAndrew%2BM.%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D6%26spage%3D521%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liming  Shao</span>, <span class="hlFld-ContribAuthor ">Una C.  Campbell</span>, <span class="hlFld-ContribAuthor ">Q. Kevin  Fang</span>, <span class="hlFld-ContribAuthor ">Noel A.  Powell</span>, <span class="hlFld-ContribAuthor ">John E.  Campbell</span>, <span class="hlFld-ContribAuthor ">Philip G.  Jones</span>, <span class="hlFld-ContribAuthor ">Taleen  Hanania</span>, <span class="hlFld-ContribAuthor ">Vadim  Alexandrov</span>, <span class="hlFld-ContribAuthor ">Irene  Morganstern</span>, <span class="hlFld-ContribAuthor ">Emily  Sabath</span>, <span class="hlFld-ContribAuthor ">Hua M.  Zhong</span>, <span class="hlFld-ContribAuthor ">Thomas H.  Large</span>, <span class="hlFld-ContribAuthor ">Kerry L.  Spear</span>. </span><span class="cited-content_cbyCitation_article-title">In vivo
              phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (6)
                                     , 1093-1101. <a href="https://doi.org/10.1039/C6MD00128A" title="DOI URL">https://doi.org/10.1039/C6MD00128A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00128A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00128A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DIn%252Bvivo%252Bphenotypic%252Bdrug%252Bdiscovery%25253A%252Bapplying%252Ba%252Bbehavioral%252Bassay%252Bto%252Bthe%252Bdiscovery%252Band%252Boptimization%252Bof%252Bnovel%252Bantipsychotic%252Bagents%26aulast%3DShao%26aufirst%3DLiming%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D6%26spage%3D1093%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shanchao  Wu</span>, <span class="hlFld-ContribAuthor ">Yu  Li</span>, <span class="hlFld-ContribAuthor ">Guixia  Xu</span>, <span class="hlFld-ContribAuthor ">Shuqiang  Chen</span>, <span class="hlFld-ContribAuthor ">Yongqiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Chaoyu  Miao</span>, <span class="hlFld-ContribAuthor ">Hua  Su</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Novel spiropyrazolone antitumor scaffold with potent activity: Design, synthesis and structure–activity relationship. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>115 </em>, 141-147. <a href="https://doi.org/10.1016/j.ejmech.2016.03.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bspiropyrazolone%252Bantitumor%252Bscaffold%252Bwith%252Bpotent%252Bactivity%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%26aulast%3DWu%26aufirst%3DShanchao%26date%3D2016%26volume%3D115%26spage%3D141%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Faryal  Chaudhry</span>, <span class="hlFld-ContribAuthor ">Benson M.  Kariuki</span>, <span class="hlFld-ContribAuthor ">David W.  Knight</span>. </span><span class="cited-content_cbyCitation_article-title">A new method for the synthesis of pyrazolidines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (26)
                                     , 2833-2837. <a href="https://doi.org/10.1016/j.tetlet.2016.05.011" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bnew%252Bmethod%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bpyrazolidines%26aulast%3DChaudhry%26aufirst%3DFaryal%26date%3D2016%26volume%3D57%26issue%3D26%26spage%3D2833%26epage%3D2837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ioannis K.  Moutsatsos</span>, <span class="hlFld-ContribAuthor ">Christian N.  Parker</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in quantitative high throughput and high content data analysis. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (4)
                                     , 415-423. <a href="https://doi.org/10.1517/17460441.2016.1154036" title="DOI URL">https://doi.org/10.1517/17460441.2016.1154036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2016.1154036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2016.1154036%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DRecent%252Badvances%252Bin%252Bquantitative%252Bhigh%252Bthroughput%252Band%252Bhigh%252Bcontent%252Bdata%252Banalysis%26aulast%3DMoutsatsos%26aufirst%3DIoannis%2BK.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D4%26spage%3D415%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Josef  Pleticha</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Maus</span>, <span class="hlFld-ContribAuthor ">Andreas S.  Beutler</span>. </span><span class="cited-content_cbyCitation_article-title">Future Directions in Pain Management. </span><span class="cited-content_cbyCitation_journal-name">Mayo Clinic Proceedings</span><span> <strong>2016,</strong> <em>91 </em>
                                    (4)
                                     , 522-533. <a href="https://doi.org/10.1016/j.mayocp.2016.02.015" title="DOI URL">https://doi.org/10.1016/j.mayocp.2016.02.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mayocp.2016.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mayocp.2016.02.015%26sid%3Dliteratum%253Aachs%26jtitle%3DMayo%2520Clinic%2520Proceedings%26atitle%3DFuture%252BDirections%252Bin%252BPain%252BManagement%26aulast%3DPleticha%26aufirst%3DJosef%26date%3D2016%26volume%3D91%26issue%3D4%26spage%3D522%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ye  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Compound annotation with real time cellular activity profiles to improve drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (3)
                                     , 269-280. <a href="https://doi.org/10.1517/17460441.2016.1143460" title="DOI URL">https://doi.org/10.1517/17460441.2016.1143460</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2016.1143460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2016.1143460%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DCompound%252Bannotation%252Bwith%252Breal%252Btime%252Bcellular%252Bactivity%252Bprofiles%252Bto%252Bimprove%252Bdrug%252Bdiscovery%26aulast%3DFang%26aufirst%3DYe%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D3%26spage%3D269%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thavy  Long</span>, <span class="hlFld-ContribAuthor ">R. Jeffrey  Neitz</span>, <span class="hlFld-ContribAuthor ">Rachel  Beasley</span>, <span class="hlFld-ContribAuthor ">Chakrapani  Kalyanaraman</span>, <span class="hlFld-ContribAuthor ">Brian M.  Suzuki</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Colette  Dissous</span>, <span class="hlFld-ContribAuthor ">James H.  McKerrow</span>, <span class="hlFld-ContribAuthor ">David H.  Drewry</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>, <span class="hlFld-ContribAuthor ">Rahul  Singh</span>, <span class="hlFld-ContribAuthor ">Conor R.  Caffrey</span>, . </span><span class="cited-content_cbyCitation_article-title">Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni. </span><span class="cited-content_cbyCitation_journal-name">PLOS Neglected Tropical Diseases</span><span> <strong>2016,</strong> <em>10 </em>
                                    (1)
                                     , e0004356. <a href="https://doi.org/10.1371/journal.pntd.0004356" title="DOI URL">https://doi.org/10.1371/journal.pntd.0004356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pntd.0004356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pntd.0004356%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Neglected%2520Tropical%2520Diseases%26atitle%3DStructure-Bioactivity%252BRelationship%252Bfor%252BBenzimidazole%252BThiophene%252BInhibitors%252Bof%252BPolo-Like%252BKinase%252B1%252B%252528PLK1%252529%25252C%252Ba%252BPotential%252BDrug%252BTarget%252Bin%252BSchistosoma%252Bmansoni%26aulast%3DLong%26aufirst%3DThavy%26date%3D2016%26date%3D2016%26volume%3D10%26issue%3D1%26spage%3De0004356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rebecca A.  Kaner</span>, <span class="hlFld-ContribAuthor ">Simon J.  Allison</span>, <span class="hlFld-ContribAuthor ">Alan D.  Faulkner</span>, <span class="hlFld-ContribAuthor ">Roger M.  Phillips</span>, <span class="hlFld-ContribAuthor ">David I.  Roper</span>, <span class="hlFld-ContribAuthor ">Samantha L.  Shepherd</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Simpson</span>, <span class="hlFld-ContribAuthor ">Nicholas R.  Waterfield</span>, <span class="hlFld-ContribAuthor ">Peter  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer metallohelices: nanomolar potency and high selectivity. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2016,</strong> <em>7 </em>
                                    (2)
                                     , 951-958. <a href="https://doi.org/10.1039/C5SC03677A" title="DOI URL">https://doi.org/10.1039/C5SC03677A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5SC03677A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5SC03677A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DAnticancer%252Bmetallohelices%25253A%252Bnanomolar%252Bpotency%252Band%252Bhigh%252Bselectivity%26aulast%3DKaner%26aufirst%3DRebecca%2BA.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D2%26spage%3D951%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atanas G.  Atanasov</span>, <span class="hlFld-ContribAuthor ">Birgit  Waltenberger</span>, <span class="hlFld-ContribAuthor ">Eva-Maria  Pferschy-Wenzig</span>, <span class="hlFld-ContribAuthor ">Thomas  Linder</span>, <span class="hlFld-ContribAuthor ">Christoph  Wawrosch</span>, <span class="hlFld-ContribAuthor ">Pavel  Uhrin</span>, <span class="hlFld-ContribAuthor ">Veronika  Temml</span>, <span class="hlFld-ContribAuthor ">Limei  Wang</span>, <span class="hlFld-ContribAuthor ">Stefan  Schwaiger</span>, <span class="hlFld-ContribAuthor ">Elke H.  Heiss</span>, <span class="hlFld-ContribAuthor ">Judith M.  Rollinger</span>, <span class="hlFld-ContribAuthor ">Daniela  Schuster</span>, <span class="hlFld-ContribAuthor ">Johannes M.  Breuss</span>, <span class="hlFld-ContribAuthor ">Valery  Bochkov</span>, <span class="hlFld-ContribAuthor ">Marko D.  Mihovilovic</span>, <span class="hlFld-ContribAuthor ">Brigitte  Kopp</span>, <span class="hlFld-ContribAuthor ">Rudolf  Bauer</span>, <span class="hlFld-ContribAuthor ">Verena M.  Dirsch</span>, <span class="hlFld-ContribAuthor ">Hermann  Stuppner</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and resupply of pharmacologically active plant-derived natural products: A review. </span><span class="cited-content_cbyCitation_journal-name">Biotechnology Advances</span><span> <strong>2015,</strong> <em>33 </em>
                                    (8)
                                     , 1582-1614. <a href="https://doi.org/10.1016/j.biotechadv.2015.08.001" title="DOI URL">https://doi.org/10.1016/j.biotechadv.2015.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biotechadv.2015.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biotechadv.2015.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBiotechnology%2520Advances%26atitle%3DDiscovery%252Band%252Bresupply%252Bof%252Bpharmacologically%252Bactive%252Bplant-derived%252Bnatural%252Bproducts%25253A%252BA%252Breview%26aulast%3DAtanasov%26aufirst%3DAtanas%2BG.%26date%3D2015%26volume%3D33%26issue%3D8%26spage%3D1582%26epage%3D1614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guy  Carter</span>, <span class="hlFld-ContribAuthor ">Valerie  Bernan</span>. </span><span class="cited-content_cbyCitation_article-title">Marine Natural Products in Pharma: How Industry Missed the Boat. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 531-540. <a href="https://doi.org/10.1201/b19081-22" title="DOI URL">https://doi.org/10.1201/b19081-22</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1201/b19081-22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1201%2Fb19081-22%26sid%3Dliteratum%253Aachs%26atitle%3DMarine%252BNatural%252BProducts%252Bin%252BPharma%25253A%252BHow%252BIndustry%252BMissed%252Bthe%252BBoat%26aulast%3DCarter%26aufirst%3DGuy%26date%3D2015%26date%3D2015%26spage%3D531%26epage%3D540%26pub%3DCRC%2520Press%26atitle%3DMarine%252BBiomedicine%26aulast%3DBaker%26aufirst%3DBill%26date%3D2015%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahul  Hameed P.</span>, <span class="hlFld-ContribAuthor ">Suresh  Solapure</span>, <span class="hlFld-ContribAuthor ">Vikas  Patil</span>, <span class="hlFld-ContribAuthor ">Philipp P.  Henrich</span>, <span class="hlFld-ContribAuthor ">Pamela A.  Magistrado</span>, <span class="hlFld-ContribAuthor ">Sowmya  Bharath</span>, <span class="hlFld-ContribAuthor ">Kannan  Murugan</span>, <span class="hlFld-ContribAuthor ">Pavithra  Viswanath</span>, <span class="hlFld-ContribAuthor ">Jayashree  Puttur</span>, <span class="hlFld-ContribAuthor ">Abhishek  Srivastava</span>, <span class="hlFld-ContribAuthor ">Eknath  Bellale</span>, <span class="hlFld-ContribAuthor ">Vijender  Panduga</span>, <span class="hlFld-ContribAuthor ">Gajanan  Shanbag</span>, <span class="hlFld-ContribAuthor ">Disha  Awasthy</span>, <span class="hlFld-ContribAuthor ">Sudhir  Landge</span>, <span class="hlFld-ContribAuthor ">Sapna  Morayya</span>, <span class="hlFld-ContribAuthor ">Krishna  Koushik</span>, <span class="hlFld-ContribAuthor ">Ramanatha  Saralaya</span>, <span class="hlFld-ContribAuthor ">Anandkumar  Raichurkar</span>, <span class="hlFld-ContribAuthor ">Nikhil  Rautela</span>, <span class="hlFld-ContribAuthor ">Nilanjana  Roy Choudhury</span>, <span class="hlFld-ContribAuthor ">Anisha  Ambady</span>, <span class="hlFld-ContribAuthor ">Radha  Nandishaiah</span>, <span class="hlFld-ContribAuthor ">Jitendar  Reddy</span>, <span class="hlFld-ContribAuthor ">K. R.  Prabhakar</span>, <span class="hlFld-ContribAuthor ">Sreenivasaiah  Menasinakai</span>, <span class="hlFld-ContribAuthor ">Suresh  Rudrapatna</span>, <span class="hlFld-ContribAuthor ">Monalisa  Chatterji</span>, <span class="hlFld-ContribAuthor ">María Belén  Jiménez-Díaz</span>, <span class="hlFld-ContribAuthor ">María Santos  Martínez</span>, <span class="hlFld-ContribAuthor ">Laura María  Sanz</span>, <span class="hlFld-ContribAuthor ">Olivia  Coburn-Flynn</span>, <span class="hlFld-ContribAuthor ">David A.  Fidock</span>, <span class="hlFld-ContribAuthor ">Amanda K.  Lukens</span>, <span class="hlFld-ContribAuthor ">Dyann F.  Wirth</span>, <span class="hlFld-ContribAuthor ">Balachandra  Bandodkar</span>, <span class="hlFld-ContribAuthor ">Kakoli  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Robert E.  McLaughlin</span>, <span class="hlFld-ContribAuthor ">David  Waterson</span>, <span class="hlFld-ContribAuthor ">Lyn  Rosenbrier-Ribeiro</span>, <span class="hlFld-ContribAuthor ">Kevin  Hickling</span>, <span class="hlFld-ContribAuthor ">V.  Balasubramanian</span>, <span class="hlFld-ContribAuthor ">Peter  Warner</span>, <span class="hlFld-ContribAuthor ">Vinayak  Hosagrahara</span>, <span class="hlFld-ContribAuthor ">Adam  Dudley</span>, <span class="hlFld-ContribAuthor ">Pravin S.  Iyer</span>, <span class="hlFld-ContribAuthor ">Shridhar  Narayanan</span>, <span class="hlFld-ContribAuthor ">Stefan  Kavanagh</span>, <span class="hlFld-ContribAuthor ">Vasan K.  Sambandamurthy</span>. </span><span class="cited-content_cbyCitation_article-title">Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2015,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/ncomms7715" title="DOI URL">https://doi.org/10.1038/ncomms7715</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncomms7715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncomms7715%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DTriaminopyrimidine%252Bis%252Ba%252Bfast-killing%252Band%252Blong-acting%252Bantimalarial%252Bclinical%252Bcandidate%26aulast%3DHameed%2BP.%26aufirst%3DShahul%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter Mbugua  Njogu</span>, <span class="hlFld-ContribAuthor ">Kelly  Chibale</span>. </span><span class="cited-content_cbyCitation_article-title">Current and Future Strategies for Improving Drug Discovery Efficiency. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 287-328. <a href="https://doi.org/10.1002/9781118819586.ch11" title="DOI URL">https://doi.org/10.1002/9781118819586.ch11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118819586.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118819586.ch11%26sid%3Dliteratum%253Aachs%26atitle%3DCurrent%252Band%252BFuture%252BStrategies%252Bfor%252BImproving%252BDrug%252BDiscovery%252BEfficiency%26aulast%3DNjogu%26aufirst%3DPeter%2BMbugua%26date%3D2015%26date%3D2015%26spage%3D287%26epage%3D328%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DAttrition%252Bin%252Bthe%252BPharmaceutical%252BIndustry%26aulast%3DAlex%26aufirst%3DAlexander%26date%3D2015%26volume%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric A.  Rae</span>, <span class="hlFld-ContribAuthor ">Richard E.  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">The problem of genotype and sex differences in life expectancy in transgenic AD mice. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience & Biobehavioral Reviews</span><span> <strong>2015,</strong> <em>57 </em>, 238-251. <a href="https://doi.org/10.1016/j.neubiorev.2015.09.002" title="DOI URL">https://doi.org/10.1016/j.neubiorev.2015.09.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neubiorev.2015.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neubiorev.2015.09.002%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520%2526%2520Biobehavioral%2520Reviews%26atitle%3DThe%252Bproblem%252Bof%252Bgenotype%252Band%252Bsex%252Bdifferences%252Bin%252Blife%252Bexpectancy%252Bin%252Btransgenic%252BAD%252Bmice%26aulast%3DRae%26aufirst%3DEric%2BA.%26date%3D2015%26volume%3D57%26spage%3D238%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael S.  Kinch</span>. </span><span class="cited-content_cbyCitation_article-title">An analysis of FDA-approved drugs for neurological disorders. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2015,</strong> <em>20 </em>
                                    (9)
                                     , 1040-1043. <a href="https://doi.org/10.1016/j.drudis.2015.02.003" title="DOI URL">https://doi.org/10.1016/j.drudis.2015.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2015.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2015.02.003%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DAn%252Banalysis%252Bof%252BFDA-approved%252Bdrugs%252Bfor%252Bneurological%252Bdisorders%26aulast%3DKinch%26aufirst%3DMichael%2BS.%26date%3D2015%26volume%3D20%26issue%3D9%26spage%3D1040%26epage%3D1043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexey  Chernobrovkin</span>, <span class="hlFld-ContribAuthor ">Consuelo  Marin-Vicente</span>, <span class="hlFld-ContribAuthor ">Neus  Visa</span>, <span class="hlFld-ContribAuthor ">Roman A.  Zubarev</span>. </span><span class="cited-content_cbyCitation_article-title">Functional Identification of Target by Expression Proteomics (FITExP) reveals protein targets and highlights mechanisms of action of small molecule drugs. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep11176" title="DOI URL">https://doi.org/10.1038/srep11176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep11176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep11176%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DFunctional%252BIdentification%252Bof%252BTarget%252Bby%252BExpression%252BProteomics%252B%252528FITExP%252529%252Breveals%252Bprotein%252Btargets%252Band%252Bhighlights%252Bmechanisms%252Bof%252Baction%252Bof%252Bsmall%252Bmolecule%252Bdrugs%26aulast%3DChernobrovkin%26aufirst%3DAlexey%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Avijit  Banik</span>, <span class="hlFld-ContribAuthor ">Richard E.  Brown</span>, <span class="hlFld-ContribAuthor ">James  Bamburg</span>, <span class="hlFld-ContribAuthor ">Debomoy K.  Lahiri</span>, <span class="hlFld-ContribAuthor ">Dheeraj  Khurana</span>, <span class="hlFld-ContribAuthor ">Robert P.  Friedland</span>, <span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Ying  Ding</span>, <span class="hlFld-ContribAuthor ">Amritpal  Mudher</span>, <span class="hlFld-ContribAuthor ">Ante L.  Padjen</span>, <span class="hlFld-ContribAuthor ">Elizabeta  Mukaetova-Ladinska</span>, <span class="hlFld-ContribAuthor ">Masafumi  Ihara</span>, <span class="hlFld-ContribAuthor ">Sudhir  Srivastava</span>, <span class="hlFld-ContribAuthor ">M.V.  Padma Srivastava</span>, <span class="hlFld-ContribAuthor ">Colin L.  Masters</span>, <span class="hlFld-ContribAuthor ">Raj N.  Kalaria</span>, <span class="hlFld-ContribAuthor ">Akshay  Anand</span>. </span><span class="cited-content_cbyCitation_article-title">Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer’s Disease: What are the Roadblocks and How Can They Be Overcome?1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2015,</strong> <em>47 </em>
                                    (4)
                                     , 815-843. <a href="https://doi.org/10.3233/JAD-150136" title="DOI URL">https://doi.org/10.3233/JAD-150136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-150136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-150136%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DTranslation%252Bof%252BPre-Clinical%252BStudies%252Binto%252BSuccessful%252BClinical%252BTrials%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BWhat%252Bare%252Bthe%252BRoadblocks%252Band%252BHow%252BCan%252BThey%252BBe%252BOvercome%25253F1%26aulast%3DBanik%26aufirst%3DAvijit%26date%3D2015%26volume%3D47%26issue%3D4%26spage%3D815%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary W  Caldwell</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              tools used for compound selection during target-based drug discovery and development. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2015,</strong> <em>10 </em>
                                    (8)
                                     , 901-923. <a href="https://doi.org/10.1517/17460441.2015.1043885" title="DOI URL">https://doi.org/10.1517/17460441.2015.1043885</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2015.1043885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2015.1043885%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DIn%252Bsilico%252Btools%252Bused%252Bfor%252Bcompound%252Bselection%252Bduring%252Btarget-based%252Bdrug%252Bdiscovery%252Band%252Bdevelopment%26aulast%3DCaldwell%26aufirst%3DGary%2BW%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D8%26spage%3D901%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bart I.  Roman</span>, <span class="hlFld-ContribAuthor ">Tine  De Ryck</span>, <span class="hlFld-ContribAuthor ">Atanas  Patronov</span>, <span class="hlFld-ContribAuthor ">Svetoslav H.  Slavov</span>, <span class="hlFld-ContribAuthor ">Barbara W.A.  Vanhoecke</span>, <span class="hlFld-ContribAuthor ">Alan R.  Katritzky</span>, <span class="hlFld-ContribAuthor ">Marc E.  Bracke</span>, <span class="hlFld-ContribAuthor ">Christian V.  Stevens</span>. </span><span class="cited-content_cbyCitation_article-title">4-Fluoro-3′,4′,5′-trimethoxychalcone as a new anti-invasive agent. From discovery to initial validation in an in vivo metastasis model. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>101 </em>, 627-639. <a href="https://doi.org/10.1016/j.ejmech.2015.06.029" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.06.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.06.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.06.029%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D4-Fluoro-3%2525E2%252580%2525B2%25252C4%2525E2%252580%2525B2%25252C5%2525E2%252580%2525B2-trimethoxychalcone%252Bas%252Ba%252Bnew%252Banti-invasive%252Bagent.%252BFrom%252Bdiscovery%252Bto%252Binitial%252Bvalidation%252Bin%252Ban%252Bin%2525C2%2525A0vivo%252Bmetastasis%252Bmodel%26aulast%3DRoman%26aufirst%3DBart%2BI.%26date%3D2015%26volume%3D101%26spage%3D627%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan A.  Lee</span>, <span class="hlFld-ContribAuthor ">Paul  Shinn</span>, <span class="hlFld-ContribAuthor ">Susan  Jaken</span>, <span class="hlFld-ContribAuthor ">Sarah  Oliver</span>, <span class="hlFld-ContribAuthor ">Francis S.  Willard</span>, <span class="hlFld-ContribAuthor ">Steven  Heidler</span>, <span class="hlFld-ContribAuthor ">Robert B.  Peery</span>, <span class="hlFld-ContribAuthor ">Jennifer  Oler</span>, <span class="hlFld-ContribAuthor ">Shaoyou  Chu</span>, <span class="hlFld-ContribAuthor ">Noel  Southall</span>, <span class="hlFld-ContribAuthor ">Thomas S.  Dexheimer</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Smallwood</span>, <span class="hlFld-ContribAuthor ">Ruili  Huang</span>, <span class="hlFld-ContribAuthor ">Rajarshi  Guha</span>, <span class="hlFld-ContribAuthor ">Ajit  Jadhav</span>, <span class="hlFld-ContribAuthor ">Karen  Cox</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Austin</span>, <span class="hlFld-ContribAuthor ">Anton  Simeonov</span>, <span class="hlFld-ContribAuthor ">G. Sitta  Sittampalam</span>, <span class="hlFld-ContribAuthor ">Saba  Husain</span>, <span class="hlFld-ContribAuthor ">Natalie  Franklin</span>, <span class="hlFld-ContribAuthor ">David J.  Wild</span>, <span class="hlFld-ContribAuthor ">Jeremy J.  Yang</span>, <span class="hlFld-ContribAuthor ">Jeffrey J.  Sutherland</span>, <span class="hlFld-ContribAuthor ">Craig J.  Thomas</span>, . </span><span class="cited-content_cbyCitation_article-title">Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (7)
                                     , e0130796. <a href="https://doi.org/10.1371/journal.pone.0130796" title="DOI URL">https://doi.org/10.1371/journal.pone.0130796</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0130796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0130796%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DNovel%252BPhenotypic%252BOutcomes%252BIdentified%252Bfor%252Ba%252BPublic%252BCollection%252Bof%252BApproved%252BDrugs%252Bfrom%252Ba%252BPublicly%252BAccessible%252BPanel%252Bof%252BAssays%26aulast%3DLee%26aufirst%3DJonathan%2BA.%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D7%26spage%3De0130796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Cecilia  Cirio</span>, <span class="hlFld-ContribAuthor ">Mark P.  de Caestecker</span>, <span class="hlFld-ContribAuthor ">Neil A.  Hukriede</span>. </span><span class="cited-content_cbyCitation_article-title">Zebrafish Models of Kidney Damage and Repair. </span><span class="cited-content_cbyCitation_journal-name">Current Pathobiology Reports</span><span> <strong>2015,</strong> <em>3 </em>
                                    (2)
                                     , 163-170. <a href="https://doi.org/10.1007/s40139-015-0080-4" title="DOI URL">https://doi.org/10.1007/s40139-015-0080-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40139-015-0080-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40139-015-0080-4%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pathobiology%2520Reports%26atitle%3DZebrafish%252BModels%252Bof%252BKidney%252BDamage%252Band%252BRepair%26aulast%3DCirio%26aufirst%3DMaria%2BCecilia%26date%3D2015%26date%3D2015%26volume%3D3%26issue%3D2%26spage%3D163%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankush  Argade</span>, <span class="hlFld-ContribAuthor ">Somasekhar  Bhamidipati</span>, <span class="hlFld-ContribAuthor ">Hui  Li</span>, <span class="hlFld-ContribAuthor ">David  Carroll</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Clough</span>, <span class="hlFld-ContribAuthor ">Holger  Keim</span>, <span class="hlFld-ContribAuthor ">Catherine  Sylvain</span>, <span class="hlFld-ContribAuthor ">Alexander B.  Rossi</span>, <span class="hlFld-ContribAuthor ">Christina  Coquilla</span>, <span class="hlFld-ContribAuthor ">Sarkiz D.  Issakani</span>, <span class="hlFld-ContribAuthor ">Esteban S.  Masuda</span>, <span class="hlFld-ContribAuthor ">Donald G.  Payan</span>, <span class="hlFld-ContribAuthor ">Rajinder  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Application of cultured human mast cells (CHMC) for the design and structure–activity relationship of IgE-mediated mast cell activation inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (10)
                                     , 2117-2121. <a href="https://doi.org/10.1016/j.bmcl.2015.03.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.03.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.03.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.03.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DApplication%252Bof%252Bcultured%252Bhuman%252Bmast%252Bcells%252B%252528CHMC%252529%252Bfor%252Bthe%252Bdesign%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bof%252BIgE-mediated%252Bmast%252Bcell%252Bactivation%252Binhibitors%26aulast%3DArgade%26aufirst%3DAnkush%26date%3D2015%26volume%3D25%26issue%3D10%26spage%3D2117%26epage%3D2121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Legname</span>. </span><span class="cited-content_cbyCitation_article-title">Approaches for discovering anti-prion compounds: lessons learned and challenges ahead. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2015,</strong> <em>10 </em>
                                    (4)
                                     , 389-397. <a href="https://doi.org/10.1517/17460441.2015.1016498" title="DOI URL">https://doi.org/10.1517/17460441.2015.1016498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2015.1016498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2015.1016498%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DApproaches%252Bfor%252Bdiscovering%252Banti-prion%252Bcompounds%25253A%252Blessons%252Blearned%252Band%252Bchallenges%252Bahead%26aulast%3DBolognesi%26aufirst%3DMaria%2BLaura%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D4%26spage%3D389%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ye  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2015,</strong> <em>10 </em>
                                    (4)
                                     , 331-343. <a href="https://doi.org/10.1517/17460441.2015.1020788" title="DOI URL">https://doi.org/10.1517/17460441.2015.1020788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2015.1020788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2015.1020788%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DCombining%252Blabel-free%252Bcell%252Bphenotypic%252Bprofiling%252Bwith%252Bcomputational%252Bapproaches%252Bfor%252Bnovel%252Bdrug%252Bdiscovery%26aulast%3DFang%26aufirst%3DYe%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D4%26spage%3D331%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric W.  Esch</span>, <span class="hlFld-ContribAuthor ">Anthony  Bahinski</span>, <span class="hlFld-ContribAuthor ">Dongeun  Huh</span>. </span><span class="cited-content_cbyCitation_article-title">Organs-on-chips at the frontiers of drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2015,</strong> <em>14 </em>
                                    (4)
                                     , 248-260. <a href="https://doi.org/10.1038/nrd4539" title="DOI URL">https://doi.org/10.1038/nrd4539</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4539%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DOrgans-on-chips%252Bat%252Bthe%252Bfrontiers%252Bof%252Bdrug%252Bdiscovery%26aulast%3DEsch%26aufirst%3DEric%2BW.%26date%3D2015%26date%3D2015%26volume%3D14%26issue%3D4%26spage%3D248%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael S.  Kinch</span>, <span class="hlFld-ContribAuthor ">Eric  Patridge</span>. </span><span class="cited-content_cbyCitation_article-title">An analysis of FDA-approved drugs for psychiatric disorders. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2015,</strong> <em>20 </em>
                                    (3)
                                     , 292-295. <a href="https://doi.org/10.1016/j.drudis.2014.08.013" title="DOI URL">https://doi.org/10.1016/j.drudis.2014.08.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2014.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2014.08.013%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DAn%252Banalysis%252Bof%252BFDA-approved%252Bdrugs%252Bfor%252Bpsychiatric%252Bdisorders%26aulast%3DKinch%26aufirst%3DMichael%2BS.%26date%3D2015%26volume%3D20%26issue%3D3%26spage%3D292%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm201649s&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm201649s%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-10%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=137&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/medium/jm-2011-01649s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Screening results of medium throughput in vitro angiogenesis assay. (A) Phenotypic primary screening: activity distribution of single point testing data of 32 000 compounds. Compounds were tested at 2 μM as described.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The mean percent inhibition was −8.2%. 3.7% and 1.9% of tested compounds were ≥2STD and >3STD above the mean (shaded) corresponding to >60% and >90% endothelial cord inhibition, respectively. (B) Phenotypic hit expansions. Compounds with confirmed endothelial cord inhibition activity, no overt cytotoxicity, and no predicted/known kinase activity were used as seeds for virtual screening of the Lilly compound collection as described in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. 19 000 compounds relating to similar structures and novel scaffolds were identified and tested as described for the primary screen. The observed mean of the single point data distribution is significantly shifted toward higher cord area inhibitory activity (10%) with 10.6% and 4.8% of tested compounds exhibiting >60% and >90% inhibition, respectively (shaded).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/medium/jm-2011-01649s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Phenotypic actives are structurally diverse. Unique compound clusters observed during the medium throughput screen and hit expansion phases are indicated. Screening actives were confirmed and triaged as described in the text; 194 compounds were used as “seeds” for similarity searching and scaffold hopping by chemoinformatics interrogation of the Lilly compound collection for the first round of hit expansion. The number of unique clusters corresponding to active compounds (single point activity >60%) from the 32 000 compound primary screen and the collective 19 000 compounds from two hit expansions are indicated. Of the 1195 active compound clusters identified after hit expansion, 178 clusters (∼4700 compounds) were observed in the medium throughput screen and 1017 clusters (∼8800 compounds) were novel active chemical scaffolds. 476 chemical scaffolds (∼4300 compounds) active in the screen were either deprioritized using criteria given in the text or were inactive upon retest.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/medium/jm-2011-01649s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Phenotypic actives utilize diverse molecular mechanisms. 451 confirmed inhibitors of endothelial cord formation (IC<sub>50</sub> < 3.5 μM) which did not display overt cytotoxicity or cell cycle activity<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> were identified following hit expansion 1. (A) Visualization of known and predicted biochemical activities of four endothelial cord formation inhibitors using a heat map display based on the phylogenetic diagrams of the kinase, GPCR, NHR, and PDE target families.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Phenotypic actives with predominant biochemical activities in kinase, GPCR, or NHR target families are indicated; a compound without identified activity is designated “unknown”. Color coding is as follows. Red indicates potent activity (EC<sub>50</sub> or IC<sub>50</sub> of ≤10 nM). Green indicates poor activity EC<sub>50</sub> or IC<sub>50</sub> of >10 uM). (B) Distribution of endothelial cord inhibition potencies for confirmed phenotypic actives. Results of database mining were visualized using the phylogenetic-activity display, and compounds were classified on the basis of their predominant biochemical activities or designated “unknown” if no tested or predicted activity was associated with the compound. The predominant target class of phenotypic actives is indicated with the total number of molecules and percentage of molecules found in each target class (inset).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/medium/jm-2011-01649s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of phenotypic actives with antiangiogenesis standards of care. (A) Structures of two compounds identified by the phenotypic endothelial cord assay. (B) Functional comparison of phenotypic actives and antiangiogenesis standard of care, Sutent and Nexavar. The biochemical kinase activity for each molecule is summarized in the kinase phylogenetic-activity display. Color coding is as follows. Red indicates potent activity (EC<sub>50</sub> or IC<sub>50</sub> of ≤10 nM). Green indicates poor activity EC<sub>50</sub> or IC<sub>50</sub> of >10 uM). Phenotypic characterization and determination of EC<sub>50</sub> and IC<sub>50</sub> values used statistically validated assays as summarized in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/medium/jm-2011-01649s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of angiogenesis in vivo. Mice bearing U87MG xenograft tumors were treated with vehicles, compound <b>A</b> (30 mg/kg) or Sutent (10 mg/kg), administered twice a day for 3 days as described in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. Tumors were removed, fixed, sectioned, stained, and examined by fluorescence microscopy as described in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. Total cell number (Hoechst 33342) and the extent of blood vessel network formation, pericyte coverge, and tumor hypoxia were monitored with antibodies to CD31, smooth muscle actin, and Glut-1 respectively. Color coding is as follows: green = CD31 (endothelial tubes); blue = total nuclei; red = smooth muscle actin; yellow = Glut-1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/medium/jm-2011-01649s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Molecular targets of phenotypic actives identified by compound structure–activity correlations. (A) Cell based activity correlation between inhibition of acetyl-CoA carboxylase and endothelial cord formation activities for 29 analogues of compound <b>B</b>. Linear regression line is indicated, <i>R</i><sup>2</sup> = 0.81 with <i>p</i> < 0.001. (B) Cell based activity correlation between inhibition of cellular β-secretase and endothelial cord formation activities for 306 analogues of compound <b>A</b>. Linear regression line is indicated, <i>R</i><sup>2</sup> = 0.65 with <i>p</i> < 0.001(inset). A subset of 15 compound <b>A</b> analogues were further tested for activity in biochemical BACE and cellular γ-secretase assays as summarized in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. Linear regression line is indicated, <i>R</i><sup>2</sup> = 0.95 with <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-10/jm201649s/production/images/large/jm-2011-01649s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201649s&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14700" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14700" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 68 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Munos, B.</span><span> </span><span class="NLM_article-title">Lessons from 60 years of pharmaceutical innovation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">968</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnrd2961" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=19949401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2gtrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=959-968&author=B.+Munos&title=Lessons+from+60+years+of+pharmaceutical+innovation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from 60 years of pharmaceutical innovation</span></div><div class="casAuthors">Munos, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">959-968</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite unprecedented investment in pharmaceutical research and development (R&D), the no. of new drugs approved by the US Food and Drug Administration (FDA) remains low.  To help understand this conundrum, this article investigates the record of pharmaceutical innovation by analyzing data on the companies that introduced the ∼1,200 new drugs that have been approved by the FDA since 1950.  This anal. shows that the new-drug output from pharmaceutical companies in this period has essentially been const., and remains so despite the attempts to increase it.  This suggests that, contrary to common perception, the new-drug output is not depressed, but may simply reflect the limitations of the current R&D model.  The implications of these findings and options to achieve sustain-ability for the pharmaceutical industry are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5CrUftSjUirVg90H21EOLACvtfcHk0lgRgwHvUzTXFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2gtrbK&md5=dd36497b2a0788257333322f77df81bc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd2961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2961%26sid%3Dliteratum%253Aachs%26aulast%3DMunos%26aufirst%3DB.%26atitle%3DLessons%2520from%252060%2520years%2520of%2520pharmaceutical%2520innovation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D959%26epage%3D968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Booth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zemmel, R.</span><span> </span><span class="NLM_article-title">Prospects for productivity</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnrd1384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=15136792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlCrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=451-456&author=B.+Boothauthor=R.+Zemmel&title=Prospects+for+productivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Prospects for productivity</span></div><div class="casAuthors">Booth, Bruce; Zemmel, Rodney</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">451-456</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Long-term declines in the productivity of pharmaceutical R&D threaten the sustainability of the current business model.  A major driver of the decline has been the rising cost, and increased rate of failure, of projects across the industry, caused in part by the confluence of new approaches, novel technologies, higher go/no-go hurdles and organizational challenges.  Here we examine several of the top culprits that are charged with driving this decline and the merits of the cases against them, and speculate on the emerging trends that will underpin the industry's future productivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc_IXtrQEaVbVg90H21EOLACvtfcHk0lgRgwHvUzTXFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlCrt7g%253D&md5=1d6d46ca196aecbd4bf95b57e00592e2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd1384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1384%26sid%3Dliteratum%253Aachs%26aulast%3DBooth%26aufirst%3DB.%26aulast%3DZemmel%26aufirst%3DR.%26atitle%3DProspects%2520for%2520productivity%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D451%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Yildirim, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusick, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabasi, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, M.</span><span> </span><span class="NLM_article-title">Drug–target network</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1119-1126&author=M.+A.+Yildirimauthor=K.+I.+Gohauthor=M.+E.+Cusickauthor=A.+L.+Barabasiauthor=M.+Vidal&title=Drug%E2%80%93target+network"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYildirim%26aufirst%3DM.%2BA.%26aulast%3DGoh%26aufirst%3DK.%2BI.%26aulast%3DCusick%26aufirst%3DM.%2BE.%26aulast%3DBarabasi%26aufirst%3DA.%2BL.%26aulast%3DVidal%26aufirst%3DM.%26atitle%3DDrug%25E2%2580%2593target%2520network%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D1119%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Paul, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mytelka, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunwiddie, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persinger, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munos, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindborg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schacht, A. L.</span><span> </span><span class="NLM_article-title">How to improve R&D productivity: the pharmaceutical industry’s grand challenge</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnrd3078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=20168317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=203-214&author=S.+M.+Paulauthor=D.+S.+Mytelkaauthor=C.+T.+Dunwiddieauthor=C.+C.+Persingerauthor=B.+H.+Munosauthor=S.+R.+Lindborgauthor=A.+L.+Schacht&title=How+to+improve+R%26D+productivity%3A+the+pharmaceutical+industry%E2%80%99s+grand+challenge"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">How to improve R&D productivity: the pharmaceutical industry's grand challenge</span></div><div class="casAuthors">Paul, Steven M.; Mytelka, Daniel S.; Dunwiddie, Christopher T.; Persinger, Charles C.; Munos, Bernard H.; Lindborg, Stacy R.; Schacht, Aaron L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The pharmaceutical industry is under growing pressure from a range of environmental issues, including major losses of revenue owing to patent expirations, increasingly cost-constrained healthcare systems and more demanding regulatory requirements.  In our view, the key to tackling the challenges such issues pose to both the future viability of the pharmaceutical industry and advances in healthcare is to substantially increase the no. and quality of innovative, cost-effective new medicines, without incurring unsustainable R&D costs.  However, it is widely acknowledged that trends in industry R&D productivity have been moving in the opposite direction for a no. of years.  Here, we present a detailed anal. based on comprehensive, recent, industry-wide data to identify the relative contributions of each of the steps in the drug discovery and development process to overall R&D productivity.  We then propose specific strategies that could have the most substantial impact in improving R&D productivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY67PCIhaBVLVg90H21EOLACvtfcHk0lgY2_tyDORRrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D&md5=2f32bcc48c869290eef18ff9400afcc5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd3078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3078%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DMytelka%26aufirst%3DD.%2BS.%26aulast%3DDunwiddie%26aufirst%3DC.%2BT.%26aulast%3DPersinger%26aufirst%3DC.%2BC.%26aulast%3DMunos%26aufirst%3DB.%2BH.%26aulast%3DLindborg%26aufirst%3DS.%2BR.%26aulast%3DSchacht%26aufirst%3DA.%2BL.%26atitle%3DHow%2520to%2520improve%2520R%2526D%2520productivity%253A%2520the%2520pharmaceutical%2520industry%25E2%2580%2599s%2520grand%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D203%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Lechleiter, J. C.</span><span> </span><span class="NLM_article-title">Lilly COE Lechleiter Calls for Repair of the “Engine of Biopharma Innovation”</span>;<span class="NLM_x"> </span><span class="NLM_year">2009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+C.+Lechleiter&title=Lilly+COE+Lechleiter+Calls+for+Repair+of+the+%E2%80%9CEngine+of+Biopharma+Innovation%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLechleiter%26aufirst%3DJ.%2BC.%26atitle%3DLilly%2520COE%2520Lechleiter%2520Calls%2520for%2520Repair%2520of%2520the%2520%25E2%2580%259CEngine%2520of%2520Biopharma%2520Innovation%25E2%2580%259D%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Macarron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojanic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirovic, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garyantes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertzberg, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paslay, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schopfer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sittampalam, G. S.</span><span> </span><span class="NLM_article-title">Impact of high-throughput screening in biomedical research</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnrd3368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=21358738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFensbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=188-195&author=R.+Macarronauthor=M.+N.+Banksauthor=D.+Bojanicauthor=D.+J.+Burnsauthor=D.+A.+Cirovicauthor=T.+Garyantesauthor=D.+V.+Greenauthor=R.+P.+Hertzbergauthor=W.+P.+Janzenauthor=J.+W.+Paslayauthor=U.+Schopferauthor=G.+S.+Sittampalam&title=Impact+of+high-throughput+screening+in+biomedical+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of high-throughput screening in biomedical research</span></div><div class="casAuthors">Macarron, Ricardo; Banks, Martyn N.; Bojanic, Dejan; Burns, David J.; Cirovic, Dragan A.; Garyantes, Tina; Green, Darren V. S.; Hertzberg, Robert P.; Janzen, William P.; Paslay, Jeff W.; Schopfer, Ulrich; Sittampalam, G. Sitta</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">188-195</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  High-throughput screening (HTS) has been postulated in several quarters to be a contributory factor to the decline in productivity in the pharmaceutical industry.  Moreover, it has been blamed for stifling the creativity that drug discovery demands.  In this article, we aim to dispel these myths and present the case for the use of HTS as part of a proven scientific tool kit, the wider use of which is essential for the discovery of new chemotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLnrSVehADbLVg90H21EOLACvtfcHk0lgY2_tyDORRrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFensbY%253D&md5=cb9853227506f3a3d774791cff9fd79d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd3368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3368%26sid%3Dliteratum%253Aachs%26aulast%3DMacarron%26aufirst%3DR.%26aulast%3DBanks%26aufirst%3DM.%2BN.%26aulast%3DBojanic%26aufirst%3DD.%26aulast%3DBurns%26aufirst%3DD.%2BJ.%26aulast%3DCirovic%26aufirst%3DD.%2BA.%26aulast%3DGaryantes%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DD.%2BV.%26aulast%3DHertzberg%26aufirst%3DR.%2BP.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DPaslay%26aufirst%3DJ.%2BW.%26aulast%3DSchopfer%26aufirst%3DU.%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26atitle%3DImpact%2520of%2520high-throughput%2520screening%2520in%2520biomedical%2520research%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D188%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Adams, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gocayne, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubnick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polymeropoulos, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merril, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, R. F.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Complementary DNA sequencing: expressed sequence tags and human genome project</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">252</span><span class="NLM_x">, </span> <span class="NLM_fpage">1651</span><span class="NLM_x">–</span> <span class="NLM_lpage">1656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=1991&pages=1651-1656&author=M.+D.+Adamsauthor=J.+M.+Kelleyauthor=J.+D.+Gocayneauthor=M.+Dubnickauthor=M.+H.+Polymeropoulosauthor=H.+Xiaoauthor=C.+R.+Merrilauthor=A.+Wuauthor=B.+Oldeauthor=R.+F.+Moreno&title=Complementary+DNA+sequencing%3A+expressed+sequence+tags+and+human+genome+project"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DM.%2BD.%26aulast%3DKelley%26aufirst%3DJ.%2BM.%26aulast%3DGocayne%26aufirst%3DJ.%2BD.%26aulast%3DDubnick%26aufirst%3DM.%26aulast%3DPolymeropoulos%26aufirst%3DM.%2BH.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DMerril%26aufirst%3DC.%2BR.%26aulast%3DWu%26aufirst%3DA.%26aulast%3DOlde%26aufirst%3DB.%26aulast%3DMoreno%26aufirst%3DR.%2BF.%26atitle%3DComplementary%2520DNA%2520sequencing%253A%2520expressed%2520sequence%2520tags%2520and%2520human%2520genome%2520project%26jtitle%3DScience%26date%3D1991%26volume%3D252%26spage%3D1651%26epage%3D1656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">International Human Genome Sequencing Consortium.</span><span> </span><span class="NLM_article-title">Finishing the euchromatic sequence of the human genome</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">431</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnature03001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=15496913" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=2004&pages=931-945&author=International+Human+Genome+Sequencing+Consortium.&title=Finishing+the+euchromatic+sequence+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature03001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03001%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DFinishing%2520the%2520euchromatic%2520sequence%2520of%2520the%2520human%2520genome%26jtitle%3DNature%26date%3D2004%26volume%3D431%26spage%3D931%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Stancato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhlik, M.</span><span> </span><span class="NLM_article-title">Enabling phenotypic lead generation through high content imaging</span> <span class="citation_source-journal">Eur. Biopharm. Rev. Digital</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=38-43&author=L.+Stancatoauthor=M.+Uhlik&title=Enabling+phenotypic+lead+generation+through+high+content+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStancato%26aufirst%3DL.%26aulast%3DUhlik%26aufirst%3DM.%26atitle%3DEnabling%2520phenotypic%2520lead%2520generation%2520through%2520high%2520content%2520imaging%26jtitle%3DEur.%2520Biopharm.%2520Rev.%2520Digital%26date%3D2008%26volume%3D1%26spage%3D38%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, J.</span><span> </span><span class="NLM_article-title">How were new medicines discovered?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=507-519&author=D.+C.+Swinneyauthor=J.+Anthony&title=How+were+new+medicines+discovered%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DAnthony%26aufirst%3DJ.%26atitle%3DHow%2520were%2520new%2520medicines%2520discovered%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D507%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Quintavalle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heynen-Genel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtneidge, S. A.</span><span> </span><span class="NLM_article-title">A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion</span> <span class="citation_source-journal">Sci Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">ra49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1126%2Fscisignal.2002032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=21791703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOis7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=ra49&author=M.+Quintavalleauthor=L.+Eliaauthor=J.+H.+Priceauthor=S.+Heynen-Genelauthor=S.+A.+Courtneidge&title=A+cell-based+high-content+screening+assay+reveals+activators+and+inhibitors+of+cancer+cell+invasion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion</span></div><div class="casAuthors">Quintavalle, Manuela; Elia, Leonardo; Price, Jeffrey H.; Heynen-Genel, Susanne; Courtneidge, Sara A.</div><div class="citationInfo"><span class="NLM_cas:title">Science Signaling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">183</span>),
    <span class="NLM_cas:pages">ra49</span>CODEN:
                <span class="NLM_cas:coden">SSCICM</span>;
        ISSN:<span class="NLM_cas:issn">1937-9145</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Acquisition of invasive cell behavior underlies tumor progression and metastasis.  To further define the mol. mechanisms underlying invasive behavior, we developed a high-throughput screening strategy to quantitate invadopodia, which are actin-rich membrane protrusions of cancer cells that contribute to tissue invasion and matrix remodeling.  We tested the LOPAC 1280 collection of pharmacol. active agents in a high-content, image-based assay and identified compds. that inhibited invadopodium formation without overt toxicity, as well as compds. that increased invadopodia no.  The chemotherapeutic agent paclitaxel increased both the no. of invadopodia and the invasive behavior of various human cancer cell lines, effects that have potential clin. implications for its use before surgical removal of a primary tumor (neoadjuvant therapy) or in patients with chemoresistant tumors.  Several compds. that inhibited invasion have been characterized as cyclin-dependent kinase (Cdk) inhibitors, and loss-of-function expts. detd. that Cdk5 was the relevant target.  We further detd. that Cdk5 promoted both invadopodium formation and cancer cell invasion by phosphorylating and thus decreasing the abundance of the actin regulatory protein caldesmon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbv3mC0BCilrVg90H21EOLACvtfcHk0lhBwT0-KmZs5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOis7bL&md5=cce5501983fe3dabbba27a66edc1abc8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2002032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2002032%26sid%3Dliteratum%253Aachs%26aulast%3DQuintavalle%26aufirst%3DM.%26aulast%3DElia%26aufirst%3DL.%26aulast%3DPrice%26aufirst%3DJ.%2BH.%26aulast%3DHeynen-Genel%26aufirst%3DS.%26aulast%3DCourtneidge%26aufirst%3DS.%2BA.%26atitle%3DA%2520cell-based%2520high-content%2520screening%2520assay%2520reveals%2520activators%2520and%2520inhibitors%2520of%2520cancer%2520cell%2520invasion%26jtitle%3DSci%2520Signaling%26date%3D2011%26volume%3D4%26spage%3Dra49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Mayer, T. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggarty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchison, T. J.</span><span> </span><span class="NLM_article-title">Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1126%2Fscience.286.5441.971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=10542155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADyaK1MXntFaqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=971-974&author=T.+U.+Mayerauthor=T.+M.+Kapoorauthor=S.+J.+Haggartyauthor=R.+W.+Kingauthor=S.+L.+Schreiberauthor=T.+J.+Mitchison&title=Small+molecule+inhibitor+of+mitotic+spindle+bipolarity+identified+in+a+phenotype-based+screen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen</span></div><div class="casAuthors">Mayer, Thomas U.; Kapoor, Tarun M.; Haggarty, Stephen J.; King, Randall W.; Schreiber, Stuart L.; Mitchison, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5441</span>),
    <span class="NLM_cas:pages">971-974</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Small mols. that perturb specific protein functions are valuable tools for dissecting complex processes in mammalian cells.  A combination of two phenotype-based screens, one based on a specific posttranslational modification, the other visualizing microtubules and chromatin, was used to identify compds. that affect mitosis.  One compd., here named monastrol, arrested mammalian cells in mitosis with monopolar spindles.  In vitro, monastrol specifically inhibited the motility of the mitotic kinesin Eg5, a motor protein required for spindle bipolarity.  All previously known small mols. that specifically affect the mitotic machinery target tubulin.  Monastrol will therefore be a particularly useful tool for studying mitotic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogQtim1hvM_LVg90H21EOLACvtfcHk0lhBwT0-KmZs5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFaqu7o%253D&md5=d1c47a3e2af49f229e5bf618ca2835f5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5441.971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5441.971%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DT.%2BU.%26aulast%3DKapoor%26aufirst%3DT.%2BM.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DKing%26aufirst%3DR.%2BW.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DSmall%2520molecule%2520inhibitor%2520of%2520mitotic%2520spindle%2520bipolarity%2520identified%2520in%2520a%2520phenotype-based%2520screen%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D971%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Yarrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totsukawa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charras, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchison, T. J.</span><span> </span><span class="NLM_article-title">Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1016%2Fj.chembiol.2005.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=15797222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1Kms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=385-395&author=J.+C.+Yarrowauthor=G.+Totsukawaauthor=G.+T.+Charrasauthor=T.+J.+Mitchison&title=Screening+for+cell+migration+inhibitors+via+automated+microscopy+reveals+a+Rho-kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor</span></div><div class="casAuthors">Yarrow, Justin C.; Totsukawa, Go; Charras, Guillaume T.; Mitchison, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">385-395</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Small-mol. kinase inhibitors are predominantly discovered in pure protein assays.  We have discovered an inhibitor of Rho-kinase (ROCK) through an image-based, high-throughput screen of cell monolayer wound healing.  Using automated microscopy, we screened a library of ∼16,000 compds. finding many that affected cell migration or cell morphol. as well as compds. that blocked mitotic progression.  We tested ∼200 compds. in a series of subassays and chose one, 3-(4-pyridyl)indole (Rockout), for more detailed characterization.  Rockout inhibits blebbing and causes dissoln. of actin stress fibers, phenocopying Rho-kinase inhibitors.  Testing Rho-kinase activity in vitro, Rockout inhibits with an IC50 of 25 μM (∼5-fold less potent than Y-27632) but has a similar specificity profile.  We also profile the wound healing assay with a library of compds. with known bioactivities, revealing multiple pathways involved in the biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB6y0EsQGnMrVg90H21EOLACvtfcHk0lhBwT0-KmZs5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1Kms7s%253D&md5=d923ac2e8b63eed510caf7ffff04f501</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DYarrow%26aufirst%3DJ.%2BC.%26aulast%3DTotsukawa%26aufirst%3DG.%26aulast%3DCharras%26aufirst%3DG.%2BT.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26atitle%3DScreening%2520for%2520cell%2520migration%2520inhibitors%2520via%2520automated%2520microscopy%2520reveals%2520a%2520Rho-kinase%2520inhibitor%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D385%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholer, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span> </span><span class="NLM_article-title">Self-renewal of embryonic stem cells by a small molecule</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17266</span><span class="NLM_x">–</span> <span class="NLM_lpage">17271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17266-17271&author=S.+Chenauthor=J.+T.+Doauthor=Q.+Zhangauthor=S.+Yaoauthor=F.+Yanauthor=E.+C.+Petersauthor=H.+R.+Scholerauthor=P.+G.+Schultzauthor=S.+Ding&title=Self-renewal+of+embryonic+stem+cells+by+a+small+molecule"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DDo%26aufirst%3DJ.%2BT.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DPeters%26aufirst%3DE.%2BC.%26aulast%3DScholer%26aufirst%3DH.%2BR.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DDing%26aufirst%3DS.%26atitle%3DSelf-renewal%2520of%2520embryonic%2520stem%2520cells%2520by%2520a%2520small%2520molecule%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17266%26epage%3D17271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span> </span><span class="NLM_article-title">Dedifferentiation of lineage-committed cells by a small molecule</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja037390k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=410-411&author=S.+Chenauthor=Q.+Zhangauthor=X.+Wuauthor=P.+G.+Schultzauthor=S.+Ding&title=Dedifferentiation+of+lineage-committed+cells+by+a+small+molecule"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fja037390k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja037390k%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DDing%26aufirst%3DS.%26atitle%3DDedifferentiation%2520of%2520lineage-committed%2520cells%2520by%2520a%2520small%2520molecule%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D410%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Carmeliet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">Molecular mechanisms and clinical applications of angiogenesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">473</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=473&publication_year=2011&pages=298-307&author=P.+Carmelietauthor=R.+K.+Jain&title=Molecular+mechanisms+and+clinical+applications+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DMolecular%2520mechanisms%2520and%2520clinical%2520applications%2520of%2520angiogenesis%26jtitle%3DNature%26date%3D2011%26volume%3D473%26spage%3D298%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Folkman, J.</span><span> </span><span class="NLM_article-title">Angiogenesis: an organizing principle for drug discovery?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=273-286&author=J.+Folkman&title=Angiogenesis%3A+an+organizing+principle+for+drug+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DAngiogenesis%253A%2520an%2520organizing%2520principle%2520for%2520drug%2520discovery%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D273%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lee, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sells Galvin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peery, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidler, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gough, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palkowitz, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moxham, C. M.</span><span> </span><span class="NLM_article-title">Open innovation for phenotypic drug discovery: the PD2 assay panel</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">588</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1177%2F1087057111405379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=21521801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFWmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=588-602&author=J.+A.+Leeauthor=S.+Chuauthor=F.+S.+Willardauthor=K.+L.+Coxauthor=R.+J.+Sells+Galvinauthor=R.+B.+Peeryauthor=S.+E.+Oliverauthor=J.+Olerauthor=T.+D.+Meredithauthor=S.+A.+Heidlerauthor=W.+H.+Goughauthor=S.+Husainauthor=A.+D.+Palkowitzauthor=C.+M.+Moxham&title=Open+innovation+for+phenotypic+drug+discovery%3A+the+PD2+assay+panel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Open innovation for phenotypic drug discovery: the PD2 assay panel</span></div><div class="casAuthors">Lee, Jonathan A.; Chu, Shaoyou; Willard, Francis S.; Cox, Karen L.; Sells Galvin, Rachelle J.; Peery, Robert B.; Oliver, Sarah E.; Oler, Jennifer; Meredith, Tamika D.; Heidler, Steven A.; Gough, Wendy H.; Husain, Saba; Palkowitz, Alan D.; Moxham, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">588-602</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Phenotypic lead generation strategies seek to identify compds. that modulate complex, physiol. relevant systems, an approach that is complementary to traditional, target-directed strategies.  Unlike gene-specific assays, phenotypic assays interrogate multiple mol. targets and signaling pathways in a target "agnostic" fashion, which may reveal novel functions for well-studied proteins and discover new pathways of therapeutic value.  Significantly, existing compd. libraries may not have sufficient chem. diversity to fully leverage a phenotypic strategy.  To address this issue, Eli Lilly and Company launched the Phenotypic Drug Discovery Initiative (PD2), a model of open innovation whereby external research groups can submit compds. for testing in a panel of Lilly phenotypic assays.  This communication describes the statistical validation, operations, and initial screening results from the first PD2 assay panel.  Anal. of PD2 submissions indicates that chem. diversity from open source collaborations complements internal sources.  Screening results for the first 4691 compds. submitted to PD2 have confirmed hit rates from 1.6% to 10%, with the majority of active compds. exhibiting acceptable potency and selectivity.  Phenotypic lead generation strategies, in conjunction with novel chem. diversity obtained via open-source initiatives such as PD2, may provide a means to identify compds. that modulate biol. by novel mechanisms and expand the innovation potential of drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXGGH-5y93H7Vg90H21EOLACvtfcHk0lgYZITxWemL4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFWmtb0%253D&md5=091f68b96728f356ddbc30461531878b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1177%2F1087057111405379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057111405379%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DChu%26aufirst%3DS.%26aulast%3DWillard%26aufirst%3DF.%2BS.%26aulast%3DCox%26aufirst%3DK.%2BL.%26aulast%3DSells%2BGalvin%26aufirst%3DR.%2BJ.%26aulast%3DPeery%26aufirst%3DR.%2BB.%26aulast%3DOliver%26aufirst%3DS.%2BE.%26aulast%3DOler%26aufirst%3DJ.%26aulast%3DMeredith%26aufirst%3DT.%2BD.%26aulast%3DHeidler%26aufirst%3DS.%2BA.%26aulast%3DGough%26aufirst%3DW.%2BH.%26aulast%3DHusain%26aufirst%3DS.%26aulast%3DPalkowitz%26aufirst%3DA.%2BD.%26aulast%3DMoxham%26aufirst%3DC.%2BM.%26atitle%3DOpen%2520innovation%2520for%2520phenotypic%2520drug%2520discovery%253A%2520the%2520PD2%2520assay%2520panel%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2011%26volume%3D16%26spage%3D588%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Traktuev, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merfeld-Clauss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolonin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arap, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasqualini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traktuev, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merfeld-Clauss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolonin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arap, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasqualini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, K. L.</span><span> </span><span class="NLM_article-title">A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2008&pages=77-85&author=D.+O.+Traktuevauthor=S.+Merfeld-Claussauthor=J.+Liauthor=M.+Koloninauthor=W.+Arapauthor=R.+Pasqualiniauthor=B.+H.+Johnstoneauthor=K.+L.+Marchauthor=D.+O.+Traktuevauthor=S.+Merfeld-Claussauthor=J.+Liauthor=M.+Koloninauthor=W.+Arapauthor=R.+Pasqualiniauthor=B.+H.+Johnstoneauthor=K.+L.+March&title=A+population+of+multipotent+CD34-positive+adipose+stromal+cells+share+pericyte+and+mesenchymal+surface+markers%2C+reside+in+a+periendothelial+location%2C+and+stabilize+endothelial+networks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraktuev%26aufirst%3DD.%2BO.%26aulast%3DMerfeld-Clauss%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DKolonin%26aufirst%3DM.%26aulast%3DArap%26aufirst%3DW.%26aulast%3DPasqualini%26aufirst%3DR.%26aulast%3DJohnstone%26aufirst%3DB.%2BH.%26aulast%3DMarch%26aufirst%3DK.%2BL.%26aulast%3DTraktuev%26aufirst%3DD.%2BO.%26aulast%3DMerfeld-Clauss%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DKolonin%26aufirst%3DM.%26aulast%3DArap%26aufirst%3DW.%26aulast%3DPasqualini%26aufirst%3DR.%26aulast%3DJohnstone%26aufirst%3DB.%2BH.%26aulast%3DMarch%26aufirst%3DK.%2BL.%26atitle%3DA%2520population%2520of%2520multipotent%2520CD34-positive%2520adipose%2520stromal%2520cells%2520share%2520pericyte%2520and%2520mesenchymal%2520surface%2520markers%252C%2520reside%2520in%2520a%2520periendothelial%2520location%252C%2520and%2520stabilize%2520endothelial%2520networks%26jtitle%3DCirc.%2520Res.%26date%3D2008%26volume%3D102%26spage%3D77%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Traktuev, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prater, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merfeld-Clauss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanjeevaiah, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saadatzadeh, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, K. L.</span><span> </span><span class="NLM_article-title">Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">1410</span><span class="NLM_x">–</span> <span class="NLM_lpage">1420</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=1410-1420&author=D.+O.+Traktuevauthor=D.+N.+Praterauthor=S.+Merfeld-Claussauthor=A.+R.+Sanjeevaiahauthor=M.+R.+Saadatzadehauthor=M.+Murphyauthor=B.+H.+Johnstoneauthor=D.+A.+Ingramauthor=K.+L.+March&title=Robust+functional+vascular+network+formation+in+vivo+by+cooperation+of+adipose+progenitor+and+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraktuev%26aufirst%3DD.%2BO.%26aulast%3DPrater%26aufirst%3DD.%2BN.%26aulast%3DMerfeld-Clauss%26aufirst%3DS.%26aulast%3DSanjeevaiah%26aufirst%3DA.%2BR.%26aulast%3DSaadatzadeh%26aufirst%3DM.%2BR.%26aulast%3DMurphy%26aufirst%3DM.%26aulast%3DJohnstone%26aufirst%3DB.%2BH.%26aulast%3DIngram%26aufirst%3DD.%2BA.%26aulast%3DMarch%26aufirst%3DK.%2BL.%26atitle%3DRobust%2520functional%2520vascular%2520network%2520formation%2520in%2520vivo%2520by%2520cooperation%2520of%2520adipose%2520progenitor%2520and%2520endothelial%2520cells%26jtitle%3DCirc.%2520Res.%26date%3D2009%26volume%3D104%26spage%3D1410%26epage%3D1420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Crawford, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span> </span><span class="NLM_article-title">VEGF inhibition: insights from preclinical and clinical studies</span> <span class="citation_source-journal">Cell Tissue Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1007%2Fs00441-008-0675-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=18766380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOru7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2009&pages=261-269&author=Y.+Crawfordauthor=N.+Ferrara&title=VEGF+inhibition%3A+insights+from+preclinical+and+clinical+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">VEGF inhibition: insights from preclinical and clinical studies</span></div><div class="casAuthors">Crawford, Yongping; Ferrara, Napoleone</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">261-269</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Angiogenesis, the growth of new blood vessels, is required for a variety of normal proliferative processes.  Furthermore, angiogenesis is well established as also playing an important role in neoplastic growth and metastasis.  Numerous regulators of angiogenesis have been identified and characterized over the last few decades.  Among these, vascular endothelial growth factor (VEGF)-A appears esp. important in several pathophysiol. processes.  Several VEGF inhibitors have been approved, by the US Food and Drug Administration, for the treatment of tumors or age-releted macular degeneration.  This review examines the various mouse tumor models in which VEGF inhibitors have been tested and the lessons learned from these studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC9mphpYUfmrVg90H21EOLACvtfcHk0lj0kgeRKXM58g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOru7vP&md5=6ed8038e44bf8a90f4e38c2fe0a08b80</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00441-008-0675-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-008-0675-8%26sid%3Dliteratum%253Aachs%26aulast%3DCrawford%26aufirst%3DY.%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DVEGF%2520inhibition%253A%2520insights%2520from%2520preclinical%2520and%2520clinical%2520studies%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2009%26volume%3D335%26spage%3D261%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Low, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stancato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, J. J.</span><span> </span><span class="NLM_article-title">Prioritizing hits from phenotypic high-content screens</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=338-345&author=J.+Lowauthor=L.+Stancatoauthor=J.+Leeauthor=J.+J.+Sutherland&title=Prioritizing+hits+from+phenotypic+high-content+screens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLow%26aufirst%3DJ.%26aulast%3DStancato%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSutherland%26aufirst%3DJ.%2BJ.%26atitle%3DPrioritizing%2520hits%2520from%2520phenotypic%2520high-content%2520screens%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26spage%3D338%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Adams, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alitalo, K.</span><span> </span><span class="NLM_article-title">Molecular regulation of angiogenesis and lymphangiogenesis</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnrm2183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=17522591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFOhsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=464-78&author=R.+H.+Adamsauthor=K.+Alitalo&title=Molecular+regulation+of+angiogenesis+and+lymphangiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular regulation of angiogenesis and lymphangiogenesis</span></div><div class="casAuthors">Adams, Ralf H.; Alitalo, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">464-478</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Blood vessels and lymphatic vessels form extensive networks that are essential for the transport of fluids, gases, macromols. and cells within the large and complex bodies of vertebrates.  Both of these vascular structures are lined with endothelial cells that integrate functionally into different organs, acquire tissue-specific specialization and retain plasticity; thereby, they permit growth during tissue repair or in disease settings.  The angiogenic growth of blood vessels and lymphatic vessels coordinates several biol. processes such as cell proliferation, guided migration, differentiation and cell-cell communication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDGRnfeGDxYLVg90H21EOLACvtfcHk0lj0kgeRKXM58g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFOhsb4%253D&md5=0e4f15ad376fb7a34a783efb77f4fdc5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrm2183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2183%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DR.%2BH.%26aulast%3DAlitalo%26aufirst%3DK.%26atitle%3DMolecular%2520regulation%2520of%2520angiogenesis%2520and%2520lymphangiogenesis%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D464%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Terstappen, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlupen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raggiaschi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaviraghi, G.</span><span> </span><span class="NLM_article-title">Target deconvolution strategies in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">–</span> <span class="NLM_lpage">903</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=891-903&author=G.+C.+Terstappenauthor=C.+Schlupenauthor=R.+Raggiaschiauthor=G.+Gaviraghi&title=Target+deconvolution+strategies+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerstappen%26aufirst%3DG.%2BC.%26aulast%3DSchlupen%26aufirst%3DC.%26aulast%3DRaggiaschi%26aufirst%3DR.%26aulast%3DGaviraghi%26aufirst%3DG.%26atitle%3DTarget%2520deconvolution%2520strategies%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D891%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hart, C. P.</span><span> </span><span class="NLM_article-title">Finding the target after screening the phenotype</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1016%2FS1359-6446%2805%2903415-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=15809197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivV2hs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=513-519&author=C.+P.+Hart&title=Finding+the+target+after+screening+the+phenotype"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Finding the target after screening the phenotype</span></div><div class="casAuthors">Hart, Charles P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">513-519</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Phenotype-based screening is accompanied by the challenge of identifying the mol. target or targets bound by the drug leads.  There are several techniques available for target identification after phenotypic screening, including direct and indirect approaches.  Here, the advantages and limitations assocd. with these technologies are reviewed.  Although most screening for new drug leads is being directed at known or emerging mol. targets, there has been a renaissance in screening based on changes in cell or organismal phenotypes.  Phenotype-based screening is accompanied by the challenge of identifying the mol. target or targets bound by the drug leads and responsible for their pharmacol. activity.  A variety of technologies and approaches are being explored for target identification after phenotypic screening.  Direct approaches employing affinity chromatog., expression cloning and protein microarrays analyze the compd. bound to its target.  Indirect approaches are based on comparison of the genome-wide activity profile of the compd. with databases of the activity profiles of other compds. with known targets or activity profiles following specific genetic changes.  This review will use case studies of target identification efforts and highlight the advantages and disadvantages of the various approaches to target identification after phenotypic screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqpg6P5ire9rVg90H21EOLACvtfcHk0lj0kgeRKXM58g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivV2hs7Y%253D&md5=6cc0459ae66b2ea689f130bc10eee804</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903415-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903415-X%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DC.%2BP.%26atitle%3DFinding%2520the%2520target%2520after%2520screening%2520the%2520phenotype%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D513%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Targeting the cancer kinome through polypharmacology</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnrc2787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=20094047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Clug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=130-137&author=Z.+A.+Knightauthor=H.+Linauthor=K.+M.+Shokat&title=Targeting+the+cancer+kinome+through+polypharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cancer kinome through polypharmacology</span></div><div class="casAuthors">Knight, Zachary A.; Lin, Henry; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-137</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Kinase inhibitors are the largest class of new cancer drugs.  However, it is already apparent that most tumors can escape from the inhibition of any single kinase.  If it is necessary to inhibit multiple kinases, how do we choose which ones.  In this Opinion article, we discuss some of the strategies that are currently being used to identify new therapeutic combinations of kinase targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkDv2FeeH58rVg90H21EOLACvtfcHk0lhmgw6FBDgjow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Clug%253D%253D&md5=9aaa314e54b43889e147a9f11ac77072</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrc2787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2787%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DTargeting%2520the%2520cancer%2520kinome%2520through%2520polypharmacology%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D130%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Lee, J. A.; Cox, K.; Kriauciunas, A.; Chu, S.</span><span> </span><span class="NLM_article-title">The Roles of High Content Cellular Imaging in Lead Optimization</span>. In  <span class="citation_source-book">High Content Screening: Science, Techniques, and Applications</span>; <span class="NLM_contrib-group">Haney, S.</span>, Ed.; <span class="NLM_publisher-name">Wiley-Interscience</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1002%2F9780470229866.ch11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=249-268&author=J.+A.+Lee&author=K.+Cox&author=A.+Kriauciunas&author=S.+Chuauthor=S.+Haney&title=High+Content+Screening%3A+Science%2C+Techniques%2C+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2F9780470229866.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470229866.ch11%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520Roles%2520of%2520High%2520Content%2520Cellular%2520Imaging%2520in%2520Lead%2520Optimization%26btitle%3DHigh%2520Content%2520Screening%253A%2520Science%252C%2520Techniques%252C%2520and%2520Applications%26aulast%3DHaney%26aufirst%3DS.%26pub%3DWiley-Interscience%26date%3D2008%26spage%3D249%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Gough, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulkower, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlynn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhlik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. A.</span><span> </span><span class="NLM_article-title">A quantitative, facile, and high-throughput image-based cell migration method is a robust alternative to the scratch assay</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1177%2F1087057110393340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=21297103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A280%3ADC%252BC3M7ntFOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=155-163&author=W.+Goughauthor=K.+I.+Hulkowerauthor=R.+Lynchauthor=P.+McGlynnauthor=M.+Uhlikauthor=L.+Yanauthor=J.+A.+Lee&title=A+quantitative%2C+facile%2C+and+high-throughput+image-based+cell+migration+method+is+a+robust+alternative+to+the+scratch+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative, facile, and high-throughput image-based cell migration method is a robust alternative to the scratch assay</span></div><div class="casAuthors">Gough Wendy; Hulkower Keren I; Lynch Renee; McGlynn Patrick; Uhlik Mark; Yan Lei; Lee Jonathan A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-63</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cell migration is a key phenotype for a number of therapeutically important biological responses, including angiogenesis.  A commonly used method to assess cell migration is the scratch assay, which measures the movement of cells into a wound made by physically scoring a confluent cell monolayer to create an area devoid of cells.  Although this method has been adequate for qualitative characterization of migration inhibitors, it does not provide the highly reproducible results required for quantitative compound structure-activity relationship evaluation because of the inconsistent size and placement of the wound area within the microplate well.  The Oris® Cell Migration Assay presents a superior alternative to the scratch assay, permitting formation of precisely placed and homogeneously sized cell-free areas into which migration can occur without releasing factors from wounded or dead cells or damaging the underlying extracellular matrix.  Herein the authors compare results from the scratch and Oris® cell migration assays using an endothelial progenitor cell line and the Src kinase inhibitor dasatinib.  They find that using the Acumen® Explorer laser microplate cytometer in combination with the Oris® Cell Migration Assay plate provides a robust, efficient, and cost-effective cell migration assay exhibiting excellent signal to noise, plate uniformity, and statistical validation metrics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTNP3aK0jreAmyYR5VtavbzfW6udTcc2eamP7uZoEUr07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7ntFOltA%253D%253D&md5=ec6e7c0f4b0e855f43fbf6d8d33da8d2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1177%2F1087057110393340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057110393340%26sid%3Dliteratum%253Aachs%26aulast%3DGough%26aufirst%3DW.%26aulast%3DHulkower%26aufirst%3DK.%2BI.%26aulast%3DLynch%26aufirst%3DR.%26aulast%3DMcGlynn%26aufirst%3DP.%26aulast%3DUhlik%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DJ.%2BA.%26atitle%3DA%2520quantitative%252C%2520facile%252C%2520and%2520high-throughput%2520image-based%2520cell%2520migration%2520method%2520is%2520a%2520robust%2520alternative%2520to%2520the%2520scratch%2520assay%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2011%26volume%3D16%26spage%3D155%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Eastwood, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmen, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iversen, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallwood, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbison, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delapp, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. F.</span><span> </span><span class="NLM_article-title">The minimum significant ratio: a statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1177%2F1087057105285611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=16490778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A280%3ADC%252BD283mvVyhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=253-261&author=B.+J.+Eastwoodauthor=M.+W.+Farmenauthor=P.+W.+Iversenauthor=T.+J.+Craftauthor=J.+K.+Smallwoodauthor=K.+E.+Garbisonauthor=N.+W.+Delappauthor=G.+F.+Smith&title=The+minimum+significant+ratio%3A+a+statistical+parameter+to+characterize+the+reproducibility+of+potency+estimates+from+concentration-response+assays+and+estimation+by+replicate-experiment+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The minimum significant ratio: a statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies</span></div><div class="casAuthors">Eastwood Brian J; Farmen Mark W; Iversen Philip W; Craft Trelia J; Smallwood Jeffrey K; Garbison Kim E; Delapp Neil W; Smith Gerald F</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-61</span>
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    </div><div class="casAbstract">The authors show by illustration that procedures used to validate the reliability of single-concentration high-throughput screens such as the signal window and Z' factor do not ensure sufficient reliability in potency estimates from concentration response assays.  They develop the minimum significant ratio as a statistical parameter to characterize the fold change between 2 compounds run in the same experiment that can be considered a real difference and use this parameter to characterize the reliability of the assay.  They adapt methods described by Bland and Altman to develop a simple set of 2 experiments to estimate the minimum significant ratio and show that this protocol can identify assays that lack reproducibility.  The methods are then extended to validate the equivalency of the same assay run by multiple laboratories.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcE509f3H8OukdrW1FkXG-fW6udTcc2eamP7uZoEUr07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283mvVyhug%253D%253D&md5=df12ee03e938b7b16652a0ddd77a1a93</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1177%2F1087057105285611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057105285611%26sid%3Dliteratum%253Aachs%26aulast%3DEastwood%26aufirst%3DB.%2BJ.%26aulast%3DFarmen%26aufirst%3DM.%2BW.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DCraft%26aufirst%3DT.%2BJ.%26aulast%3DSmallwood%26aufirst%3DJ.%2BK.%26aulast%3DGarbison%26aufirst%3DK.%2BE.%26aulast%3DDelapp%26aufirst%3DN.%2BW.%26aulast%3DSmith%26aufirst%3DG.%2BF.%26atitle%3DThe%2520minimum%2520significant%2520ratio%253A%2520a%2520statistical%2520parameter%2520to%2520characterize%2520the%2520reproducibility%2520of%2520potency%2520estimates%2520from%2520concentration-response%2520assays%2520and%2520estimation%2520by%2520replicate-experiment%2520studies%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2006%26volume%3D11%26spage%3D253%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delves, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magny, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandel, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3827</span><span class="NLM_x">–</span> <span class="NLM_lpage">3838</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200108t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3827-3838&author=C.+W.+Chungauthor=H.+Costeauthor=J.+H.+Whiteauthor=O.+Mirguetauthor=J.+Wildeauthor=R.+L.+Gosminiauthor=C.+Delvesauthor=S.+M.+Magnyauthor=R.+Woodwardauthor=S.+A.+Hughesauthor=E.+V.+Boursierauthor=H.+Flynnauthor=A.+M.+Bouillotauthor=P.+Bamboroughauthor=J.+M.+Brusqauthor=F.+J.+Gellibertauthor=E.+J.+Jonesauthor=A.+M.+Riouauthor=P.+Homesauthor=S.+L.+Martinauthor=I.+J.+Uingsauthor=J.+Toumauthor=C.+A.+Clementauthor=A.+B.+Boullayauthor=R.+L.+Grimleyauthor=F.+M.+Blandelauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=J.+Kirilovskyauthor=E.+Nicodeme&title=Discovery+and+characterization+of+small+molecule+inhibitors+of+the+BET+family+bromodomains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span></div><div class="casAuthors">Chung, Chun-wa; Coste, Herve; White, Julia H.; Mirguet, Olivier; Wilde, Jonathan; Gosmini, Romain L.; Delves, Chris; Magny, Sylvie M.; Woodward, Robert; Hughes, Stephen A.; Boursier, Eric V.; Flynn, Helen; Bouillot, Anne M.; Bamborough, Paul; Brusq, Jean-Marie G.; Gellibert, Francoise J.; Jones, Emma J.; Riou, Alizon M.; Homes, Paul; Martin, Sandrine L.; Uings, Iain J.; Toum, Jerome; Clement, Catherine A.; Boullay, Anne-Benedicte; Grimley, Rachel L.; Blandel, Florence M.; Prinjha, Rab K.; Lee, Kevin; Kirilovsky, Jorge; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3827-3838</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epigenetic mechanisms of gene regulation have a profound role in normal development and disease processes.  An integral part of this mechanism occurs through lysine acetylation of histone tails which are recognized by bromodomains.  While the biol. and structural characterization of many bromodomain contg. proteins has advanced considerably, the therapeutic tractability of this protein family is only now becoming understood.  This paper describes the discovery and mol. characterization of potent (nM) small mol. inhibitors that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4).  By using a combination of phenotypic screening, chemoproteomics, and biophys. studies, we have discovered that the protein-protein interactions between bromodomains and acetylated histones can be antagonized by selective small mols. that bind at the acetylated lysine recognition pocket.  X-ray crystal structures of compds. bound into bromodomains of Brd2 and Brd4 elucidate the mol. interactions of binding and explain the precisely defined stereochem. required for activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8VauuYkT5YLVg90H21EOLACvtfcHk0licyMxSiSO1qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D&md5=ebc0f6062321dece877259d775f1c19b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm200108t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200108t%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%2BH.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DWilde%26aufirst%3DJ.%26aulast%3DGosmini%26aufirst%3DR.%2BL.%26aulast%3DDelves%26aufirst%3DC.%26aulast%3DMagny%26aufirst%3DS.%2BM.%26aulast%3DWoodward%26aufirst%3DR.%26aulast%3DHughes%26aufirst%3DS.%2BA.%26aulast%3DBoursier%26aufirst%3DE.%2BV.%26aulast%3DFlynn%26aufirst%3DH.%26aulast%3DBouillot%26aufirst%3DA.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DGellibert%26aufirst%3DF.%2BJ.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DRiou%26aufirst%3DA.%2BM.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%2BL.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DC.%2BA.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DGrimley%26aufirst%3DR.%2BL.%26aulast%3DBlandel%26aufirst%3DF.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520small%2520molecule%2520inhibitors%2520of%2520the%2520BET%2520family%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3827%26epage%3D3838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Park, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Y.</span><span> </span><span class="NLM_article-title">Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1alpha protein-dependent mechanism</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">2306</span><span class="NLM_x">–</span> <span class="NLM_lpage">2316</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1002%2Fijc.25589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=20715173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVSrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2011&pages=2306-2316&author=S.+Y.+Parkauthor=J.+H.+Kangauthor=K.+J.+Jeongauthor=J.+Leeauthor=J.+W.+Hanauthor=W.+S.+Choiauthor=Y.+K.+Kimauthor=J.+Kangauthor=C.+G.+Parkauthor=H.+Y.+Lee&title=Norepinephrine+induces+VEGF+expression+and+angiogenesis+by+a+hypoxia-inducible+factor-1alpha+protein-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism</span></div><div class="casAuthors">Park, Soon-Young; Kang, Joo-Hee; Jeong, Kang-Jin; Lee, Jang-Soon; Han, Jeong-Whan; Choi, Wahn-Soo; Kim, Yong-Kee; Kang, Jae-Ku; Park, Chang-Gyo; Lee, Hoi Young</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2306-2316</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A growing no. of studies have demonstrated that physiol. factors can influence the progression of several cancers via cellular immune function, angiogenesis and metastasis.  Recently, stress-induced catecholamines have been shown to increase the expression of various cancer progressive factors, including vascular endothelial growth factor (VEGF), matrix metalloproteinases and interleukins.  However, a detailed mechanism remains to be identified.  In this study, we investigated the role of adrenergic receptors and hypoxia-inducible factor (HIF)-1α protein in catecholamine-induced VEGF expression and angiogenesis.  Treatment of the cells with norepinephrine (NE) or isoproterenol induced VEGF expression and HIF-1α protein amt. in a dose-dependent manner.  Induction of VEGF expression by NE was abrogated when the cells were transfected with HIF-1α-specific siRNA.  Similarly, adenylate cyclase activator forskolin and cAMP-dependent protein kinase A inhibitor H-89 enhanced and decreased HIF-1α protein amt., resp.  More importantly, conditioned medium of NE-stimulated cancer cells induced angiogenesis in a HIF-1α protein-dependent manner.  In addn., pretreatment of cells with propranolol, a β-adrenergic receptor (AR) blocker, completely abolished induction of VEGF expression and HIF-1α protein amt. by NE in all of the tested cancer cells.  However, treatment with the α1-AR blocker prazosin inhibited NE-induced HIF-1α protein amt. and angiogenesis in SK-Hep1 and PC-3 but not MDA-MB-231 cells.  Collectively, our results suggest that ARs and HIF-1α protein have crit. roles in NE-induced VEGF expression in cancer cells, leading to stimulation of angiogenesis.  These findings will help to understand the mechanism of cancer progression by stress-induced catecholamines and design therapeutic strategies for cancer angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdNsc4TlCL8bVg90H21EOLACvtfcHk0licyMxSiSO1qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVSrs70%253D&md5=ca91c902a32df0c253d920aa8ff03de6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fijc.25589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25589%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DKang%26aufirst%3DJ.%2BH.%26aulast%3DJeong%26aufirst%3DK.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DJ.%2BW.%26aulast%3DChoi%26aufirst%3DW.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BK.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DC.%2BG.%26aulast%3DLee%26aufirst%3DH.%2BY.%26atitle%3DNorepinephrine%2520induces%2520VEGF%2520expression%2520and%2520angiogenesis%2520by%2520a%2520hypoxia-inducible%2520factor-1alpha%2520protein-dependent%2520mechanism%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2011%26volume%3D128%26spage%3D2306%26epage%3D2316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Asada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebihara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sora, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span> </span><span class="NLM_article-title">Depletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1/2 phosphorylation</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=408-417&author=M.+Asadaauthor=S.+Ebiharaauthor=S.+Yamandaauthor=K.+Niuauthor=T.+Okazakiauthor=I.+Soraauthor=H.+Arai&title=Depletion+of+serotonin+and+selective+inhibition+of+2B+receptor+suppressed+tumor+angiogenesis+by+inhibiting+endothelial+nitric+oxide+synthase+and+extracellular+signal-regulated+kinase+1%2F2+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsada%26aufirst%3DM.%26aulast%3DEbihara%26aufirst%3DS.%26aulast%3DYamanda%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DK.%26aulast%3DOkazaki%26aufirst%3DT.%26aulast%3DSora%26aufirst%3DI.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DDepletion%2520of%2520serotonin%2520and%2520selective%2520inhibition%2520of%25202B%2520receptor%2520suppressed%2520tumor%2520angiogenesis%2520by%2520inhibiting%2520endothelial%2520nitric%2520oxide%2520synthase%2520and%2520extracellular%2520signal-regulated%2520kinase%25201%252F2%2520phosphorylation%26jtitle%3DNeoplasia%26date%3D2009%26volume%3D11%26spage%3D408%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Muthig, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilsbach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haubold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivacevic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hein, L.</span><span> </span><span class="NLM_article-title">Upregulation of soluble vascular endothelial growth factor receptor 1 contributes to angiogenesis defects in the placenta of alpha 2B-adrenoceptor deficient mice</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=682-691&author=V.+Muthigauthor=R.+Gilsbachauthor=M.+Hauboldauthor=M.+Philippauthor=T.+Ivacevicauthor=M.+Gesslerauthor=L.+Hein&title=Upregulation+of+soluble+vascular+endothelial+growth+factor+receptor+1+contributes+to+angiogenesis+defects+in+the+placenta+of+alpha+2B-adrenoceptor+deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuthig%26aufirst%3DV.%26aulast%3DGilsbach%26aufirst%3DR.%26aulast%3DHaubold%26aufirst%3DM.%26aulast%3DPhilipp%26aufirst%3DM.%26aulast%3DIvacevic%26aufirst%3DT.%26aulast%3DGessler%26aufirst%3DM.%26aulast%3DHein%26aufirst%3DL.%26atitle%3DUpregulation%2520of%2520soluble%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%25201%2520contributes%2520to%2520angiogenesis%2520defects%2520in%2520the%2520placenta%2520of%2520alpha%25202B-adrenoceptor%2520deficient%2520mice%26jtitle%3DCirc.%2520Res.%26date%3D2007%26volume%3D101%26spage%3D682%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Vahlensieck, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pridzun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichenbach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinnen, A.</span><span> </span><span class="NLM_article-title">Identification of the yeast ACC1 gene product (acetyl-CoA carboxylase) as the target of the polyketide fungicide soraphen A</span> <span class="citation_source-journal">Curr. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1007%2FBF00309532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=7916271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADyaK2cXksFekt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=95-100&author=H.+F.+Vahlensieckauthor=L.+Pridzunauthor=H.+Reichenbachauthor=A.+Hinnen&title=Identification+of+the+yeast+ACC1+gene+product+%28acetyl-CoA+carboxylase%29+as+the+target+of+the+polyketide+fungicide+soraphen+A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the yeast ACC1 gene product (acetyl-CoA carboxylase) as the target of the polyketide fungicide soraphen A</span></div><div class="casAuthors">Vahlensieck, H. F.; Pridzun, L.; Reichenbach, H.; Hinnen, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Genetics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-100</span>CODEN:
                <span class="NLM_cas:coden">CUGED5</span>;
        ISSN:<span class="NLM_cas:issn">0172-8083</span>.
    </div><div class="casAbstract">Soraphen A, a polyketide isolated from the myxobacterium Sorangium cellulosum, is a potent inhibitor of fungal growth.  The authors have used a genetic approach to localize the target of this drug, employing Saccharomyces cerevisiae as a model organism.  The authors have isolated soraphen A-resistant mutants and found that all of them map at the same genetic locus and exhibit a broad range of semidominant phenotypes.  Data from genetic crosses of soraphen A-resistant clones with an acc1 mutant revealed that ACC1, coding for acetyl-CoA carboxylase (E.C. 6.4.1.2), is tightly linked to soraphen A resistance.  Partially-purified enzyme exts. contg. acetyl-CoA carboxylase were prepd. and assayed for their soraphen A sensitivity.  The authors' expts. showed that the catalytic activity of the wild-type enzyme is inhibited in vitro by soraphen A while the mutant enzyme remains catalytically active.  Taken together these data strongly suggest that the ACC1 gene product is the primary target for soraphen A in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqPfaLATS617Vg90H21EOLACvtfcHk0liQKUaLYkGOTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFekt7k%253D&md5=c635af44a644c11be2966f1841801640</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2FBF00309532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00309532%26sid%3Dliteratum%253Aachs%26aulast%3DVahlensieck%26aufirst%3DH.%2BF.%26aulast%3DPridzun%26aufirst%3DL.%26aulast%3DReichenbach%26aufirst%3DH.%26aulast%3DHinnen%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520the%2520yeast%2520ACC1%2520gene%2520product%2520%2528acetyl-CoA%2520carboxylase%2529%2520as%2520the%2520target%2520of%2520the%2520polyketide%2520fungicide%2520soraphen%2520A%26jtitle%3DCurr.%2520Genet.%26date%3D1994%26volume%3D25%26spage%3D95%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Jump, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres-Gonzalez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, L. K.</span><span> </span><span class="NLM_article-title">Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2011&pages=649-660&author=D.+B.+Jumpauthor=M.+Torres-Gonzalezauthor=L.+K.+Olson&title=Soraphen+A%2C+an+inhibitor+of+acetyl+CoA+carboxylase+activity%2C+interferes+with+fatty+acid+elongation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJump%26aufirst%3DD.%2BB.%26aulast%3DTorres-Gonzalez%26aufirst%3DM.%26aulast%3DOlson%26aufirst%3DL.%2BK.%26atitle%3DSoraphen%2520A%252C%2520an%2520inhibitor%2520of%2520acetyl%2520CoA%2520carboxylase%2520activity%252C%2520interferes%2520with%2520fatty%2520acid%2520elongation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D81%26spage%3D649%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Izumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusakabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hikita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwao, H.</span><span> </span><span class="NLM_article-title">Pravastatin accelerates ischemia-induced angiogenesis through AMP-activated protein kinase</span> <span class="citation_source-journal">Hypertens. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fhr.2009.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=19498441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1WksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=675-679&author=Y.+Izumiauthor=M.+Shiotaauthor=H.+Kusakabeauthor=Y.+Hikitaauthor=T.+Nakaoauthor=Y.+Nakamuraauthor=T.+Muroauthor=K.+Miuraauthor=M.+Yoshiyamaauthor=H.+Iwao&title=Pravastatin+accelerates+ischemia-induced+angiogenesis+through+AMP-activated+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Pravastatin accelerates ischemia-induced angiogenesis through AMP-activated protein kinase</span></div><div class="casAuthors">Izumi, Yasukatsu; Shiota, Masayuki; Kusakabe, Hiromi; Hikita, Yuko; Nakao, Takafumi; Nakamura, Yasuhiro; Muro, Takashi; Miura, Katsuyuki; Yoshiyama, Minoru; Iwao, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">675-679</span>CODEN:
                <span class="NLM_cas:coden">HRESE4</span>;
        ISSN:<span class="NLM_cas:issn">0916-9636</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Statins exert pleiotropic effects on the cardiovascular system, in part through an increase in nitric oxide (NO) bioavailability.  In this study, we examd. the role of pravastatin in ischemia-induced angiogenesis.  Unilateral hindlimb ischemia was surgically induced in C57BL/6J mice.  Phosphorylation of AMP-activated protein kinase (AMPK), acetyl-CoA carboxylase (ACC) and endothelial NO synthase (eNOS) was increased in ischemic tissues.  Furthermore, mice treated with pravastatin showed higher increases in phosphorylation than did untreated mice.  Laser Doppler anal. has shown that pravastatin treatment accelerates the development of collateral vessels and angiogenesis in response to hindlimb ischemia.  Capillary d. in the ischemic hindlimb was also increased by pravastatin treatment.  An in vitro study on human umbilical vein endothelial cells (HUVECs) revealed that pravastatin increased the phosphorylation of AMPK.  Pravastatin-induced phosphorylation of eNOS, one of the downstreams of AMPK, was inhibited by compd. C, an AMPK antagonist.  The increased migration and tube formation of HUVECs by pravastatin were significantly blocked by compd. C treatment.  The accelerated angiogenesis by pravastatin after hindlimb ischemia was significantly reduced after treatment with compd. C. Thus, ischemia induced AMPK phosphorylation in vivo.  Furthermore, pravastatin could also activate AMPK in vivo and in vitro.  Such phosphorylation results in eNOS activation and angiogenesis, which provide a novel explanation for one of the pleiotropic effects of statins that is beneficial for angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4xmsXTCyuTLVg90H21EOLACvtfcHk0liQKUaLYkGOTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1WksLo%253D&md5=37bbbe7e8e123fbc22493d1f7fa3e3f9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fhr.2009.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fhr.2009.77%26sid%3Dliteratum%253Aachs%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DShiota%26aufirst%3DM.%26aulast%3DKusakabe%26aufirst%3DH.%26aulast%3DHikita%26aufirst%3DY.%26aulast%3DNakao%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DMuro%26aufirst%3DT.%26aulast%3DMiura%26aufirst%3DK.%26aulast%3DYoshiyama%26aufirst%3DM.%26aulast%3DIwao%26aufirst%3DH.%26atitle%3DPravastatin%2520accelerates%2520ischemia-induced%2520angiogenesis%2520through%2520AMP-activated%2520protein%2520kinase%26jtitle%3DHypertens.%2520Res.%26date%3D2009%26volume%3D32%26spage%3D675%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Stahmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spengler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heslegrave, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viollet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, R.</span><span> </span><span class="NLM_article-title">Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">10638</span><span class="NLM_x">–</span> <span class="NLM_lpage">10652</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=10638-10652&author=N.+Stahmannauthor=A.+Woodsauthor=K.+Spenglerauthor=A.+Heslegraveauthor=R.+Bauerauthor=S.+Krauseauthor=B.+Violletauthor=D.+Carlingauthor=R.+Heller&title=Activation+of+AMP-activated+protein+kinase+by+vascular+endothelial+growth+factor+mediates+endothelial+angiogenesis+independently+of+nitric-oxide+synthase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStahmann%26aufirst%3DN.%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DSpengler%26aufirst%3DK.%26aulast%3DHeslegrave%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DR.%26aulast%3DKrause%26aufirst%3DS.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DCarling%26aufirst%3DD.%26aulast%3DHeller%26aufirst%3DR.%26atitle%3DActivation%2520of%2520AMP-activated%2520protein%2520kinase%2520by%2520vascular%2520endothelial%2520growth%2520factor%2520mediates%2520endothelial%2520angiogenesis%2520independently%2520of%2520nitric-oxide%2520synthase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D10638%26epage%3D10652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=Beta-secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0lg51-fR2qtfEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DBeta-secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Kopan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeter, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weintraub, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nye, J. S.</span><span> </span><span class="NLM_article-title">Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1683</span><span class="NLM_x">–</span> <span class="NLM_lpage">1688</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=1683-1688&author=R.+Kopanauthor=E.+H.+Schroeterauthor=H.+Weintraubauthor=J.+S.+Nye&title=Signal+transduction+by+activated+mNotch%3A+importance+of+proteolytic+processing+and+its+regulation+by+the+extracellular+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopan%26aufirst%3DR.%26aulast%3DSchroeter%26aufirst%3DE.%2BH.%26aulast%3DWeintraub%26aufirst%3DH.%26aulast%3DNye%26aufirst%3DJ.%2BS.%26atitle%3DSignal%2520transduction%2520by%2520activated%2520mNotch%253A%2520importance%2520of%2520proteolytic%2520processing%2520and%2520its%2520regulation%2520by%2520the%2520extracellular%2520domain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D1683%26epage%3D1688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Boulton, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, M. B.</span><span> </span><span class="NLM_article-title">gamma-Secretase: a multifaceted regulator of angiogenesis</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1111%2Fj.1582-4934.2008.00274.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=18266961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlCrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=781-795&author=M.+E.+Boultonauthor=J.+Caiauthor=M.+B.+Grant&title=gamma-Secretase%3A+a+multifaceted+regulator+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase: a multifaceted regulator of angiogenesis</span></div><div class="casAuthors">Boulton, Michael E.; Cai, Jun; Grant, Maria B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">781-795</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Physiol. angiogenesis is essential for development, homeostasis and tissue repair but pathol. neovascularization is a major feature of tumors, rheumatoid arthritis, and ocular complications.  Studies over the last decade have identified γ-secretase (I), a presenilin-dependent protease, as a key regulator of angiogenesis through: (1) regulated intramembrane proteolysis and transmembrane cleavage of receptors (e.g., VEGFR-1, Notch, ErbB-4, and IGFI-R) followed by translocation of the intracellular domain to the nucleus; (2) translocation of full length membrane-bound receptors to the nucleus (VEGFR-1); (3) phosphorylation of membrane bound proteins (VEGFR-1 and ErbB-4); (4) modulation of adherens junctions (cadherin) and regulation of permeability; and (5) cleavage of amyloid precursor protein to amyloid-β which is able to regulate the angiogenic process.  The I-induced translocation of receptors to the nucleus provides an alternative intracellular signaling pathway, which acts as a potent regulator of transcription.  I is a complex composed of 4 different integral proteins (presenilin, nicastrin, Aph-1, and Pen-2), which det. the stability, substrate binding, substrate specificity, and proteolytic activity of I.  This seeming complexity allows numerous possibilities for the development of targeted I agonists/antagonists, which can specifically regulate the angiogenic process.  Here, the authors consider the structure and function of I, the growing evidence for its role in angiogenesis and the substrates involved, I as a therapeutic target, and future challenges in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofMkO5vC81e7Vg90H21EOLACvtfcHk0lg51-fR2qtfEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlCrt7g%253D&md5=3ee783ce0b1a3a4d8ea356553a6dd885</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00274.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00274.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoulton%26aufirst%3DM.%2BE.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DGrant%26aufirst%3DM.%2BB.%26atitle%3Dgamma-Secretase%253A%2520a%2520multifaceted%2520regulator%2520of%2520angiogenesis%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2008%26volume%3D12%26spage%3D781%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Majercak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolffe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getty, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shughrue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosahl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koblan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabrook, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, D. J.</span><span> </span><span class="NLM_article-title">LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer’s disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17967</span><span class="NLM_x">–</span> <span class="NLM_lpage">17972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17967-17972&author=J.+Majercakauthor=W.+J.+Rayauthor=A.+Espesethauthor=A.+Simonauthor=X.+P.+Shiauthor=C.+Wolffeauthor=K.+Gettyauthor=S.+Marineauthor=E.+Stecauthor=M.+Ferrerauthor=B.+Struloviciauthor=S.+Bartzauthor=A.+Gatesauthor=M.+Xuauthor=Q.+Huangauthor=L.+Maauthor=P.+Shughrueauthor=J.+Burchardauthor=D.+Colussiauthor=B.+Pietrakauthor=J.+Kahanaauthor=D.+Beherauthor=T.+Rosahlauthor=M.+Shearmanauthor=D.+Hazudaauthor=A.+B.+Sachsauthor=K.+S.+Koblanauthor=G.+R.+Seabrookauthor=D.+J.+Stone&title=LRRTM3+promotes+processing+of+amyloid-precursor+protein+by+BACE1+and+is+a+positional+candidate+gene+for+late-onset+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMajercak%26aufirst%3DJ.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DEspeseth%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DShi%26aufirst%3DX.%2BP.%26aulast%3DWolffe%26aufirst%3DC.%26aulast%3DGetty%26aufirst%3DK.%26aulast%3DMarine%26aufirst%3DS.%26aulast%3DStec%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DStrulovici%26aufirst%3DB.%26aulast%3DBartz%26aufirst%3DS.%26aulast%3DGates%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DShughrue%26aufirst%3DP.%26aulast%3DBurchard%26aufirst%3DJ.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DKahana%26aufirst%3DJ.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DRosahl%26aufirst%3DT.%26aulast%3DShearman%26aufirst%3DM.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DSachs%26aufirst%3DA.%2BB.%26aulast%3DKoblan%26aufirst%3DK.%2BS.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DStone%26aufirst%3DD.%2BJ.%26atitle%3DLRRTM3%2520promotes%2520processing%2520of%2520amyloid-precursor%2520protein%2520by%2520BACE1%2520and%2520is%2520a%2520positional%2520candidate%2520gene%2520for%2520late-onset%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17967%26epage%3D17972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Child, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divito, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span> </span><span class="NLM_article-title">Loss of function of ATXN1 increases amyloid beta-protein levels by potentiating beta-secretase processing of beta-amyloid precursor protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">8515</span><span class="NLM_x">–</span> <span class="NLM_lpage">8526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=8515-8526&author=C.+Zhangauthor=A.+Browneauthor=D.+Childauthor=J.+R.+Divitoauthor=J.+A.+Stevensonauthor=R.+E.+Tanzi&title=Loss+of+function+of+ATXN1+increases+amyloid+beta-protein+levels+by+potentiating+beta-secretase+processing+of+beta-amyloid+precursor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DBrowne%26aufirst%3DA.%26aulast%3DChild%26aufirst%3DD.%26aulast%3DDivito%26aufirst%3DJ.%2BR.%26aulast%3DStevenson%26aufirst%3DJ.%2BA.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26atitle%3DLoss%2520of%2520function%2520of%2520ATXN1%2520increases%2520amyloid%2520beta-protein%2520levels%2520by%2520potentiating%2520beta-secretase%2520processing%2520of%2520beta-amyloid%2520precursor%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D8515%26epage%3D8526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Westmeyer, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Multhaup, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assfalg-Machleidt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Dimerization of beta-site beta-amyloid precursor protein-cleaving enzyme</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">53205</span><span class="NLM_x">–</span> <span class="NLM_lpage">53212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=53205-53212&author=G.+G.+Westmeyerauthor=M.+Willemauthor=S.+F.+Lichtenthalerauthor=G.+Lurmanauthor=G.+Multhaupauthor=I.+Assfalg-Machleidtauthor=K.+Reissauthor=P.+Saftigauthor=C.+Haass&title=Dimerization+of+beta-site+beta-amyloid+precursor+protein-cleaving+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestmeyer%26aufirst%3DG.%2BG.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DLurman%26aufirst%3DG.%26aulast%3DMulthaup%26aufirst%3DG.%26aulast%3DAssfalg-Machleidt%26aufirst%3DI.%26aulast%3DReiss%26aufirst%3DK.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DDimerization%2520of%2520beta-site%2520beta-amyloid%2520precursor%2520protein-cleaving%2520enzyme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D53205%26epage%3D53212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Multhaup, G.</span><span> </span><span class="NLM_article-title">Amyloid precursor protein and BACE function as oligomers</span> <span class="citation_source-journal">Neurodegener. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1159%2F000095266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=17047367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2hu7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=270-274&author=G.+Multhaup&title=Amyloid+precursor+protein+and+BACE+function+as+oligomers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid precursor protein and BACE function as oligomers</span></div><div class="casAuthors">Multhaup, Gerd</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">270-274</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Processing of the amyloid precursor protein (APP) by β- and γ-secretases leads to the generation of amyloid-β (Aβ) peptides, which are the toxic agents in the pathogenesis of Alzheimer's disease.  The mol. reasons for the sequential Aβ generation by secretase activities have remained unclear.  Our studies support an oligomerization-dependent mechanism for the conversion of APP into Aβ.  By different lines of evidence, we showed that APP is capable of forming homodimers and tetramers.  Oligomerization of APP occurs in a zipper-like mechanism primarily mediated by two highly conserved sites of the ectodomain.  We also found that in human brain tissue β-secretase (BACE) occurred as a dimer, whereas the sol. ectodomain of truncated BACE exclusively occurred in the monomeric form.  A mutational anal. of the active sites supports the idea that BACE might have acquired a specific catalytic activity by oligomerization, which is stabilized through the transmembrane and the cytoplasmic domains.  Our results predict that APP homodimers are functionally active within the plasma membrane and most likely represent substrates for BACE oligomers.  Understanding the mol. tasks of homophilic binding of substrates and secretases will allow to find secretase inhibitors which specifically bind to contact sites of dimers and thus inhibit Aβ formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmaKif2dpsC7Vg90H21EOLACvtfcHk0lg8cCck50INBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2hu7nO&md5=1e910cfa116440363488a03b85977438</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1159%2F000095266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000095266%26sid%3Dliteratum%253Aachs%26aulast%3DMulthaup%26aufirst%3DG.%26atitle%3DAmyloid%2520precursor%2520protein%2520and%2520BACE%2520function%2520as%2520oligomers%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2006%26volume%3D3%26spage%3D270%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Paris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadros, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelleDonne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullan, M.</span><span> </span><span class="NLM_article-title">Inhibition of angiogenesis and tumor growth by beta and gamma-secretase inhibitors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">514</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1016%2Fj.ejphar.2005.02.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=15878319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=514&publication_year=2005&pages=1-15&author=D.+Parisauthor=A.+Quadrosauthor=N.+Patelauthor=A.+DelleDonneauthor=J.+Humphreyauthor=M.+Mullan&title=Inhibition+of+angiogenesis+and+tumor+growth+by+beta+and+gamma-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of angiogenesis and tumor growth by β and γ-secretase inhibitors</span></div><div class="casAuthors">Paris, Daniel; Quadros, Amita; Patel, Nikunj; DelleDonne, Anthony; Humphrey, James; Mullan, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">514</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The involvement of β-secretase and γ-secretase in producing the β-amyloid component of senile plaques found in the brain of Alzheimer's patients has fueled a major research effort to design selective inhibitors of these proteases.  Interestingly, γ-secretase cleaves several proteins including Notch, E-cadherin, CD44 and ErbB-4 (erythroblastic leukemia viral oncogene homolog 4), which are important modulators of angiogenesis.  The β-amyloid precursor protein, which is cleaved by β-secretase and γ-secretase to produce β-amyloid, is highly expressed in the endothelium of neoforming vessels suggesting that it might play a role during angiogenesis.  These data prompted us to explore the effects of β and γ-secretase inhibitors of different structures on angiogenesis and tumor growth.  Both the γ and β-secretase inhibitors tested reduce endothelial cell proliferation without inducing cellular toxicity, suppress the formation of capillary structures in vitro and oppose the sprouting of microvessel outgrowths in the rat aortic ring model of angiogenesis.  Moreover, they potently inhibit the growth and vascularization of human glioblastoma and human lung adenocarcinoma tumors xenotransplanted into nude mice.  Altogether these data suggest that the γ and β-secretases play an essential role during angiogenesis and that inhibitors of the β and γ-secretases may constitute new classes of anti-angiogenic and anti-tumoral compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1y0XOIrQfe7Vg90H21EOLACvtfcHk0lg8cCck50INBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOhtrs%253D&md5=ae559ec177f22f9bcaf3f47cf5b3a081</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.02.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.02.050%26sid%3Dliteratum%253Aachs%26aulast%3DParis%26aufirst%3DD.%26aulast%3DQuadros%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DDelleDonne%26aufirst%3DA.%26aulast%3DHumphrey%26aufirst%3DJ.%26aulast%3DMullan%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520angiogenesis%2520and%2520tumor%2520growth%2520by%2520beta%2520and%2520gamma-secretase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D514%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Prinz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlange, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asadullah, K.</span><span> </span><span class="NLM_article-title">Believe it or not: how much can we rely on published data on potential drug targets?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=712&author=F.+Prinzauthor=T.+Schlangeauthor=K.+Asadullah&title=Believe+it+or+not%3A+how+much+can+we+rely+on+published+data+on+potential+drug+targets%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrinz%26aufirst%3DF.%26aulast%3DSchlange%26aufirst%3DT.%26aulast%3DAsadullah%26aufirst%3DK.%26atitle%3DBelieve%2520it%2520or%2520not%253A%2520how%2520much%2520can%2520we%2520rely%2520on%2520published%2520data%2520on%2520potential%2520drug%2520targets%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Lumpkin, M.; Woodcock, J.; Zoon, K.</span> <span class="citation_source-book">Guidance for Industry: Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well Characterized, Therapeutic, Biotechnology-Derived Products</span>; <span class="NLM_publisher-name">Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research</span>: <span class="NLM_publisher-loc">Rockville, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">1995</span><span class="NLM_x">; </span>p 10.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=M.+Lumpkin&author=J.+Woodcock&author=K.+Zoon&title=Guidance+for+Industry%3A+Content+and+Format+of+Investigational+New+Drug+Applications+%28INDs%29+for+Phase+1+Studies+of+Drugs%2C+Including+Well+Characterized%2C+Therapeutic%2C+Biotechnology-Derived+Products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLumpkin%26aufirst%3DM.%26btitle%3DGuidance%2520for%2520Industry%253A%2520Content%2520and%2520Format%2520of%2520Investigational%2520New%2520Drug%2520Applications%2520%2528INDs%2529%2520for%2520Phase%25201%2520Studies%2520of%2520Drugs%252C%2520Including%2520Well%2520Characterized%252C%2520Therapeutic%252C%2520Biotechnology-Derived%2520Products%26pub%3DCenter%2520for%2520Drug%2520Evaluation%2520and%2520Research%2520and%2520Center%2520for%2520Biologics%2520Evaluation%2520and%2520Research%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span> </span><span class="NLM_article-title">Biochemical mechanisms of new molecular entities (NMEs) approved by United States FDA during 2001–2004: mechanisms leading to optimal efficacy and safety</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.2174%2F156802606776743093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=16719803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtV2jurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=461-478&author=D.+C.+Swinney&title=Biochemical+mechanisms+of+new+molecular+entities+%28NMEs%29+approved+by+United+States+FDA+during+2001%E2%80%932004%3A+mechanisms+leading+to+optimal+efficacy+and+safety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical mechanisms of new molecular entities (NMEs) approved by United States FDA during 2001-2004: mechanisms leading to optimal efficacy and safety</span></div><div class="casAuthors">Swinney, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">461-478</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The United States FDA approved 85 New Mol. Entities (NMEs) during the period from Jan. 2001 to Nov. 2004 of which 60 were pharmaceuticals with known mol. targets.  The majority targeted enzymes (48%) or G-protein coupled receptors (GPCRs) (33%).  Eighty percent of the NMEs interacted at the same site as endogenous effector; either as competitive inhibitor/antagonist (67%) or agonist (13%).  Three biochem. operations defined the modes of action of the NMEs: (1) mass action competition (equil.), (2) a drug stabilized conformational change in the target that is important to the response (conformational), and(or) (3) drug action is less-responsive to mass action competition with effectors due to non-equil. kinetics (non-equil. kinetic).  Approx. 80% of the NMEs elicit a response utilizing conformational and(or) non-equil. kinetic mechanisms.  The remaining 20% of NMEs find mass action competition with the endogenous substrate or ligand sufficient for therapeutic utility.  These observations indicate that for the majority of drug targets, mass action-driven equil. binding alone may not be sufficient for maximal therapeutic utility.  A key determinant of the biochem. mode of action for these NMEs was to minimize the potential for toxicity, either by providing a maximal response at a low dose to minimize off-target toxicities, or by providing a mechanism to minimize the incidence of mechanism-based toxicity while retaining a sufficiently efficacious response.  This principle appears to be independent of target class and provides insight as to intrinsic biochem. features and approaches required for a maximal therapeutic index.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7meEijEZ3GrVg90H21EOLACvtfcHk0lgFGcj7mYeNfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtV2jurs%253D&md5=091dc5bf90bf465ccf21160bd9140067</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F156802606776743093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776743093%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26atitle%3DBiochemical%2520mechanisms%2520of%2520new%2520molecular%2520entities%2520%2528NMEs%2529%2520approved%2520by%2520United%2520States%2520FDA%2520during%25202001%25E2%2580%25932004%253A%2520mechanisms%2520leading%2520to%2520optimal%2520efficacy%2520and%2520safety%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D461%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Can we rationally design promiscuous drugs?</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1016%2Fj.sbi.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=16442279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=127-136&author=A.+L.+Hopkinsauthor=J.+S.+Masonauthor=J.+P.+Overington&title=Can+we+rationally+design+promiscuous+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Can we rationally design promiscuous drugs?</span></div><div class="casAuthors">Hopkins, Andrew L.; Mason, Jonathan S.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug design is now used widely in modern medicinal chem.  The application of structural biol. to medicinal chem. has heralded the 'rational drug design' vision of discovering exquisitely selective ligands.  However, recent advances in post-genomic biol. are indicating that polypharmacol. may be a necessary trait for the efficacy of many drugs, therefore questioning the 'one drug, one target' assumption of current rational drug design.  By combining advances in chemoinformatics and structural biol., it might be possible to rationally design the next generation of promiscuous drugs with polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWdh60x9AHrVg90H21EOLACvtfcHk0lgFGcj7mYeNfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D&md5=8f9e95a41976b8e3ac790f2fff2c406f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCan%2520we%2520rationally%2520design%2520promiscuous%2520drugs%253F%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Mestres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregori-Puigjane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valverde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sole, R. V.</span><span> </span><span class="NLM_article-title">The topology of drug–target interaction networks: implicit dependence on drug properties and target families</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1051</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1039%2Fb905821b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=19668871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1Kksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=1051-1057&author=J.+Mestresauthor=E.+Gregori-Puigjaneauthor=S.+Valverdeauthor=R.+V.+Sole&title=The+topology+of+drug%E2%80%93target+interaction+networks%3A+implicit+dependence+on+drug+properties+and+target+families"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The topology of drug-target interaction networks: Implicit dependence on drug properties and target families</span></div><div class="casAuthors">Mestres, Jordi; Gregori-Puigjane, Elisabet; Valverde, Sergi; Sole, Ricard V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1051-1057</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The availability of interaction data between small mol. drugs and protein targets has increased substantially in recent years.  Using seven different databases, we were able to assemble a total of 4767 unique interactions between 802 drugs and 480 targets, which means that on av. every drug is currently acknowledged to interact with 6 targets.  The application of network theory to the anal. of these data reveals an unexpectedly complex picture of drug-target interactions.  The results confirm that the topol. of drug-target networks depends implicitly on data completeness, drug properties, and target families.  The implications for drug discovery are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNAnnU4e6Jl7Vg90H21EOLACvtfcHk0lgFGcj7mYeNfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1Kksbo%253D&md5=a0999bf0521936fba03400554411e8d7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1039%2Fb905821b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb905821b%26sid%3Dliteratum%253Aachs%26aulast%3DMestres%26aufirst%3DJ.%26aulast%3DGregori-Puigjane%26aufirst%3DE.%26aulast%3DValverde%26aufirst%3DS.%26aulast%3DSole%26aufirst%3DR.%2BV.%26atitle%3DThe%2520topology%2520of%2520drug%25E2%2580%2593target%2520interaction%2520networks%253A%2520implicit%2520dependence%2520on%2520drug%2520properties%2520and%2520target%2520families%26jtitle%3DMol.%2520BioSyst.%26date%3D2009%26volume%3D5%26spage%3D1051%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Garnier, J. P.</span><span> </span><span class="NLM_article-title">Rebuilding the R&D engine in big pharma</span> <span class="citation_source-journal">Harv. Bus. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><div class="note"><p class="first last">72–6, 128.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=18543809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A280%3ADC%252BD1czns1arug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=68-70&author=J.+P.+Garnier&title=Rebuilding+the+R%26D+engine+in+big+pharma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Rebuilding the R&D engine in big pharma</span></div><div class="casAuthors">Garnier Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Harvard business review</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">68-70, 72-6, 128</span>
        ISSN:<span class="NLM_cas:issn">0017-8012</span>.
    </div><div class="casAbstract">From December 2000 to February 2008, the top 15 companies in the pharmaceutical industry lost roughly $850 billion in shareholder value.  Although a number of factors--including the rise of generics, pricing pressures, regulatory requirements, and legal entanglements--are to blame, Garnier, the CEO of GlaxoSmithKline, believes that declining R&D productivity is his industry's primary problem.  The way to solve it, he says, is to return power to the scientists--by reorganizing R&D into highly focused groups headed by inspirational leaders, seeking the best science outside as well as inside a company, fixing broken processes, and promoting a strong culture of innovation and passion for excellence.  GSK has replaced its organizational pyramid with 12 "centers of excellence.  The company has worked to untangle the quest for breakthrough drugs from the effort to develop best-in-class offerings and has overhauled incentives for the scientists who actually make discoveries.  It has also pursued contractual relationships with academia and biotech companies in a bid to secure the best science, wherever it may reside.  When the company began a sweeping reengineering of its R&D, it had only two products in late-stage development.  Today it has 34--the most in the industry.  But much more remains to be done, the author says.  Significant cost efficiencies could be achieved by offshoring clinical trials.  Development of new blockbuster drugs could be simplified and accelerated if researchers targeted only a limited segment of the potential patient population and then expanded to others over time.  The innovation malaise in pharmaceuticals is not unique, Garnier says.  Many other industries face the same challenges.  A cultural revolution and a broad transformation of the organization are necessary first steps to rebuilding the R&D engine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvsDraBS9Q3YHWj6b1v8uTfW6udTcc2eY71lNZX1llGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czns1arug%253D%253D&md5=c7c719004c9b33d42944a20cdfa53b28</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarnier%26aufirst%3DJ.%2BP.%26atitle%3DRebuilding%2520the%2520R%2526D%2520engine%2520in%2520big%2520pharma%26jtitle%3DHarv.%2520Bus.%2520Rev.%26date%3D2008%26volume%3D86%26spage%3D68%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Munos, B.</span><span> </span><span class="NLM_article-title">Can open-source drug R&D repower pharmaceutical innovation?</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fclpt.2010.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=20407458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A280%3ADC%252BC3c3nslamtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2010&pages=534-536&author=B.+Munos&title=Can+open-source+drug+R%26D+repower+pharmaceutical+innovation%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Can open-source drug R&D repower pharmaceutical innovation?</span></div><div class="casAuthors">Munos B</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">534-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Open-source R&D initiatives are multiplying across biomedical research.  Some of them-such as public-private partnerships-have achieved notable success in bringing new drugs to market economically, whereas others reflect the pharmaceutical industry's efforts to retool its R&D model.  Is open innovation the answer to the innovation crisis? This Commentary argues that although it may likely be part of the solution, significant cultural, scientific, and regulatory barriers can prevent it from delivering on its promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAiiHGLxu2vpagfuraLLzSfW6udTcc2eY71lNZX1llGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3nslamtQ%253D%253D&md5=1b4605c16a25e79195e5fa3cb7a66a8f</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2010.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2010.26%26sid%3Dliteratum%253Aachs%26aulast%3DMunos%26aufirst%3DB.%26atitle%3DCan%2520open-source%2520drug%2520R%2526D%2520repower%2520pharmaceutical%2520innovation%253F%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2010%26volume%3D87%26spage%3D534%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Ma, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zemmel, R.</span><span> </span><span class="NLM_article-title">Value of novelty?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=571-572&author=P.+Maauthor=R.+Zemmel&title=Value+of+novelty%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%26aulast%3DZemmel%26aufirst%3DR.%26atitle%3DValue%2520of%2520novelty%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D571%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Flordellis, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manolis, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paris, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karabinis, A.</span><span> </span><span class="NLM_article-title">Rethinking target discovery in polygenic diseases</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1791</span><span class="NLM_x">–</span> <span class="NLM_lpage">1798</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.2174%2F156802606778194226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=17017957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCgsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1791-1798&author=C.+S.+Flordellisauthor=A.+S.+Manolisauthor=H.+Parisauthor=A.+Karabinis&title=Rethinking+target+discovery+in+polygenic+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Rethinking target discovery in polygenic diseases</span></div><div class="casAuthors">Flordellis, Christodoulos S.; Manolis, Antonis S.; Paris, Herve; Karabinis, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1791-1798</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Despite an extraordinary investment in R&D the yield of successful new drugs has been disproportionately low in recent years, suggesting that the whole process of drug development requires rethinking and reform.  Most analyses on this issue focus on mol. target discovery considerations.  Target identification is characterized by a surplus of potential targets, but there is a translational bottleneck primarily due to limitations of currently employed target validation platforms.  Meanwhile, the clin. entities, to which treatments are directed, are also highly complex in terms of pathophysiol. mechanisms and manifestations.  In the present study we discuss the limitations of current mol. target discovery approaches mainly in regard to selectivity and efficacy.  We also describe the constraints imposed on drug development by the current diagnostic constructs and the tendency towards dissecting the complex clin. phenotypes to component intermediate phenotypes.  Finally, we describe how the reconsideration of mol. and clin. targets in polygenic diseases may lead to new strategies of pharmacol. intervention directed against component dysfunctions, rather than the whole complex phenotype.  Such strategies involve the combination of single ligands that act selectively on multiple mols. involved in a particular disease, or the employment of "multi-targeted" drugs, i.e. single drug mols. that hit selectively multiple receptors sharing common binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNNx-xJ_B6bVg90H21EOLACvtfcHk0ljvcQ0UTQVxjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCgsLnP&md5=360d99f61a2dd180aa83f05f79b1f250</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F156802606778194226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778194226%26sid%3Dliteratum%253Aachs%26aulast%3DFlordellis%26aufirst%3DC.%2BS.%26aulast%3DManolis%26aufirst%3DA.%2BS.%26aulast%3DParis%26aufirst%3DH.%26aulast%3DKarabinis%26aufirst%3DA.%26atitle%3DRethinking%2520target%2520discovery%2520in%2520polygenic%2520diseases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1791%26epage%3D1798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Lindsay, M. A.</span><span> </span><span class="NLM_article-title">Target discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=831-8&author=M.+A.+Lindsay&title=Target+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindsay%26aufirst%3DM.%2BA.%26atitle%3DTarget%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D831%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Edwards, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span> </span><span class="NLM_article-title">Open access chemical and clinical probes to support drug discovery</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1038%2Fnchembio0709-436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=19536100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVags7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=436-40&author=A.+M.+Edwardsauthor=C.+Bountraauthor=D.+J.+Kerrauthor=T.+M.+Willson&title=Open+access+chemical+and+clinical+probes+to+support+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Open access chemical and clinical probes to support drug discovery</span></div><div class="casAuthors">Edwards, Aled M.; Bountra, Chas; Kerr, David J.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">436-440</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society.  Duplication could be reduced, and productivity could be increased, by performing basic biol. and clin. proofs of concept within open access industry-academia partnerships.  Chem. biologists could play a central role in this effort.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEVfmfLQWObLVg90H21EOLACvtfcHk0lgsKVPPCrgOSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVags7g%253D&md5=fada9d85153aeb065c0130889be2160f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnchembio0709-436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio0709-436%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DKerr%26aufirst%3DD.%2BJ.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DOpen%2520access%2520chemical%2520and%2520clinical%2520probes%2520to%2520support%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D436%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Fishman, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. A.</span><span> </span><span class="NLM_article-title">Pharmaceuticals: a new grammar for drug discovery</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2005&pages=491-493&author=M.+C.+Fishmanauthor=J.+A.+Porter&title=Pharmaceuticals%3A+a+new+grammar+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFishman%26aufirst%3DM.%2BC.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26atitle%3DPharmaceuticals%253A%2520a%2520new%2520grammar%2520for%2520drug%2520discovery%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D491%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Mullard, A.</span><span> </span><span class="NLM_article-title">Reliability of “new drug target” claims called into question</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=643-644&author=A.+Mullard&title=Reliability+of+%E2%80%9Cnew+drug+target%E2%80%9D+claims+called+into+question"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DReliability%2520of%2520%25E2%2580%259Cnew%2520drug%2520target%25E2%2580%259D%2520claims%2520called%2520into%2520question%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D643%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Appels, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beijnen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schellens, J. H.</span><span> </span><span class="NLM_article-title">Development of farnesyl transferase inhibitors: a review</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=565-578&author=N.+M.+Appelsauthor=J.+H.+Beijnenauthor=J.+H.+Schellens&title=Development+of+farnesyl+transferase+inhibitors%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppels%26aufirst%3DN.%2BM.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26atitle%3DDevelopment%2520of%2520farnesyl%2520transferase%2520inhibitors%253A%2520a%2520review%26jtitle%3DOncologist%26date%3D2005%26volume%3D10%26spage%3D565%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Fingleton, B.</span><span> </span><span class="NLM_article-title">MMPs as therapeutic targets—still a viable option?</span> <span class="citation_source-journal">Semin. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=61-68&author=B.+Fingleton&title=MMPs+as+therapeutic+targets%E2%80%94still+a+viable+option%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFingleton%26aufirst%3DB.%26atitle%3DMMPs%2520as%2520therapeutic%2520targets%25E2%2580%2594still%2520a%2520viable%2520option%253F%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2008%26volume%3D19%26spage%3D61%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Boyce, S.; Hill, R.</span> <span class="citation_source-book">Proceedings of the 9th World Congress on Pain</span>; <span class="NLM_contrib-group">Devor, M.</span>, Ed.; <span class="NLM_publisher-name">International Association for the Study of Pain Press</span>: <span class="NLM_publisher-loc">Vienna, Austria</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=313-324&author=S.+Boyce&author=R.+Hillauthor=M.+Devor&title=Proceedings+of+the+9th+World+Congress+on+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBoyce%26aufirst%3DS.%26btitle%3DProceedings%2520of%2520the%25209th%2520World%2520Congress%2520on%2520Pain%26aulast%3DDevor%26aufirst%3DM.%26pub%3DInternational%2520Association%2520for%2520the%2520Study%2520of%2520Pain%2520Press%26date%3D2000%26spage%3D313%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Overington, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">How many drug targets are there?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=993-996&author=J.+P.+Overingtonauthor=B.+Al-Lazikaniauthor=A.+L.+Hopkins&title=How+many+drug+targets+are+there%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DHow%2520many%2520drug%2520targets%2520are%2520there%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D993%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Martin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kofron, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traphagen, L. M.</span><span> </span><span class="NLM_article-title">Do Structurally Similar Molecules Have Similar Biological Activity?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4350</span><span class="NLM_x">–</span> <span class="NLM_lpage">4358</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020155c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4350-4358&author=Y.+C.+Martinauthor=J.+L.+Kofronauthor=L.+M.+Traphagen&title=Do+Structurally+Similar+Molecules+Have+Similar+Biological+Activity%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm020155c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020155c%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DY.%2BC.%26aulast%3DKofron%26aufirst%3DJ.%2BL.%26aulast%3DTraphagen%26aufirst%3DL.%2BM.%26atitle%3DDo%2520Structurally%2520Similar%2520Molecules%2520Have%2520Similar%2520Biological%2520Activity%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4350%26epage%3D4358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Yoder, M. C.</span><span> </span><span class="NLM_article-title">Is endothelium the origin of endothelial progenitor cells?</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1161%2FATVBAHA.109.191635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=20453169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1alsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=1094-1103&author=M.+C.+Yoder&title=Is+endothelium+the+origin+of+endothelial+progenitor+cells%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Is Endothelium the Origin of Endothelial Progenitor Cells?</span></div><div class="casAuthors">Yoder, Mervin C.</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1094-1103</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Endothelial cells provide the dynamic lining of blood vessels throughout the body and provide many tissue-specific functions, in addn. to providing a nonthrombogenic surface for blood cells and conduit for oxygen and nutrient delivery.  As might be expected, some endothelial cells are injured or become senescent and are sloughed into the bloodstream, and most circulating endothelial cells display evidence of undergoing apoptosis or necrosis.  However, there are rare viable circulating endothelial cells that display properties consistent with those of a progenitor cell for the endothelial lineage.  This article reviews historical and current literature to present some evidence that the endothelial lining of blood vessels may serve as a source for rare endothelial colony-forming cells that display clonal proliferative potential, self-renewal, and in vivo vessel forming ability.  The article also discusses the current gaps in our knowledge to prove whether the colony-forming cells are in fact derived from vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtajvMrsPh2LVg90H21EOLACvtfcHk0lgsKVPPCrgOSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1alsbg%253D&md5=8ea613403cbd88dbc71c9af4d29daa1b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.109.191635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.109.191635%26sid%3Dliteratum%253Aachs%26aulast%3DYoder%26aufirst%3DM.%2BC.%26atitle%3DIs%2520endothelium%2520the%2520origin%2520of%2520endothelial%2520progenitor%2520cells%253F%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2010%26volume%3D30%26spage%3D1094%26epage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Alberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennessy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagelos, P. R.</span><span> </span><span class="NLM_article-title">Regulation of lipid synthesis in cultured animal cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">249</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=249&publication_year=1974&pages=5241-5249&author=A.+W.+Albertsauthor=K.+Fergusonauthor=S.+Hennessyauthor=P.+R.+Vagelos&title=Regulation+of+lipid+synthesis+in+cultured+animal+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlberts%26aufirst%3DA.%2BW.%26aulast%3DFerguson%26aufirst%3DK.%26aulast%3DHennessy%26aufirst%3DS.%26aulast%3DVagelos%26aufirst%3DP.%2BR.%26atitle%3DRegulation%2520of%2520lipid%2520synthesis%2520in%2520cultured%2520animal%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1974%26volume%3D249%26spage%3D5241%26epage%3D5249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Bijleveld, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geelen, M. J.</span><span> </span><span class="NLM_article-title">Measurement of acetyl-CoA carboxylase activity in isolated hepatocytes</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">918</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=918&publication_year=1987&pages=274-283&author=C.+Bijleveldauthor=M.+J.+Geelen&title=Measurement+of+acetyl-CoA+carboxylase+activity+in+isolated+hepatocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBijleveld%26aufirst%3DC.%26aulast%3DGeelen%26aufirst%3DM.%2BJ.%26atitle%3DMeasurement%2520of%2520acetyl-CoA%2520carboxylase%2520activity%2520in%2520isolated%2520hepatocytes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1987%26volume%3D918%26spage%3D274%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Zhang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldenburg, K. R.</span><span> </span><span class="NLM_article-title">A simple statistical parameter for use in evaluation and validation of high throughput screening assays</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm201649s&amp;key=10.1177%2F108705719900400206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm201649s&amp;key=10838414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=67-73&author=J.+H.+Zhangauthor=T.+D.+Chungauthor=K.+R.+Oldenburg&title=A+simple+statistical+parameter+for+use+in+evaluation+and+validation+of+high+throughput+screening+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span></div><div class="casAuthors">Zhang; Chung; Oldenburg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ability to identify active compounds (3hits2) from large chemical libraries accurately and rapidly has been the ultimate goal in developing high-throughput screening (HTS) assays.  The ability to identify hits from a particular HTS assay depends largely on the suitability or quality of the assay used in the screening.  The criteria or parameters for evaluating the 3suitability2 of an HTS assay for hit identification are not well defined and hence it still remains difficult to compare the quality of assays directly.  In this report, a screening window coefficient, called 3Z-factor,2 is defined.  This coefficient is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements, and therefore is suitable for assay quality assessment.  The Z-factor is a dimensionless, simple statistical characteristic for each HTS assay.  The Z-factor provides a useful tool for comparison and evaluation of the quality of assays, and can be utilized in assay optimization and validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkwW5JDdXnbsNIRw0GKUoEfW6udTcc2eYfJ_VCI4vo8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D&md5=0ec4ed2ccdd3b4a16521567a0975d31f</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1177%2F108705719900400206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400206%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DChung%26aufirst%3DT.%2BD.%26aulast%3DOldenburg%26aufirst%3DK.%2BR.%26atitle%3DA%2520simple%2520statistical%2520parameter%2520for%2520use%2520in%2520evaluation%2520and%2520validation%2520of%2520high%2520throughput%2520screening%2520assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26spage%3D67%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Butina, D.</span><span> </span><span class="NLM_article-title">Unsupervised data base clustering based on Daylight’s fingerprint and Tanimoto similarity: a fast and automated way to cluster small and large data sets</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci9803381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm201649s&amp;key=1%3ACAS%3A528%3ADyaK1MXktVWhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1999&pages=747-750&author=D.+Butina&title=Unsupervised+data+base+clustering+based+on+Daylight%E2%80%99s+fingerprint+and+Tanimoto+similarity%3A+a+fast+and+automated+way+to+cluster+small+and+large+data+sets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Unsupervised data base clustering based on Daylight's fingerprint and Tanimoto similarity: a fast and automated way to cluster small and large data sets</span></div><div class="casAuthors">Butina, Darko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">747-750</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Jarvis-Patrick's (J-P) algorithm is one of the most commonly used clustering algorithms within the global pharmaceutical industry.  The implementation of the J-P under Daylight software, using Daylight's fingerprints and the Tanimoto similarity index, can deal with sets of 100 k mols. in a matter of a few hours.  However, the J-P clustering algorithm has several assocd. problems which make it difficult to cluster large data sets in a consistent and timely manner.  The clusters produced are greatly dependent on the choice of the two parameters needed to run J-P clustering, such that this method tends to produce clusters which are either very large and heterogeneous or homogeneous but too small.  In any case, J-P always requires time-consuming manual tuning.  An algorithm which will identify dense clusters where similarity within each cluster reflects the Tanimoto value used for the clustering and, more importantly, where the cluster centroid will be at least similar, at the given Tanimoto value, to every other mol. within the cluster in a consistent and automated manner, is presented.  The similarity term used throughout the paper reflects the overall similarity between two given mols., as defined by Daylight's fingerprints and the Tanimoto similarity index.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCrA2wdJndA7Vg90H21EOLACvtfcHk0lh1cf-2SM6pjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVWhtLw%253D&md5=e11c02e1e777f88e208ec5fdc5405c47</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fci9803381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci9803381%26sid%3Dliteratum%253Aachs%26aulast%3DButina%26aufirst%3DD.%26atitle%3DUnsupervised%2520data%2520base%2520clustering%2520based%2520on%2520Daylight%25E2%2580%2599s%2520fingerprint%2520and%2520Tanimoto%2520similarity%253A%2520a%2520fast%2520and%2520automated%2520way%2520to%2520cluster%2520small%2520and%2520large%2520data%2520sets%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D1999%26volume%3D39%26spage%3D747%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201649s&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm201649s%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-10%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201649s" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999bafdded3c7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
